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Abstract
The focus o f this descriptive-comparative study was to investigate the relationships between 
potential access (race, age, socioeconomic status (SES), and the means of discovery of 
breast cancer), realized access (the length o f  time between discovery o f breast abnormality 
and diagnosis o f breast cancer, and the length o f time between diagnosis and initiation of 
breast cancer treatment), and stage at diagnosis of breast cancer, in African American and 
Caucasian women, receiving care within an equal economic access health care system. The 
research questions were answered through secondary analysis, using data obtained from the 
tumor registry records of 62 African American and 573 Caucasian women diagnosed with 
breast cancer within the Department o f Defense Military Health System, from January 1, 
1988 through December 31, 1997. Descriptive statistics were used to describe the sample 
and the study variables; and independent samples chi-square tests, t-tests, Mann Whitney U 
tests, analysis of variance, multiple regression, and logistic regression were used to analyze 
the data. Results indicate that, when compared to Caucasian women, African American 
women: (a) were diagnosed at a significantly later stage of breast cancer, (b) were 
significantly younger at the time of diagnosis, (c) were from a significantly lower SES, (d) 
had a significantly higher percentage of incidental breast self exam (BSE) discovered breast 
abnormalities, and (e) had a significantly lower percentage o f mammogram discovered 
breast abnormalities. Women with breast abnormalities discovered by incidental BSE were 
almost six times more likely to be diagnosed in late stage breast cancer than women with 
mammogram discovered breast abnormalities. There were no significant differences noted 
between African American and Caucasian women in length o f time between discovery and 
diagnosis, and length of time between diagnosis and treatment.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DEDICATION
I would like to dedicate this dissertation to:
The memory of my father, Elijah Gannon Sr., whose strong work ethic and 
tenacious approach to life taught me to persevere, and encouraged me to purpose to 
succeed.
The memory of my brother-in-law, Dr. Levi B. Baldwin Jr., whose confidence in 
me and in who God created me to be gave me the confidence to navigate uncharted 
waters.
The memory o f Eloise Lewis, whose battle with breast cancer intensified my query 
of factors related to access and stage at diagnosis of breast cancer in African American 
women.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGMENTS
I would like to express my sincere appreciation and thanks to those individuals who 
supported me during this endeavor.
To my dissertation committee:
Dr. Jane Georges, my chair, for her example, expertise, experience and 
encouragement.
Dr. Jan Harrison, for her expertise, enthusiasm, experience, and invaluable 
suggestions.
Dr. Peter Johnstone, for his mentorship, friendship, expertise, and 
enthusiasm.
To Dr. R. H. RifFenburgh, for his statistical expertise and methodological 
guidance.
To the tumor registrar assistants at Naval Medical Center San Diego, for their 
invaluable assistance, encouragement, and creation o f an enthusiastic 
environment for data collection.
To my family:
My daughter and son, Monica and Rodney Moss, for their love, patience, 
and emotional support.
My grandchildren, Meghan and Micah Moss, for their creation of healthy, 
happy, distractions on cue.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
My sisters, Etta Baldwin and Jacquelyn Ruffin, for their love, example, 
support, confidence, and encouragement.
My mother, Mary Garmon and my brother, Elijah Garmon Jr., for their 
love, support, and inspiration.
My nieces and nephews for their confidence and encouragement.
My Pastors, Russell and Barbara Plilar, for their emotional support, love, 
confidence, encouragement, and enthusiasm.
Seedtime and Harvest Church for their love, confidence, and 
encouragement.
To Cindy Lopez and Robin McKenzie, for their friendship and editorial assistance.
To my professors, for their example, encouragement, and enthusiasm.
To the United States Navy Nurse Corps for providing me with the opportunity to pursue 
this long-held goal.
Most of all, to God, Whose Strength enabled me to achieve this goal in excellence, with 
strength, and with confidence.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table o f Contents
Page
Abstract
Dedication   ii
Acknowledgments .............................................................................................  iii
List of Figures   viii
List of Tables .............................................................................................  ix
List of Appendices .............................................................................................  xi
Chapter
I. INTRODUCTION ................................................................................  1
Statement of Problem................................................................... 4
Purpose of the Study ................................................................... 6
Specific Aims.................................................................................  6
Conceptual Framework ..............................................................  8
Research Questions .................................................................. 12
Importance of the Study ............................................................  13
Definition of Terms ....................................................................  15
Assumptions................................................................................ 20
H. REVIEW OF THE LITERATURE ....................................................  21
Economic Access and Stage at Diagnosis ...............................  21
Potential Access and Stage at Diagnosis ...............................  29
Age ............................................................................  30
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Race ..................................................................................  32
Socioeconomic Status ......................................................  48
Means of Discovery o f Breast Cancer................................ 53
Realized Access and Stage at Diagnosis ...................................... 66
Diagnosis Delays ................................................................  67
Treatment Delays ...............................................................  71
Conclusion .......................................................................................  73
m . METHODOLOGY ....................................................................................  77
Design................................................................................................ 77
Setting................................................................................................ 77
Population and Sample ....................................................................  80
Instrumentation ................................................................................  81
Data Collection and Recording .......................................................  81
Data Analysis .................................................................................... 83
Limitations ....................................................................................... 86
Human Subjects ..............................................................................  87
Summary .........................................................................................  86
IV. RESULTS ....................................................................................................  88
Description of the Sample ..............................................................  88
Descriptive Analysis of the Study Variables ................................. 96
Data Analysis Related to the Research Questions...........................  101
Research Question 1.............................................................  101
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Research Question 2............................................................  115
Research Question 3............................................................  120
Research Question 4 ............................................................  125
Research Question 5............................................................  130
Presentation of Results from Supplemental Data Analysis  130
Summary ........................................................................................  145
V. SUMMARY, DISCUSSION, IMPLICATIONS,
AND CONCLUSION ...............................................................................  146
Summary of the Study ..................................................................  146
Discussion ....................................................................................  148
Implications for Nursing .............................................................  170
Practice ............................................................................ 170
Education ..............................................................  172
Research ........................................................................... 173
Conclusion ...................................................................................  177
References ..........................................................................................................  180
Appendices ........................................................................................................... 198
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List o f Figures
Figure Page
1. Framework for the Study of Access to Breast Health Care
for Women in the Military Health System ...........................................  11
2. Revised Framework for the Study of Access to Breast Health
Care for Women in the Military Health System ................................  174
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Tables
Table Page
1. American Joint Committee on Cancer Primary
Tumor Classification ....................................................................................  18
2. American Joint Committee on Cancer Lymph
Nodes Classification ....................................................................................  18
3. American Joint Committee on Cancer Distant
Metastasis Classification .......................................................................  18
4. American Joint Committee on Cancer Clinical
Staging of Breast Cancer ......................................................................  19
5. Summary of Demographic and Study Variable
Characteristics ............................................................................................  89
6. Distribution of Demographic and Study
Variable Characteristics By Race .............................................................  98
7. Relationship Between Stage at Diagnosis
and Age at Diagnosis ................................................................................ 102
8. One Way Analysis of Variance of Mean Age
at Diagnosis and Stage at Diagnosis By Race .......................................... 105
9. Relationship Between Stage at Diagnosis and
Age at Diagnosis By Race ........................................................................  106
10. Relationship Between Stage at Diagnosis and Race ...............................  107
11. Relationship Between Stage at Diagnosis and
Rank of Sponsor ....................................................................................... 109
12. Relationship Between Stage at Diagnosis and
Means o f Discovery .................................................................................  I l l
13. Distribution o f Rank o f Sponsor By Race .............................................  113
14. Distribution o f Means of Discovery By Race ........................................  114
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15. Relationship Between Stage at Diagnosis and Length
of Time Between Discovery and Diagnosis ...............................................  116
16. Relationship Between Stage at Diagnosis and Length
of Time Between Diagnosis and Treatment ...............................................  118
17. Relationship Between Age at Diagnosis and
Variables of Realized Access ......................................................................  121
18. General Regression of Age at Diagnosis, Race, SES, 
and Means of Discovery on Length of Time Between
Discovery and Diagnosis .............................................................................  123
19. Intercorrelation Matrix of Variables of
Potential Access (Length of Time Between Discovery
and Diagnosis) .............................................................................................. 124
20. General Regression of Age at Diagnosis, Race, SES, 
and Means of Discovery on Length of Time Between
Diagnosis and Treatment ............................................................................  126
21. Intercorrelation Matrix o f Variables of
Potential Access (Length of Time Between Diagnosis
and Treatment) ............................................................................................  127
22. Logistic Regression Analysis o f Late Stage at Diagnosis
as a Function of Variables o f Potential Access ........................................  129
23. Logistic Regression Analysis of Late Stage at Diagnosis
as a Function of Variables of Realized Access ......................................... 131
24. Relationship Between Variables of
Potential Access and Means o f Discovery ...............................................  133
25. Distribution o f Variables of Potential Access By Age ..............................  136
26. T Test Summary Table o f Selected Study Variables
By Means of Discovery ..............................................................................  138
27. Logistic Regression Analysis o f  Provider Discovered Breast
Abnormalities as a Function of Selected Demographic Variables .......... 140
28. Distribution of Means o f Discovery, By Year .........................................  143
x
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List o f Appendices
Appendix Page
A. Breast Cancer Medical Record Data
Collection Sheet .........................................................................  199
B. Human Subjects Letter, Naval Medical
Center San Diego ............................................................................. 201
C. Human Subjects Letter University of
San Diego .......................................................................................... 202
xi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 1 
INTRODUCTION 
Breast cancer is a major medical problem affecting the quality of life of all 
American women. Second to lung cancer as the leading cause of cancer death in women 
in the United States, breast cancer occurs in American women more often than any other 
type of cancer. From 1993 through 1995, calculated over a life time, one in every 18 
women developed invasive cancer of the lungs and bronchus, while one in every 8 women 
developed cancer o f the breast (Landis et al., 1999). In 1999, approximately 175,000 
American women will be newly diagnosed with breast cancer, and an estimated 43,300 
will die of this invasive disease (Landis, Murray, Bolden, & Wingo, 1999).
Healthy People 2000. published in 1990, set three broad goals for all Americans: 
increasing the span o f healthy life, reducing health disparities, and achieving access to 
preventive services (Department of Health and Human Services [DHHS], 1990). Healthy 
People 2000 set a specific goal o f reducing breast cancer death rates from an age adjusted 
baseline of 22.9 per 100,000 women in 1987, to no more than 20.6 per 100,000 women by 
the year 2000. In addition, Healthy People 2000 acknowledged a disparity in breast cancer 
death rates between White women and women of color; and targeted women of color for 
increased preventive services relating to breast cancer (DHHS, 1990).
The United States Bureau of Census reported (as cited in Parker, Davis, Wingo, 
Ries, & Heath, 1998), that in 1990, White Americans constituted about 84 percent o f the
1
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United States population. African Americans made up approximately 12 percent of the 
population; and Hispanics constituted about 9 percent. Asian and Pacific Islanders 
comprised about 3 percent of the United States population in 1990. Composition of this 
group included Chinese, Filipino, Hawaiian, Japanese, Korean, and Vietnamese 
Americans. Native Americans made up about 0.8 percent of the United States population 
in 1990, and included American Indians and Alaska Natives. From 1990 to 1995, the age 
adjusted breast cancer incidence rates for women in the United States, by race and 
ethnicity per 100,000 were: (a) 113.2 for White women, (b) 99.0 for African American 
women, (c) 71.4 for Asian/Pacific Islander women, (d) 69.3 for Hispanic women, and (e) 
31.9 for American Indian women. However, the age adjusted breast cancer mortality 
rates for women by race and ethnicity per 100,000 from 1990 to 1995 were: (a) 31.5 for 
African American women, (b) 26.0 for White women, (c) 15.3 for Hispanic women, (d)
11.7 for American Indian women, and (e) 11.6 for Asian/Pacific Islander women (Landis 
et al., 1999). Even though White women have the highest incidence of breast cancer in the 
United States and the mortality rate cited above for White women is well above the 
Healthy People 2000 goal o f 20.6 per 100,000 women, the breast cancer mortality rate in 
African American women is higher than the mortality rate in White women, and in all 
other groups of women o f color.
Because of this disparity in mortality rate between African American and White 
women, and because African American women comprise the largest ethnic minority group 
in the United States, current research examining breast cancer disparity between White 
women and women o f color has focused primarily on African American women. From
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1989 to 1993, age adjusted breast cancer mortality rates in the United States for White 
women decreased by approximately she percent, while breast cancer mortality rates rose 
about one percent for African American women (National Cancer Institute [NCI], 1996). 
Hence, breast cancer impacts achievement of the Healthy People 2000 goal o f increasing 
the span of healthy life for all American women; however, the disproportionate influence 
of breast cancer mortality on the lives of African American women threatens to also 
impede achievement o f the Healthy People 2000 goal of reduced disparities in health care.
Delayed diagnosis is consistently cited as the cause o f the disparity in breast cancer 
mortality between White women and African American women (Bedell, Wood, Lezotte, 
Sedlacek, & Orleans, 1995; Hunter et al., 1993; Long, 1993; Mandelblatt, Andrews, Kao, 
Wallace & Kemer, 1995; Simon & Severson, 1996; Thompson, Montano, Mahloch, 
Mullen, & Taylor, 1997). From 1989 to 1994, 50 percent o f the African American 
women diagnosed with breast cancer presented with localized tumors, as compared to 62 
percent o f the White women diagnosed; and the five year breast cancer survival rate for 
White women was 87 percent as compared to 71 percent for African American women 
(Landis et al., 1999).
Access barriers have been identified as the primary cause of diagnosis delay 
(Ansell, Lacey, Whitman, Chen, & Phillips, 1994; Ayanian, Kohler, Abe, & Epstein, 1993; 
Lauver, Coyle & Panchmatia, 1995). Studies exploring access as a barrier to cancer care 
and screening have defined access primarily in terms o f availability of care, or in relation to 
economic factors and health insurance coverage (Ayanian et al., 1993; Mandelblatt, 
Andrews, Kao, Wallace, & Kemer, 1995; Mandelblatt, Andrews, Kemer, Zauber, &
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Burnett, 1991; Michels, Taplin, Carter, & Kugler; 1995; Zaloznik, 1995, 1997). As a 
result, providing economic access to breast health care has become the primary focus for: 
increasing African American women’s participation in breast cancer screening programs, 
eliminating delayed diagnosis, and decreasing breast cancer mortality in African American 
women.
The Department of Defense (DoD) Military Health System (MHS) provides 
“equal” health care access to all active duty and retired members of the Armed Forces, and 
their family members (Assistant Secretary o f Defense for Health Affairs [ASDHA],
1996a). Race and socioeconomic status are not a factor in determining who will receive 
care. Thus, if economic access to care is the primary factor creating delayed diagnosis of 
breast cancer, there should be no significant difference in stage at diagnosis o f breast 
cancer between White women and African American women receiving care within the 
MHS.
Statement of the Problem 
Research is needed to describe the relationship between access and stage at 
diagnosis for women being treated for breast cancer inside the MHS. The 1996 National 
Defense Authorization Act allocated 25 million dollars for breast cancer prevention and 
treatment within the DoD MHS (Assistant Secretary o f  Defense for Health Affairs 
[ASDHA], 1996b). The result of this legislation was twofold: development o f the DoD 
Breast Cancer Prevention, Diagnosis, and Education Initiative; and movement o f breast 
cancer prevention, diagnosis, and treatment to the forefront of DoD MHS health 
promotion and disease prevention strategies. Thus, the overall objective o f the DoD’s
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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breast cancer initiative was “to ensure awareness of, and easy access to, superior medical 
and diagnostic technology and follow-up care for the early detection and optimum 
treatment o f breast cancer in active duty women and women beneficiaries” (ASDHA, 
1996b, p.2). Within the DoD MHS there are varying levels of rank and therefore varying 
levels of socioeconomic strata. Economic access to health care, however, is purported to 
be “equal” despite rank or socioeconomic status. Therefore, the disparity in breast cancer 
stage at diagnosis between White women and African American women in the larger 
population, attributed to lack of economic access to breast health care, is expected to be 
nonexistent inside the DoD MHS. Furthermore, the existence of government funding for 
breast health care in the MHS could lead policy makers and providers o f  health care to 
conclude that “ ...easy access to, superior medical and diagnostic technology and follow-up 
care for the early detection and optimum treatment of breast cancer..” exists for all 
women receiving breast health care in the MHS.
The year 2000 is rapidly approaching and breast cancer continues to attack all 
American women. Successful achievement o f the Healthy People 2000 goal of reduced 
disparity in breast cancer mortality is contingent upon a reduced mortality rate in African 
American women. If economic access to breast health care is the key to combating breast 
cancer mortality and eliminating stage at diagnosis disparity between White women and 
women of color, then all such legislation and policy issuance should focus on providing 
economic access to breast health care for all women. However, if significant disparity 
exists in breast cancer stage at diagnosis between White women and women of color in an
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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“equal” access system, then economic access must be eliminated as the primary cause of 
the disparity, and other contributors to delayed diagnosis must be identified.
Purpose o f  the Study 
The purpose of this study was to describe the relationship between access and 
stage at diagnosis of breast cancer in African American and Caucasian women being 
diagnosed with breast cancer within the DoD MHS. Relationships between stage at 
diagnosis of breast cancer and age, socioeconomic status, the means o f discovery of breast 
cancer, the length of time between discovery of breast abnormality and diagnosis of breast 
cancer, and the length of time between diagnosis and initiation of breast cancer treatment, 
were explored to provide relevant knowledge concerning the interrelationships between 
these variables in women receiving care within the MHS.
African American women and White women were the focus o f this research study. 
The term African American women is used interchangeably with the term Black women in 
the health care literature; therefore these terms were used interchangeably in this study.
The term Caucasian women is used interchangeably with the term White women in the 
health care literature; therefore these terms were also used interchangeably in this study.
Specific Aims 
The specific aims of this study were to:
1) Describe the age and socioeconomic status (defined as rank) o f women identifying 
their race as Caucasian or African American and being diagnosed with breast cancer at 
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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2) Describe the means of discovery of breast cancer (breast self exam, clinical breast 
exam, mammogram) in women identifying their race as Caucasian or African American 
and being diagnosed with breast cancer at Naval Medical Center San Diego from January 
1, 1988 to December 31, 1997.
3) Identify the length of time in days between discovery o f breast lump, mass, or 
abnormality and diagnosis of breast cancer, and between diagnosis o f breast cancer and 
initiation o f treatment, in women identifying their race as Caucasian or African American 
and being diagnosed with breast cancer at Naval Medical Center San Diego from January 
1, 1988 to December 31, 1997.
4) Identify the stage at diagnosis o f breast cancer in women identifying their race as 
Caucasian or African American and being diagnosed with breast cancer at Naval Medical 
Center San Diego from January 1, 1988 to December 31, 1997.
5) Compare the relationship between age, socioeconomic status, race and the means o f 
discovery o f breast cancer, length of time before diagnosis, length o f time between 
diagnosis and initiation of treatment, and stage at diagnosis in women identifying their race 
as Caucasian and being diagnosed with breast cancer at Naval Medical Center San Diego 
from January 1, 1988 to December 31, 1997 with the relationship between age, 
socioeconomic status, race, and the means of discovery o f breast cancer, length of time 
before diagnosis, length of time between diagnosis and initiation o f  treatment, and stage at 
diagnosis in women identifying their race as African American and being diagnosed with 
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 
1997.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Conceptual Framework 
The conceptual framework for this study was based on the Aday/Andersen 
Framework for the Study of Access (Aday & Andersen, 1974). The Aday/Andersen 
access model was initially applied directly in a national survey o f access to medical care 
conducted in 1976 (Aday, Andersen, Fleming, 1980). This model has subsequently 
provided the framework for numerous community surveys o f access to medical care 
(Aday, 1985; Aday, et al., 1993; Andersen, Giachello, & Aday, 1986; Northam, 1996; 
Urrutia-Rojas & Aday, 1991), and studies evaluating the impact of access barriers on 
health care (Aday, Andersen, Loevy, & Kremer, 1984; Champion & Menon, 1997;
Guidry, Aday, Zhang, & Winn, 1997; Guidry, et al., 1996; Miller & Champion, 1997).
The Aday/ Andersen framework defines access as “ ...those dimensions which 
describe the potential and actual entry of a given population group to the health care 
delivery system” (Aday, Fleming, & Andersen, 1984, p. 13). Health care policy is 
characterized as the starting point for access in this model since improved access is 
considered to  be a primary goal of most health care policies (Aday & Andersen, 1974). 
Indicators o f  potential access are identified as characteristics of the health care delivery 
system and the population at risk, while indicators of actual or realized access are 
identified as utilization and satisfaction. More specifically, the likelihood of an individual’s 
entering the health care delivery system is purported to be influenced by the structure of 
the system, and the nature of the needs, wants, and resources brought to the care-seeking 
process by potential consumers of health care; and the realization o f entrance into the 
health care delivery system is demonstrated by a population’s reported rates o f  utilization,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and through their subjective evaluation o f the health care services they obtain (Aday, 
Fleming, & Andersen, 1984).
In conceptualizing potential access, characteristics of the health care delivery 
system are operationalized as the availability and organization of health care resources 
(Aday, Andersen, & Fleming, 1980). Health care resources include health care personnel, 
structures in which the health care is delivered, the education provided, and equipment and 
materials used in providing the care. Characteristics of the population at risk are 
operationalized as predisposing, enabling, and need-oriented. Predisposing characteristics 
include such variables as age, sex, race, and values concerning health and illness, and 
describe the “propensity” of individuals to use health care services. Enabling 
characteristics include such variables as income, insurance coverage, and geographic 
location in relation to the health care services, and describe the “means” individuals have 
at their disposal for the use of services. The need for health care may be either perceived 
by the individual or determined by the health care delivery system, and refers to the most 
immediate initiator of health care service use, the illness level (Aday, Andersen, &
Fleming, 1980).
Realized access is conceptualized by characteristics of the utilization o f services 
and consumer satisfaction (Aday, Andersen, & Fleming, 1980). Utilization of health care 
services can be objectively measured and is operationalized by evaluation of the type of 
services utilized, the site of the health care encounter, the purpose of the utilization of 
services, and the time interval involved with utilization of services. The time interval can 
be evaluated in terms of whether or not an individual entered the health care system within
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
a given period o f time, by the number of visits within a given period o f time, or by the 
degree of coordination o f services associated with a particular illness. Consumer 
satisfaction is operationalized as a subjective measure of the consumer’s attitudes toward 
the health care delivery system and their satisfaction with their experiences with the health 
care delivery system (Aday, Andersen, & Fleming, 1980).
This study did not investigate all o f the variables described by Aday and Andersen 
(1974). Data were collected regarding the age, race, and socioeconomic status o f the 
population at risk. Variables characterizing the event initiating utilization o f specialized 
breast health care services were evaluated. Aspects of utilization of health care services 
were also evaluated. A schematic model of the variables selected for inclusion in this 
study is presented in Figure 1. The arrows depict the flow o f influence theorized by the 
investigator to exist between potential and realized access, and stage at diagnosis of breast 
cancer. This conceptual model also provided the framework for the literature review 
presented in chapter two.
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1. What are the relationships between age, race, socioeconomic status, the means 
of discovery of breast cancer, and stage at diagnosis of breast cancer in women identifying 
their race as Caucasian or African American, and being diagnosed with breast cancer at 
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
2. What are the relationships between the length of time between discovery and 
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of 
treatment o f breast cancer, and stage at diagnosis of breast cancer in women identifying 
their race as Caucasian or African American, and being diagnosed with breast cancer at 
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
3. To what extent do the variables age, race, socioeconomic status, and the 
means o f discovery o f breast cancer predict the length of time between discovery and 
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of 
treatment o f  breast cancer, in women identifying their race as Caucasian or African 
American, and being diagnosed with breast cancer at Naval Medical Center San Diego 
from January 1, 1988 to December 31, 1997.
4. To what extent do the variables age, race, socioeconomic status, and the means 
of discovery o f breast cancer predict stage at diagnosis o f breast cancer in women 
identifying their race as Caucasian or African American, and being diagnosed with breast 
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
5 . To what extent do the variables length of time between discovery and diagnosis 
of breast cancer, and length of time between diagnosis and initiation o f treatment of breast
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cancer, predict stage at diagnosis of breast cancer in women identifying their race as 
Caucasian or African American, and being diagnosed with breast cancer at Naval Medical 
Center San Diego from Januaiy 1, 1988 to December 31, 1997.
Importance of the Study 
Addressing the problem of access by focusing principally on availability of care, 
economic barriers, and health insurance coverage, excludes the impact of other aspects of 
access, and assumes that economic access to care translates into utilization of health care 
services (Bashshur, Homan, & Smith, 1994; Facione & Facione, 1997; Friedman, 1994; 
Guidry et al., 1996; Pearlman, Rakowski, Ehrich, & Clark, 1996).
Steiner (1991), states:
Access to health care is more than the mere availability o f physicians and county 
hospitals or clinics to serve the medically indigent within a certain geographic area; 
it is the availability of services that are financially accessible to the patient; it is the 
availability of effective cancer prevention and early detection educational 
messages that are culturally sensitive and meaningful to the patient population; and 
it is the availability of acceptable, appropriate, and comprehensive early detection 
and treatment services in an environment that is concerned about the needs of the 
person, treats the person with dignity, provides care in a timely fashion, and 
provides quality, culturally sensitive care (p. 1736 ).
The success o f health care service availability in decreasing morbidity and mortality 
associated with cancer depends on actual utilization of services (Mandelblatt et al., 1993);
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and utilization o f cancer screening services is guided by a perception o f their necessity and 
appropriateness, as well as their availability.
The existing nursing research on African American women’s access to breast 
health programs has been inadequate in its provision of knowledge o f  factors influencing 
African American women’s participation in breast health care (Bibb, 1997). This 
inadequacy presents a practice problem for the discipline of nursing, since the primary 
purpose of nursing research is to improve nursing practice (Bunting & Campbell, 1994; 
Hunt, 1996); and nursing’s involvement in African American women’s participation in 
breast health programs is crucial if breast cancer mortality is to be reduced. “Research 
based knowledge is incorporated into one’s critical thinking about identified practice 
problems and changes are made in the individual’s personal professional practice on the 
basis of this knowledge” (Crane, 1995). Therefore, continuing to focus current research 
on testing availability of care and health care insurance, as an exclusive determinant of 
African American’s women participation in breast cancer screening programs, could 
impede nursing’s progress in improving access to breast health care.
Research is used to generate and test theory (Chinn & Kramer, 1995), and existing 
research on access has generated evidence of additional delineators o f access to breast 
health care which should be examined. This study provides an opportunity to examine the 
relationship between other aspects o f access and utilization o f breast health care services 
within an “equal” economic access health care delivery system; and to provide a 
knowledge base for the formation of hypotheses to be tested in future breast health care 
research focused on women of color.
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Definition o f Terms
Economic access: the availability of health care and health insurance coverage (Aday, 
Andersen, Fleming, 1980), as indicated by a woman’s eligibility to receive care in the 
MHS being indicated on the Tumor Registry medical record.
Potential access:
Age: the age o f the woman at the time o f diagnosis as indicated on the Tumor 
Registry medical record.
Race: the classification of an individual based on physical characteristics.
1. Black woman is defined as any woman identified as non-Hispanic black or 
African American on the Tumor Registry medical record.
2. White woman is defined as any woman identified as non-Hispanic White or 
Caucasian on the Tumor Registry medical record.
Socioeconomic Status fSESV the active duty rank o f the woman or military 
sponsor entitling the woman to receive health care within the MHS (Clark & Thompson,
1994), as indicated on the Tumor Registry medical record.
1. Enlisted ranks are defined as E l (enlisted at the first level of rank) through 
E9 (enlisted at the ninth level of rank).
2. Officer ranks are defined as Chief Warrant Officer (CWO) and 01
(commissioned officer at the first level of rank) through 010 (commissioned officer at the 
tenth level o f  rank).
3. Junior Enlisted ranks are defined as E l through E5.
4. Senior Enlisted ranks are defined as E6 through E9.
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5. Junior Officer ranks are defined as CWO through 04.
6. Senior Officer ranks are defined as 05  through Ol 0
Means of discovery of breast cancer: The means of discovery o f a breast lump, 
mass, or abnormality that initiated the woman’s utilization o f specialized breast health 
services and resulted in the diagnosis of breast cancer. Indicated on the Tumor Registry 
medical record as one o f the following means:
1. Intentional breast self exam (BSE): discovered by the woman while 
routinely examining her own breasts.
2. Incidental BSE: incidentally or accidentally discovered by the woman or 
significant other.
3. Routine clinical breast exam (CBE): discovered by a provider o f health care 
within the MHS or other health care delivery system during a routine breast health care 
exam.
4. Secondary CBE: discovered by a provider of health care within the MHS 
or other health care delivery system during a physical exam for purposes other than 
routine breast health care.
5. Routine mammogram: discovered during performance o f routine clinical 
mammogram.
6. Secondary mammogram: discovered during a clinical mammogram 
performed as a result of a complaint of a medical condition other than breast related. 
Realized access:
Utilization o f services measured by:
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Length of time between discovery and diagnosis - the length o f time in days 
between discovery of breast lump, mass, or abnormality and diagnosis o f breast cancer, as 
indicated on the Tumor Registry medical record.
Length of time between diagnosis and treatment - the length o f time in days 
between diagnosis o f breast cancer and initiation of treatment of breast cancer (excision of 
lump, mastectomy, chemotherapy, or radiation therapy), as indicated on the Tumor 
Registry medical record.
Stage at diagnosis o f breast cancer: refers to the grouping of patients according to the 
extent of their disease as indicated on their Tumor Registry medical record. This grouping 
is defined in accordance with the classifications outlined for clinical staging o f breast 
cancer in the American Joint Committee On Cancer (AJCQ Cancer Staging Manual 
(1997). Staging is based on classification o f the primary tumor (T), regional lymph nodes 
(N), and distant metastasis (M). A summary o f these classifications is presented in tables 
1, 2, and 3. Table 4 summarizes the clinical staging o f breast cancer at diagnosis, using 
the TNM classifications.
Stage classifications for this study are defined as:
1. In situ: Stage 0
2. Stage 1: Stage I
3. Stage 2: Stages HA and IIB
4. Stage 3: Stages IIIA and DIB
5. Stage 4: Stage IV
6. Earlv stage: In situ and stage 1; Late stage:
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Table 1 AJCC Primary Tumor (T) Classification
TX Primary tumor cannot be assessed
TO No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor 2 cm or less in greatest dimension
T2 Tumor more than 2 cm but not more than 5 cm in greatest dimension
T3 Tumor more than 5 cm in greatest dimension
T4 Tumor o f any size with direct extension to chest wall or skin.
Table 2 AJCC Lvmph Nodes fND Classification
NX Regional lymph nodes cannot be assessed
NO No regional lymph node metastasis
N1 Metastasis to moveable ipsilateral axillary lymph node(s)
N2 Metastasis to ipsilateral axillary lymph node(s) fixed to one another or to other structures
N3 Metastasis to ipsilateral internal mammary lymph node(s)
Table 3 AJCC Distant Metastasis (TVO Classification
MX Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
Table 4 AJCC Clinical Staging of Breast Cancer
Stage Primary Tumor Regional Lymph Nodes Distant Metastasis
Stage 0 Tis NO MO
Stage I T1 NO MO
Stage HA TO N1 MO
T1 N1 MO
T2 NO MO
Stage UB T2 N1 MO
T3 NO MO





Stage IHB T4 Any N MO
Any T N3 MO
Stage IV Any T Any N M l
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Assumptions
The assumptions on which this study was based include:
1. All information contained in the Tumor Registry medical record is accurate and 
reflects information included in the woman’s hospital medical record.
2. Health care resources within the MHS are adequate in terms o f the availability 
of health care personnel, equipment, and educational services.
3. All women entitled to receive health care within the MHS have “equal” 
economic access to breast health care services.
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CHAPTER II 
REVIEW OF THE LITERATURE 
The literature pertaining to breast cancer mortality disparity between African 
American and Caucasian women was critically reviewed for its relevance to this study. 
This chapter presents a review o f research studies and findings that support the 
relationship between the study variables: economic access, age, race, SES, the means of 
discovery o f breast cancer, delay in diagnosis of breast cancer, delay in treatment of breast 
cancer, and stage at diagnosis of breast cancer. Studies included in this review tend to 
address multiple aspects of this study’s variables. For instance, age, race, and SES are 
included as demographic variables in many o f the studies reviewed, and the means of 
discovery o f breast cancer (BSE, CBE, mammogram) is frequently included as a variable 
in studies examining delay in diagnosis and treatment of breast cancer. Therefore, for 
organizational purposes, the following subsections are arranged based on the major 
variable examined in the research study under review, as it relates to stage at diagnosis of 
breast cancer, and breast cancer mortality disparity between African American and 
Caucasian women.
Economic Access and Stage at Diagnosis of Breast Cancer 
Studies exploring access as a barrier to cancer care and screening have defined 
access primarily in terms of economic access and in relation to health care insurance 
coverage. Many of these studies have focused on access to care created by federally,
21
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state, and locally financed health care programs, resulting from implementation o f health 
care policy. “Improved access to care is an important goal of much o f  health policy” 
(Aday & Andersen, 1974, p. 212). However, barriers to access may occur at the health 
care delivery system level or at a personal level; and an individual’s ability and willingness 
to participate in health care determines access, as well as the economic availability of 
health care (Aday, et al., 1993; Bashshur, Homan, Smith, 1994; DeBaca, 1994; Facione, 
Dodd, Holzemer, & Meleis, 1997; Facione & Facione, 1997; Friedman, 1994; Guidry, 
Aday, Zhang, & Winn, 1997; Guidry, et al., 1996; Katz, Hislop, Thomas, & Larson, 1993; 
Lauver & Ho, 1993; Lierman, 1988; Northam, 1996; Powell, Schwartz, & Hussain,
1995). In this study, economic access to health care was controlled for by examining 
participation in breast health care by women eligible to receive care within the MHS. The 
studies included in this section of the review examine the relationship between health 
insurance coverage, demographic characteristics of the individual seeking care, and stage 
at diagnosis o f breast cancer.
In examining the relationship between health insurance coverage and clinical 
outcomes among women with breast cancer, Ayanian, Kohler, Abe, and Epstein (1993) 
studied the state cancer registry records o f 4675 women, 35 to 64 years o f age, diagnosed 
with breast cancer in New Jersey between 1985 and 1987. The findings of this study 
reported that 88.3 percent of the women with private insurance were White, 70.8 percent 
of those uninsured were White, and 64.4 percent of those with Medicaid were White. The 
researchers compared the stage of breast cancer at diagnosis among uninsured and 
Medicaid patients with the stage at diagnosis o f disease among privately insured patients
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and found that uninsured women (P< 0.001) and women covered by Medicaid (P= 0.01) 
presented with significantly more advanced disease than those women who were privately 
insured. Stratification o f the population according to age revealed that significantly more 
advanced disease was present among uninsured women 50 to 64 years o f age (P< 0.001) 
and those covered by Medicaid who were 35 to 49 years of age (P= 0.02), than among 
those women with private health insurance coverage, in the same age groups. An 
evaluation of stage specific survival by type of insurance coverage found that survival was 
worse for uninsured (P< 0.001) and Medicaid (P< 0.001) patients with local disease, than 
for privately insured patients. Survival was also worse for uninsured (P< 0.001) and 
Medicaid (P< 0.001) patients with regional disease than for privately insured patients, but 
there was no difference among the comparison groups for distant disease. The results of 
this study support that women without health care insurance and with Medicaid coverage 
presented with more advanced disease than did women with private health insurance.
After using multivariate analysis to estimate the adjusted risk of death among uninsured 
and Medicaid patients, when compared to those who were privately insured, the 
researchers found that uninsured and Medicaid patients had a greater adjusted risk of 
death. In addition, those women who were uninsured or with Medicaid, had poorer 
survival with local and regional disease than did those with private health care insurance; 
and association between survival and type of insurance coverage was identified.
Chaulk, Kazandjian, and Pipesh (1995) conducted a retrospective analysis using 
hospital discharge data from 1989 through 1993 to explore racial differences in breast 
cancer illness, comorbidity, and mortality in Maryland’s unique hospital all-payer rate
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setting system. The all-payer rate setting system has been shown to constrain economic 
incentives in the decision to hospitalize and provide services once hospitalized. In a 
sample of 14,016 women (11,231 White, 2487 Black, and 298 other racial origin), the 
researchers found that despite the presence of the all payer system, Black women 
hospitalized for breast cancer were more likely to be severely ill than white women. The 
findings o f the study also demonstrated that more Black women died (2 .3%  or 58 of 
2487) between 1989 and 1993, than did White women (1.4 % or 161 of 11,231). In 
addition, a relationship between the type of insurance coverage and the severity o f the 
illness was also found to be present and was irrespective o f  race. The percent o f women 
insured by Medicare was 44.9, 44.5 percent had private insurance, 4.3 percent were 
enrolled in a Health Maintenance Organization (HMO), and 2.5 percent were uninsured. 
Medicaid recipients were significantly more ill than Medicare enrollees, privately insured 
women, or women insured by an HMO. The researchers did not control for education, 
care seeking behavior, or geographic access to services, and the discharge data reviewed 
for the study did not indicate whether or when breast cancer screening was performed on 
the women in the study. This study also demonstrated a relationship between the type o f 
health care insurance coverage and stage at diagnosis o f disease.
Mandelblatt, Andrews, Kao, Wallace and Kemer (1995) used data from the New 
York state department o f health tumor registry to examine the impact o f demographic 
variable such as age, race, ethnicity, and type of reporting hospital; and social context 
variables such as area o f residence, socioeconomic status and access to screening 
mammography, on breast cancer stage at diagnosis among New York women between
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1980 and 1985. Chi-square and t-tests were used to assess the relationship between the 
demographic variables and each stage. Late stage (stages 2, 3, and 4) breast cancer was 
found to occur at a significantly higher proportion among women 50 to 64 years o f  age 
(54.7%) than among women 20 to 49 years o f age (50.9 %) and women 65 and older 
(50.5%) (P< 0.0001). Late stage disease occurred at the highest proportion in African 
American women (59.2%), followed by Hispanic women (54.6 %), and White women 
(50.4%) (P< 0.001). Women diagnosed in public hospitals had a higher proportion o f late 
stage disease (63.7 %) than did women diagnosed in nonpublic hospitals (51.1 %). Three 
logistic regression models were used to evaluate the impact of demographic variables, 
social context variables, and both class of variables combined, on the outcome of having 
breast cancer diagnosed in a late stage, compared to an early stage. Women diagnosed in 
public hospitals were 45 percent more likely to be diagnosed at a later stage than women 
diagnosed in other types o f hospitals (P< 0.0001); and African American women were 34 
percent more likely to be diagnosed at a later stage than White women (P< 0.0001). The 
odds of having late stage disease were 28 percent higher for women living in areas with 
the lowest socioeconomic status ranking, when compared with women living in an area of 
the highest socioeconomic status ranking. Mammography capacity was a significant 
independent predictor o f stage at diagnosis of breast cancer (P= 0.016).
Zaloznik (1995) conducted a retrospective review of DoD MHS breast cancer 
cases recorded in the DoD Automated Tumor Registry (ACTUR), from 1976 to 1992, to 
determine if there were any differences in stage at diagnosis of breast cancer or survival 
between Caucasian and African American women being diagnosed in the MHS. Zaloznik
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examined a total o f 6414 (89.58% of total) records o f Caucasians and 746 (10.41% of 
total) records o f African Americans. The subjects were stratified according to age at 
diagnosis, race, and stage at diagnosis, and the researcher found that there were no 
statistically significant differences in stage at presentation between Caucasian and African 
American women. Caucasian women had significantly (P = < 0.0001) more tumors < 1.0 
centimeters than did African American women. African American women had more 
tumors that measured 2.1 to 3.0 centimeters in size. The median age for diagnosis of 
breast cancer in African American women was 50, as compared to age 58 in Caucasian 
women. Twenty-four percent of the African American women studied were less than 40 
years old at presentation, compared to nine percent o f the Caucasian women (P=<
0.0001). Even though the findings of this study did not report a significant difference in 
the stage at diagnosis o f breast cancer between African American and Caucasian women, 
significant differences were reported in tumor size and age at diagnosis. This study did 
not evaluate the effect o f socioeconomic status or geographic location of the treatment 
facility on stage at diagnosis, nor did it look at care seeking or screening behaviors.
Wojcik, Spinks, and Optenberg (1998) conducted a retrospective review o f 6577 
DoD MHS central tumor registry records to evaluate the effects of age, stage o f cancer at 
diagnosis, tumor size, grade, lymph node involvement, waiting time between diagnosis and 
first treatment, marital status, military dependent status, alcohol usage, tobacco usage, and 
family history on breast cancer survival. The 5879 White (89.4% of the total) and 698 
African American (10.6% of the total) women included in the study ranged in age from 19 
to 97 years, and were diagnosed with breast cancer between 1975 and 1994.
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Chi-square analysis and t-tests were used to compare the characteristics of the 
African American and White women. The Cox proportional hazards model and several 
multiple regression models were applied to examine the effects of the independent 
variables on survival status. Almost 90 percent o f the women in the study were civilian 
spouses of active duty service members or military retirees, and 4.9 percent o f the women 
were active duty members themselves. Within the group of African American women,
10.3 percent were on active duty when diagnosed with breast cancer as compared to 4.3 
percent within the group of White women. The mean age at the time of diagnosis for 
African American women was 50 years as compared to 57.1 years for the White women; 
and 22.8 percent of the African American women were diagnosed with breast cancer at 
less than 40 years of age, as compared to 9.2 percent of the White women. Wojcik, et al. 
found statistically significant (p = 0.0001) differences in overall survival between the 
African American and White women. The mortality rate among African American women 
was 24.77 percent as compared with 18.08 percent for White women. Tumor stage at the 
time of diagnosis appeared to be the strongest predictor of death from ail causes. The risk 
of death for women with tumors diagnosed at stage 3 was 6.55 times higher than for 
women diagnosed at stage 0. African American women had significantly larger tumors 
than White women (2.53 centimeters as compared to  2.28 centimeters, p = 0.013); and 
48.86 percent of the African American women were diagnosed at stages 2 and 3 as 
compared to 38.65 percent of the White women. The waiting time from diagnosis to 
treatment was significantly shorter for African American women (21.15 days) than for 
White women (29.51 days; p = 0.0024).
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Despite the significant difference in survival status between African American and 
White women within the DoD MHS, Wojcik, et al. found that the five year risk o f death 
for African American women receiving care in the DoD (1.37), when compared with 
White women, was less than the relative risk reported in the Surveillance, Epidemiology, 
and End Results (SEER) Program of the National Cancer Institute (1.86). The survival 
rate for White women receiving care within the DoD was comparable to rates reported in 
SEER. Based on these study findings, the researchers surmised that ready access to 
medical facilities improves survival for African American women, and support that even 
though ready access is necessary for receipt of definitive medical care, it is not a sufficient 
condition for equalizing survival rates between African American and Caucasian women. 
Wojcik, et al. did not examine the effects of socioeconomic status or means o f  discovery 
on stage at diagnosis or survival status, and suggest that other explanations may 
contribute to diagnosis of African American women at younger ages and later stages of 
breast cancer.
The studies presented above support the existence of a relationship between 
economic access and stage at diagnosis of breast cancer. The studies also identify 
differences in stage at diagnosis of breast cancer relative to the type of health care 
insurance coverage, irrespective to race. Even when access to care was provided though 
health insurance or public policy as a result o f local, state, or federal health care funding, 
diagnosis delay occurred. Existence of economic access to health care did not always 
result in early diagnosis of breast cancer, and other factors such as age, race, and SES 
were found to influence breast cancer diagnosis outcomes.
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Even though the studies presented above examined the impact of age, race, and 
SES on stage at diagnosis of breast cancer, and the type o f  health care insurance being 
utilized, the studies did not address the influence o f the means o f discovery o f breast 
cancer (BSE, CBE, mammogram), or delays in diagnosis o f breast cancer, on stage at 
diagnosis in women with economic access to health care.
Potential Access and Stage at Diagnosis o f Breast Cancer 
The availability and organization of resources within a health care delivery system, 
and the characteristics o f the desires, needs, and resources that a potential consumer 
brings to the care seeking process, influence the probability of an individual’s entry into 
the health care system (Aday, Fleming, & Andersen, 1984; Andersen, Giachello, & Aday, 
1986; Berk & Schur, 1998; Guidry, et al., 1996). Therefore, potential access is 
characterized by: predisposing factors such as age, sex, race, religion, and values 
concerning health and illness; enabling factors such as income, insurance coverage, and 
attributes of the community in which the individual lives; and need factors such as illness 
level and the need for health care services as perceived by the individual or health care 
delivery system (Aday & Andersen, 1974; Aday, Andersen, & Fleming, 1980). Because 
the setting for this study was the MHS, the assumption was made that health insurance 
coverage was available and equal for all eligible military beneficiaries. Nevertheless, 
factors such as age, race, SES, and the event initiating breast health care differ among 
individuals receiving care in the MHS, and may cause varying levels of potential access 
within an equal access system. Therefore, the following section presents a review o f the
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literature of the relationship between variables of potential access identified for inclusion in 
this study, and stage at diagnosis o f breast cancer.
The single most important risk factor for breast cancer in women is age, although 
race and ethnicity modify the effect o f age on the risk o f developing breast cancer (Vogel,
1996). The purpose of this review, however, is to explore the relationship between age 
and stage at diagnosis of breast cancer. Age is represented as a demographic variable in 
most of the studies presented in this chapter. Therefore, this section of the literature 
review will focus on studies in which age was the major variable of the study in examining 
its relationship to stage at diagnosis o f breast cancer.
Newman and Alfonso (1997) evaluated stage at diagnosis of breast cancer 
distribution, relative to age, in women treated for breast cancer between 1990 and 1995 at 
the Long Island College Hospital in Brooklyn, New York. For the purposes of this study, 
the researchers conducted a retrospective review of tumor registry data, hospital and 
physician office records, and pathology reports on 283 White patients and 143 Black 
patients. The two groups of women were stratified according to age and women 50 years 
and older were designated as the older patient population, and women younger than 50 
years were designated as the younger population. SES was estimated by access to 
primary care management through the outpatient public clinic as compared to access to 
private medical care. Chi-square analysis was used to determine statistical significance. 
Newman and Alfonso found that the mean age at diagnosis for White women was 63 years 
compared to 56 years for Black women; and that approximately one fifth o f the White
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
women were diagnosed at less than 50 years of age compared to one third o f the Black 
women (P = 0.008). Black women were diagnosed with in situ breast cancer in 8.6 
percent of the cases, and stage 1 cancer in 23.7 percent o f the cases, while White women 
were diagnosed with in situ breast cancer in 10.4 percent o f  the cases and stage 1 breast 
cancer in 37.2 percent o f the cases (P = 0.004). Stage 3 and 4 cancers were diagnosed at a 
significantly higher rate in Black women (27.3 percent) when compared to White women 
(18.6 percent) (P = 0.049).
Stage 2, 3, and 4 breast cancer was diagnosed at a proportion of 64.6 percent in 
the younger population o f women as compared to 55.8 percent in the older population. 
There were no notable differences in the distribution o f stage at diagnosis of breast cancer 
in the older patient population. In the younger population, in situ breast cancer was 
diagnosed in 22 percent of the Black women as compared to 6.4 percent of the White 
women; and stage 0 and 1 breast cancer was diagnosed at a significantly lower rate in 
Black women at 21.3 percent, when compared to 49.0 percent in White women (P = 
0.004). Stage 3 disease occurred at the highest proportion in the younger Black women. 
Stage 0 and 1 breast cancers occurred at a proportion of 38.1 percent in younger Black 
women as compared to 21.3 percent in older Black women (P = 0.049).
Black women were diagnosed through the hospital’s public health clinic in 9.7 
percent (14 of 144) of the cases as compared to 1.3 percent (3 of 239) of the White 
women, but over 90 percent o f  both groups of women had access through the private 
practice setting. The stage at diagnosis o f breast cancer distribution for Black women o f 
all ages was similar among the public clinic patients and private practice setting patients.
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Stage 0 breast cancer was diagnosed in 9 .7 percent of the Black women receiving care in 
the private setting, zero percent was diagnosed in women receiving care in the public 
setting. Stage 1 and 2 breast cancers were diagnosed in 63.7 percent o f the Black women 
receiving care in the private setting as compared to 64.3 percent in the public setting.
Stage 3 and 4 cancers were diagnosed in 26.6 percent o f the Black women receiving care 
in the private setting as compared to 35.7 percent in the public setting.
The study presented above confirms that there is a higher incidence of late stage 
breast cancer diagnosed in Black women when compared to White women. The study 
also confirms that late stage breast cancer is diagnosed at a higher rate in younger Black 
women when compared to older Black women and White women o f all ages. However, 
these race related variances do not appear to be associated with the type o f health care 
coverage since the majority o f the Black women in the study had access to and used 
private medical care; and the distribution of stage at diagnosis of breast cancer in Black 
women receiving care through the public clinic was similar to the distribution of those 
receiving care through the private practice setting. This study did not examine the 
influence o f care seeking behaviors on stage at diagnosis o f breast cancer.
Race
Most o f the arguments for biological contributions to the disparity in breast cancer 
death rates are based on race. However, there is growing consensus in the health care 
literature to support that human races are not biological entities, and that racial 
classification in the United States is determined by social and political parameters (Hahn & 
Stroup, 1994; Herman, 1996; Roach & Alexander, 1995). In addition, the concept o f race
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has been purported to be socially meaningful, but of limited biological significance; and the 
factors creating the breast cancer mortality disparity have been argued to be not as much 
biological as they are cultural, social, geographical, and structural (Adams, 1995; Bayne- 
Smith, 1996; Frank-Stromborg & Olsen, 1993; Freeman, 1997; Kato & Mann, 1996; 
Williams, Lauizzo-Mourey, & Warren, 1994). The studies presented in the following 
section integrate examination of the relationship between cultural, social, structural, and 
biological perspectives of race, and stage at diagnosis of breast cancer in African 
American and Caucasian women.
Coates et al. (1990) examined the effects o f nutritional status on breast cancer 
survival differences among 469 Black and 1491 White women diagnosed with breast 
cancer in Georgia between 1975 and 1979. Nutritional status variables included height 
measured in meters, weight measured in kilograms, and serum albumin, hemoglobin, and 
lymphocyte counts. Demographic, medical, and clinical characteristics such as: age in 
years, marital status, education in years, menopausal status at diagnosis, prior history of 
cancer, family history of cancer, history of breast self examination, number of lymp nodes 
involved, type of treatment (surgery, radiation therapy, hormone therapy, chemotherapy), 
occupational status o f the patient’s household, stage at diagnosis of breast cancer, tumor 
histology, time between the recognition of symptoms and the first medical consultation, 
and time between the first medical consultation and diagnosis were also included in the 
analysis. This study employed several statistical tests. Stage and race specific median 
body mass indices, lymphocyte counts, and levels o f serum albumin and hemoglobin were 
compared to assess associations between race and nutritional status indicators. Odds
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ratios and corresponding approximate 95 percent confidence intervals were used to 
evaluate the associations between race and the nutritional status indicators, and between 
race and other suspected prognostic factors identified through the research literature. 
Univariate survival analyses, with the Kaplan-Meier product estimation procedure, were 
performed to assess the relationship between suspected prognostic factors and survival 
from breast cancer. The Wilcoxon test statistic was used to assess statistical significance 
of differences between survival curves. The prognostic effect of race was evaluated using 
the Cox proportional hazards regression approach with adjustments made for nutritional 
status variables and other confounding prognostic factors.
Coates et al. found that Black women in this study were more likely to be younger, 
unmarried, less educated, and of a low occupational status than White women. Black 
women were less likely to have a personal history o f breast cancer than were White 
women; and Black women were less likely to perform BSE than were White women.
Black women tended to have a longer time between recognition of symptoms and seeking 
medical care; and Black women tended to have more advanced disease and lymph node 
involvement, and were more likely to present with nipple bleeding and ulceration, at the 
time of diagnosis, than were White women. Because Black women were more likely to 
present with advanced, inoperable disease, when compared to White women, the 
percentage of Black women not undergoing surgery was elevated. When data were 
adjusted for stage at diagnosis of breast cancer, socioeconomic status, and other 
prognostic factors mentioned above, poorer survival rates were demonstrated in Black 
women when compar ed to White women. There was a strong association between race
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and three of the four nutritional status measures. Lower levels o f serum albumin and 
hemoglobin and higher relative body weight were more common among Black women 
than among White women, and were independently associated with poorer survival. 
Approximately 76 percent of the White women in the study survived five years as 
compared to 57 percent o f the Black women. The black-to-white hazard rate ratio among 
women with stage 3 disease was 1.61. Adjustment for demographic, medical, and clinical 
characteristics among women with stage 3 disease reduced the black-white difference in 
mortality rates in these women to a ratio rate o f 1.54. However, simultaneous adjustment 
for all four o f the nutritional status variables reduced the rate ratio to 1.14, resulting in a 
74 percent reduction in excess risk for Black women.
The results o f this study support that differences in the nutritional status of Black 
and White women may contribute to differences in survival. Black women were more 
likely to have lower serum albumin and hemoglobin levels than White women, and were 
more likely to be overweight. These differences were associated with poorer survival 
rates, and in women with stage 3 disease, adjustment for these nutritional status indicators 
explained three fourths o f the excess risk o f mortality among the Black women in this 
study. Serum albumin, commonly used as an indicator of nutritional status, reflects 
protein calorie nutrition intake. However, serum albumin is also a reflection o f disease 
status in various illnesses (Coates et al., 1990). The researchers in this study 
acknowledged that the lower serum albumin levels in the Black women in this study could 
be a reflection o f nutritional status or a reflection of the extent o f the disease within stage. 
Decreased serum hemoglobin levels can reflect malnutrition or may result from the
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presence o f  disease, including breast cancer. Therefore, the associations found between 
decreased serum albumin and hemoglobin levels could be indicative o f either nutritional 
status or disease severity. This study’s findings about the poorer survival rates among 
overweight Black women with breast cancer are consistent with other research studies 
(Coates et al., 1990); however, it is not clear if the association noted between obesity and 
stage at diagnosis is a reflection of masking o f  signs and symptoms of breast cancer due to 
being overweight or hormonal mechanisms.
Jones, Kasi, Cumen, Owens, and Dubrow (1997) also evaluated the effect of 
obesity on poorer stage at diagnosis outcomes for Black women when compared to White 
women. In conducting a retrospective review of 145 Black women and 177 White women 
diagnosed with breast cancer in Connecticut between January 1987 and March 1989, these 
researchers examined the extent to which the observed racial differences in stage at 
diagnosis o f  breast cancer could be explained by racial differences in severe obesity. Odds 
ratios and their 95 percent confidence interval and logistic regression were used to test for 
significant associations between race, obesity, and stage at diagnosis. Jones et al. found 
that severe obesity was associated with both race and stage at diagnosis o f breast cancer. 
Severe obesity was more likely to occur in Black women (26 percent) than in White 
women (7 percent); and severe obesity was significantly associated with diagnosis of 
breast cancer in stage 2 or greater. After adjustment for severe obesity, the risk of 
diagnosis o f breast cancer at a later stage was reduced by 33 percent in Black women as 
compared to White women. The findings o f this study concluded that severe obesity may
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play an important role in explaining the higher prevalence of late stage diagnosis o f breast 
cancer in Black women.
Hunter et al. (1993) obtained data from the National Cancer Institute’s 
Black/White Survival Study for the period 1985 to 1986 and evaluated the relationship 
between selected demographic, lifestyle, health care access, antecedent medical experience 
factors, and stage at diagnosis o f breast cancer in 649 Black and 573 White women. The 
women included in the study were newly diagnosed with primary breast cancer between 
January 1, 1985 and December 31, 1986; ranged in age from 20 to 79; and resided in one 
of the following areas: Atlanta, Georgia; New Orleans, Louisiana; or the San Francisco- 
Oakland, California area. Approximately 70 percent of the Black breast cancer cases 
were randomly selected from each metropolitan area, and a sample of White breast 
cancer cases was matched by age groups to adjust for the tendency for the Black women 
to be younger than the White women at the time o f diagnosis. Adjustment of the patient 
selection rates resulted in a slight imbalance in the race distribution in the study, 53 
percent Black women and 47 percent White women. Hunter et al. collected data from 
medical records, review of histology slides, and patient interviews. Demographic factors 
included marital status, education, and total family income. Lifestyle factors included 
smoking history and body mass index. Antecedent medical experience factors included 
history of BSE and CBE during the six years prior to breast cancer diagnosis; length of 
time from the woman’s recognition of a symptom to the first visit to a physician for that 
symptom; and current medical conditions that the women had at the time of admission to 
the hospital for a diagnosis o f breast cancer. Access to medical care factors included the
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type of health insurance and usual source of medical care. Stage at diagnosis was 
classified according to the tumor-lymph node-metastases (TNM) system for breast cancer 
based on post surgical pathologic evaluation criteria o f the American Joint Committee on 
Cancer (Stages: in situ, I, II, HI, and IV).
Hunter et al. evaluated the differences in breast cancer stage at diagnosis and the 
distribution of the factors mentioned above, between the Black and White women 
included in this study by using chi-square tests for independence, and chi-square test for 
trend, where appropriate. Log-linear models were used to evaluate the relationship 
between each factor and stage at diagnosis separately in the groups of Black and White 
women. Logistic regression models were used to examine explanatory factors that 
showed a statistically significant association with stage at diagnosis in both groups of 
women. The researchers found a highly significant association between race and stage at 
diagnosis (P < .00005). Black women had a more advanced stage o f disease at diagnosis. 
There were no significant differences in age adjusted race-stage relationship by 
metropolitan area. Women younger than 50 years old with in situ disease were 
significantly more likely to be White, while those with stage III or IV were significantly 
more likely to be Black. There was no statistically significant difference in stage at 
diagnosis observed in women 65 to 79 years of age. Black women were more likely than 
White women (P < .001) to have less than a high school education, be overweight, and 
have a lower total family income. Black women were also more frequently never married 
and more often current smokers, and had a greater history of existing medical conditions. 
In addition, a greater proportion of Black women, than White women, were found to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
either have no insurance or have public assisted health care, with their usual source o f 
medical care being the hospital outpatient clinic, emergency room, or public clinic. The 
majority o f  the women in both groups reported practicing BSE and participating in CBE; 
and the length o f time from recognition o f symptoms to  seeking medical consultation was 
equal in both races. A recent history o f CBE was significantly associated with lower stage 
disease in both groups (Black women, P < .01; White women, P < .04); and a history o f 
delay between recognition of symptoms and medical consultation was positively related to 
a higher stage at diagnosis in both races (P < .00005). Limited access to health care, usual 
source o f medical care, larger body mass index, and history o f low mammography use 
factors were associated with a higher stage at diagnosis of breast cancer only in the Black 
women in the study. Lower income was associated marginally with higher stage of disease 
only in the White women in the study (P = .06); and less education was associated 
marginally with higher stage of disease at diagnosis only in the Black women in the study 
(P = .07).
The Black women in this study were diagnosed at a higher stage of disease than 
the White women. In the Black women, access to health care, lifestyle, and antecedent 
medical experience were factors found to be associated with higher stage at diagnosis; and 
in the White women in this study, SES tended to have more influence on higher stage at 
diagnosis o f  breast cancer. Women with higher total family income, and medical care 
through private physicians or private medical clinics were found to present with lower 
stage of disease, suggesting that higher stage at diagnosis is related to poorer access to 
health care and lower SES. However, this association is social, and perhaps
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environmental, but there are no data in this study to support that it is biological. The race- 
stage association observed in this study is complex and supports that there are multiple 
factors influencing differences between stage at diagnosis in the Black and White women 
included in this study. Hunter et al. evaluated factors associated with race, age, SES, the 
means o f  discovery of breast cancer, and treatment and diagnosis delay. However, the 
evaluation was conducted across three metropolitan areas with varying social, political, 
and environmental climates; and in access systems that have the potential to vary in health 
care availability, quality, and promptness. Even though this study is systematic and 
comprehensive in its evaluation of factors associated with differences in stage at diagnosis 
of breast cancer between Black and White women, studies systematically evaluating the 
influence o f these factors on stage at diagnosis of breast cancer in an equal economic 
access system are needed.
Eley et al. (1994) used data from the National Cancer Institute’s Black/White 
Cancer Survival Study for the period of 1985 to 1986 to examine the impact of recognized 
prognostic factors on the observed poorer breast cancer survival rate in Black women 
when compared to White women. The study included 612 Black and 518 White women, 
age 20 to 79 from three different geographic areas. The sampling design was based on 
random sampling of Black subjects and frequency matching o f White subjects by age 
groups. Data were derived from personal interviews with the women, abstracts o f the 
hospital records, and a central pathology review of biology and surgical specimens in 
exploring the impact of stage at diagnosis, histopathologic characteristics of the tumor, 
treatment, concurrent medical conditions, socioeconomic status, and usual source of care,
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on survival differences. Frequency tables and chi-square test were used to examine 
bivariate relationships between race and the variables mentioned above. Cox proportional 
hazards regression was used to asses the impact of the variables mentioned above on racial 
differences in survival after diagnosis of breast cancer. After controlling for age and 
geographic area, Eley et al. found that the risk of dying from breast cancer was 2.2 times 
greater for Black women than for White women and concluded that approximately 75 
percent o f the racial difference in survival was explained by the prognostic factors 
explored in the study (stage at diagnosis, histopathologic characteristics of the tumor, 
treatment, concurrent medical conditions, SES, usual source of medical care, marital 
status, occupation, poverty index). Approximately 40 percent of the difference in the 
survival rate was explained by a more advanced stage of the disease in the Black women. 
After controlling for stage and tumor pathology, information about treatment did not 
explain the survival difference. Racial differences in stage at diagnosis of breast cancer 
appeared to be largely influenced by social and demographic factors.
Simon and Severson (1996) examined racial differences in survival of breast cancer 
in 8622 White and 1880 African American women diagnosed with breast cancer in the 
Detroit metropolitan area between 1988 and 1992. This retrospective analysis was 
conducted using medical and demographic data obtained from the Metropolitan Detroit 
Cancer Surveillance System. Demographic data included age at diagnosis, race, marital 
status at diagnosis, and census derived socioeconomic rank. Clinical variables included 
tumor size, stage at diagnosis, histologic type and histologic grade. Factors relating to the 
characteristics of the hospital in which each woman received their first course o f cancer
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related surgery included the number of beds in the hospital, presence of a residency 
training program, and the proportion of Medicaid and/or Medicare patients discharged 
from each hospital. The chi-square test was used to assess differences between age, 
marital status, socioeconomic census rank, tumor size, stage at diagnosis, histologic type 
and grade o f the tumor, number o f beds in the hospital, presence of residency training, 
proportion o f Medicaid and/or Medicare discharges, and race. The relative risk o f death 
from any cause in African American women, when compared to White women, was 
estimated using Cox proportional hazards regression.
Simon and Severson found that the African American women in this study were 
more likely to be younger than the White women, when diagnosed with breast cancer. In 
addition, African American women were more likely to live in a census tract with a lower 
socioeconomic census rank than were White women. African American women were 
found to present at a more advanced stage, with larger tumors, and a higher tumor 
histologic grade. When examining local (confined to the breast) and regional (spread 
beyond the breast by direct extension or to regional lymph nodes) stage disease, the 
researchers found that White women had a significantly better survival than did African 
American women (log rank, P = 0.0001). Although not significantly different within 
remote (direct extension or metastases to organs other than regional or distant lymph 
nodes) stage disease, White women seemed to have better survival rates than did African 
American women (log rank, P = 0.3). There was a significant difference in survival 
between African American women and White women in the first four years after 
diagnosis, however there was no significant difference in women who lived longer than
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four years. There was a significant interaction between age at diagnosis and race (P = 
0.005). Fifty percent o f the variation in survival between African American and White 
women was accounted for by adjusting for age, marital status, socioeconomic census rank, 
stage at diagnosis, characteristics o f the tumor, number of beds in the hospital of 
treatment, presence of residency training, and the proportion of Medicaid and/or Medicare 
discharges.
Roach et al. (1997) evaluated the prognostic significance o f  race and survival in 
stage 2 breast cancer in 185 African American, 1325 White, 12 Oriental, and 34 other 
[race] women treated with adjuvant chemotherapy in the Cancer and Leukemia Group B 
(CALGB) trial 8541. Retrospective analysis was conducted using data from the CALGB 
database. Women included in the CALGB trial had: (a) Histologically confirmed stage 2 
breast cancer with no or minimal symptoms; (b) clear margins following radical, modified, 
or breast conserving surgery; (c) chemotherapy preceded by dissection o f level one and 
two lymph nodes; (d) chemotherapy followed by external beam irradiation consisting o f 50 
Gy to the entire breast and 1.5 Gy boost to the area of incision; (e) initial chemotherapy 
including CAF (cyclophosphamide, doxorubicin, fluorouracil); (f) tamoxifen added in 
women who were perimenopausal, or who were postmenopausal with positive estrogen 
receptors; and (g) chemotherapy prescribed based on actual body weight. Women 
included in the CALGB 8541 trial were randomly assigned to receive either a high dose, 
standard dose, or low dose intensity o f chemotherapy; and were stratified according to 
type of breast management, menopausal status, number of lymph nodes involved, and 
estrogen receptor status.
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In this study, differences in disease free survival and overall survival were assessed. 
“Disease free survival was defined as the time from randomization to a documented 
relapse or death without a relapse. Overall survival was defined as the time from 
randomization to death from any cause” (Roach et al., 1997, p 108). The proportional 
hazards model for multivariate analyses, the log rank test, and the stratified log rank test 
for univariate analyses were used to assess differences in disease free and overall survival.
African American women were found to be slightly more likely to be estrogen 
receptor positive (34 percent) than were White women (26 percent) (P = 0.03). Ninety 
percent o f the African American women were more likely to have had a mastectomy when 
compared to White women (84 percent) (P = 0.03). African American women tended to 
be younger (median 46 years) than White women (median 50 years) (P < 0.01); and 
African American women tended to have tumors somewhat larger (median 3.0 
centimeters) than White women (median 2.5 centimeters) (P < 0.01). When compared to 
White women, African American women tended to have more delays in treatment (P = 
0.01); had a 1.35 (P = 0.04) times higher risk of death; and were 1.24 (P = 0.09) times as 
likely to fail treatment. However, after adjusting for prognostic factors such as dose, 
intensity o f chemotherapy, number o f positive lymph nodes, estrogen receptor status, and 
age, these researchers found that race was not an independent prognostic factor for overall 
survival or disease free survival. Roach et al. concluded that they could not 
“mechanistically” explain the existence of significant biologic breast cancer cause and 
effect factors related to skin color and that “ ...efforts directed at early detection of breast 
cancer in African American women are likely to have greater impact on improving their
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survival than efforts directed at identifying a biologic basis for their lower survival” (p. 
111).
Krieger, Van Den Eeden, Zava, and Okamoto (1997) assessed the distributions of 
breast cancer prognostic biomarkers by race and ethnicity in 48 White, 44 Black, and 43 
Asian women diagnosed with breast cancer within a large health maintenance organization 
in the San Francisco area between 1966 and 1990. The study was based on tumor 
samples obtained from a random sample of 50 White, 50 Black, and 50 Asian women 
selected for inclusion in a nested case control study examining the relationship between 
exposure to organochlorines and risk o f breast cancer. Women were included in this study 
based on self identified race and ethnicity, diagnosis of breast cancer at least sue months 
after receiving a multiphasic examination at the health maintenance organization, and prior 
to December 31, 1990, and the researchers’ ability to locate tumor blocks (archival 
paraffin-embedded tumor biopsy specimens).
A multiphasic self administered questionnaire, supplemented by a physical 
examination provided data on the women’s sociodemographic, reproductive, and 
anthropometric characteristics. Data were obtained through medical record chart review 
pertaining to the women’s age and parity; menopausal status at the time o f diagnosis; 
tumor characteristics such as stage, grade, laterality, size, and lymph node involvement; 
and surgical assession number for each cases’ tumor block. The researchers reviewed 
pathology reports to determine which blocks should be analyzed for tumor markers; and 
immunohistochemistry on thin sections ( 4 - 5  microns) prepared from paraffin blocks was 
used to determine biomarkers. The stage of a breast tumor was categorized as local,
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regional, or distant; and tumor size was categorized as < 20 millimeters or > 20 
millimeters.
Odds ratios and their 95 percent confidence interval and univariate analyses were 
used to assess sociodemographic, reproductive, anthropometric, and breast cancer tumor 
characteristic distributions overall and by race and ethnicity. Multivariate logistic 
regression was used to adjust for place of birth, menopausal status, and age at diagnosis, 
and to compare tumor characteristic and socioeconomic distributions by race and 
ethnicity. Approximately 66 percent of the women studied were diagnosed with local 
disease. Forty percent had tumors that measured < 20 millimeters, and 44 percent of the 
women studied had lymph node involvement. There were no notable differences in tumor 
stage and lymph node involvement across racial and ethnic and socioeconomic groups. 
When compared to White women, and after adjusting for age at diagnosis, menopausal 
status, place of birth, and socioeconomic status, Black women were 3 .5 times more likely 
to have breast tumors > 20 millimeters; and Asian women were 3.7 times more likely to 
have tumors > 20 millimeters. After adjusting for age at diagnosis, menopausal status, and 
place of birth, there was no notable differences in tumor size by socioeconomic status, 
however tumor size tended to be larger in women who had completed four or more years 
of college. Approximately 70 percent of the tumors found in all three racial and ethnic 
groups were estrogen receptor positive; and there were no clear patterns o f differences in 
distribution of breast cancer molecular prognostic markers by socioeconomic class. 
Therefore, disparities in breast cancer mortality rates between the racial and ethnic groups
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
47
evaluated in this study could not be explained solely by differential distributions of 
molecular breast cancer prognostic biomarkers.
The studies presented above identify multiple factors influencing the disparity in 
stage at diagnosis and mortality between African American and Caucasian women. These 
studies also support the premise that race is not biological, but rather social, cultural, 
and/or structural. Delayed diagnosis of breast cancer has been shown to occur at a higher 
rate in the African American women in the studies presented above; however, diagnosis 
delay has also been shown to be associated with social, cultural, and structural constructs 
such as SES, educational level, type of health insurance coverage, and obesity. Several of 
the studies in this section evaluated the relationship between stage at diagnosis o f breast 
cancer, and many o f the variables proposed to be examined in this study. Age, race, SES, 
preventive health practices such as BSE, CBE, and mammograms, as well delays related 
to the diagnosis and treatment of breast cancer, and their relationship to stage at diagnosis 
outcomes in African American and Caucasian women have been systematically examined . 
In many instances, the findings were inconclusive. Late stage at diagnosis was repeatedly 
demonstrated to be associated with African American women. Young African American 
women, in particular, were found to have more advanced disease and larger tumors. 
However, many o f  the African American women in the studies presented above were from 
low SES; and it is not clear if these differences between the African American and White 
women in these studies are associated with race, health insurance coverage, or SES. 
Studies examining access as a multifaceted concept are needed to help provide knowledge 
and understanding this phenomena.
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Socioeconomic Status
The major factor related to late stage at diagnosis is low socioeconomic status, 
which has been demonstrated to result in diminished resources and lack o f access to health 
care services (Freeman & Wasfie, 1989; Griffin, 1994;). The studies presented in this 
section evaluate the impact of SES on access to breast health care and stage at diagnosis 
of breast cancer.
Wells and Horm (1992) examined the influence o f race and socioeconomic factors 
on stage at diagnosis o f breast cancer in cases of invasive breast cancer in 17,949 White 
women and 2838 Black women, reported through the U. S. National Cancer Institutes 
Surveillance Epidemiology and End Results (SEER) program in the San Francisco- 
Oakland, Detroit, and Atlanta metropolitan area from 1978 to 1982. In situ cases of 
breast cancer were also available for analysis in this study, 917 among White women and 
126 cases among Black women. The researchers chose the median family income strata to 
ensure that each race group contained enough persons for meaningful analysis; and race- 
specific indicators of median education and family income were used because Whites and 
Blacks residing in the same census tract areas were found to have different education 
and/or income distributions. The Spearman rank correlation coefficient was computed to 
test the relationship between stage at diagnosis of breast cancer and income and education. 
The study findings revealed that Black women were diagnosed at a later stage than White 
women; and that there were 45.7 percent of the Black women diagnosed in localized or in 
situ stages compared to 52.1 percent of the White women. Eleven percent of the Black 
women were diagnosed with breast cancer that had metastasized into the distant stage
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compared to seven percent o f the White women. The study findings also revealed a less 
advanced stage with increasing educational level or income among both Black and White 
women (P < .001). Black women in the lowest educational and income strata had a 
poorer stage o f disease at presentation than did White women; and Black women in the 
upper educational and upper income strata had a slightly better stage of disease at 
diagnosis than White women. Both Black and White women in the upper education and 
income strata were found to have a higher incidence of breast cancer. This increase in 
incidence was attributed to  the higher incidence rates of in situ and localized breast cancer 
in this group o f women. Incidence o f breast cancer in the distant stage was found to 
decrease with increasing education and income; and the differences between education and 
income factors influence on stage at diagnosis of breast cancer was found to be more 
striking in Black women.
Wagner and Schatzkin (1994) used several sources o f  existing data to determine 
temporal trends in breast cancer mortality in American women by age, race, and 
socioeconomic status from 1969 through 1989. County level socioeconomic data relating 
to the median family income and percentage of persons in a household 25 years of age or 
older with a high school education, were obtained from the area resource file for the 1970 
and 1980 census years. Mortality data was obtained from the compressed mortality file 
and was also county based. Mortality data on White women was available separately for 
1968 through 1989; and on Black women separately for 1979 through 1989. Detailed 
death records obtained from the mortality files of the National Center for Health Statistics 
and population estimates provided by the National Cancer Institute were used to obtain
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mortality data for Black women from 1969 through 1972. The study findings revealed 
that from 1969 through 1972 to 1987 through 1989, mortality climbed 21.4 percent for 
Black women age 25 to 44; 38.3 percent for Black women age 45 to 65; and 54.3 percent 
for Black women over age 64. For White women, in the same time period, mortality 
declined 14.4 percent among younger women and 5.1 percent among middle aged women; 
but mortality increased by 14.7 percent for older White women. The researchers also 
found that breast cancer mortality increasing among both race groups, had risen more 
rapidly in the lower socioeconomic strata counties. In women 45 to 64, breast cancer 
mortality was supported to be declining in women in higher socioeconomic strata counties 
and rising in lower socioeconomic strata. In women 25 to  44 years of age, breast cancer 
mortality was demonstrated to be decreasing in both higher and lower socioeconomic 
strata counties, but at a higher rate of decrease in higher socioeconomic strata counties.
Franzini, Williams, Franklin, Singletary and Theriault (1997) examined the effects 
of race and SES on survival in 964 White, 205 Hispanic, and 163 Black women treated for 
breast cancer at the University of Texas M. D. Anderson Cancer Center from 1987 to 
1991. Demographic information including race and ethnicity, age at diagnosis, and ability 
to pay for health care, was collected on the women included in this study at registration. 
The clinical variables examined in this study included stage o f disease at diagnosis, 
histology, treatment administered in the first four months, and participation in a clinical 
research protocol. Racial differences in demographic, disease, and treatment 
characteristics were assessed using odds ratios and their corresponding 95 percent 
confidence intervals. The Mantel-Cox test was used to assess differences in the survival
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curves between subgroups; and the independent effects o f race, age, stage, treatment,
SES, and histology on survival was assessed using the multivariate Cox proportional 
hazards model, after adjusting for the effects o f all other factors included in the model. 
Overall there was no notable difference in the age distribution between Black and White 
women but Hispanic women were diagnosed at younger ages. Black and Hispanic women 
were less likely to be in high SES groups, and Black women tended to be poorer 
economically when compared to Hispanic women. When compared to White women, 
early stage disease was less prevalent among Hispanic and Black women. Black women 
tended to have more distant metastasis when compared with Hispanic women and a higher 
percentage o f Hispanic women had disease that involved lymph nodes. The differences in 
treatment by either race or SES were negligible when adjustments were made by stage of 
breast cancer at diagnosis. Histological type did not differ by race. There were significant 
(P = 0.0005) differences in survival by race. The differences continued to be significant 
across race (P = 0.02) when stratified by stage, but differences in survival by race were 
eliminated when both stage at diagnosis and SES were controlled for (P =15). Women in 
lower SES had significantly poorer survival (P < 0.0001). Adjusting for stage at diagnosis 
(P = 0.003)and for stage and race (P = 0.008) did not eliminate these significant survival 
differences. Race and histology were not significant independent predictors of survival; 
however, age, stage at diagnosis, protocol participation, treatment choices, and SES were 
all found to be significant independent predictors of survival (P < 0.05). When the 
relationship between race and SES was investigated, the excess risk for Black women was 
found to be 98 percent when compared to White women. The excess risk decreased to
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non-significance at 34 percent in Black women when all prognostic variables were 
controlled. Prognostic variables explained 66 percent of the unadjusted excess risk in 
Black women in this study; stage at diagnosis explained 38 percent, and SES explained 45 
percent.
Heck, Wagner, Schatzkin, Deveas, & Breen (1997) assessed the relationship 
between socioeconomic status and breast cancer mortality by examining educational 
levels on death certificates of women dying between 1989 and 1993. Death certificates of 
women 25 years or older, whose death certificate listed breast cancer as the underlying 
cause o f death were included in the study. Ethnic groups were categorized as Hispanic, 
non Hispanic White, non Hispanic Black, and non Hispanic Asian. Educational levels 
were categorized as 0 through 8 years, 9 through 11 years, 12 years, 13 through 15 years, 
and 16 or more years o f education. Data were collected by review o f death certificates 
and analyzed using the SAS program. The researchers found that women with fewer than 
12 years of education had lower mortality rates than women with at least twelve years; 
and the highest rate of breast cancer mortality was found among women with 12 years o f 
education and among those with 16 years or more of education. Asian women in this 
study had the lowest age adjusted mortality rates, while Black non Hispanic women had 
the highest rates, followed by White non Hispanic women. Within each non White 
population o f this study, the mortality rate for breast cancer increased with greater 
education through 12 years. The mortality rate for non Hispanic Black women with 16 or 
more years o f  education was similar to that of women with 12 years, but lower than that 
of women with 13 to 15 years. The non Hispanic White women included in this study did
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not demonstrate a strong positive gradient o f mortality by educational level. The findings 
of this study are interesting and vary from findings relating to educational level presented 
earlier in this section. In addition, the assumption was made that educational level was an 
appropriate measure o f SES and that the educational level of the decedent as listed on the 
death certificate was accurate. However, the results of this study support the inclusion o f 
SES as a variable in this study.
The studies presented above support a significant relationship between low SES 
and delayed diagnosis of breast cancer. Other factors such as age, educational level, stage 
at diagnosis of breast cancer, tumor characteristics, and treatment modalities, were also 
found to be significant predictors of breast cancer outcomes. In Black women high 
educational levels were associated with both early stage at diagnosis and high mortality. 
Delayed diagnosis of breast cancer was demonstrated to be more prevalent in African 
American women when compared to White women; but since low SES seemed to be more 
prevalent in the African American women than in the White women included in these 
studies, it is not clear if the poorer outcomes in African American women are associated 
with race, SES, or a combination o f the two. Nevertheless, there is strong support for the 
inclusion o f SES in this study as a variable o f potential access
Means of Discovery o f Breast Cancer 
The American Cancer Society and the National Cancer Institute recommend three 
strategies for early detection o f breast cancer: mammography, clinical breast exam (CBE), 
and breast self exam (BSE). Mammography has been promoted as the optimal prevention 
strategy for breast cancer, and its effectiveness as a screening procedure for detecting
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breast cancer at an early stage has been well documented in the literature (Champion & 
Miller, 1996; Crooks & Neutens, 1993; Frazier, Jiles, & Mayberry, 1996; Long, 1993; 
Miller & Champion, 1996; Thomas, Fox, Leake, & Roetzheim, 1996 ). Mammography 
results have been estimated to be 75-90 percent effective in detection o f  breast 
abnormalities, and mammography used in conjunction with CBE has been proven to be 
very effective. Although not recommended as the only breast cancer screening activity, 
BSE has also been proven effective in discovery o f breast abnormalities.
BSE is a useful method because (a) most tumors are found by women themselves 
either accidentally or during self examination; (b) retrospective data show that 
patients diagnosed at earlier stages o f breast cancer were more likely to have 
practiced regular BSE than patients diagnosed at later stages; (c) the cost benefit 
ratio of mammography may not be advantageous for women < 40 years of age 
who have a lower incidence of breast cancer than older women; (d) mammography 
screening may not be readily available to all women, especially those in rural and 
poor inner city locations; and [(e)] screening mammography is recommended every 
1-2 years for women > 50, thus creating a need for BSE practice between 
mammographies (Han, Baumann, & Cimprich, 1996, p. 197).
Therefore, mammography conducted in conjunction with CBE and BSE is the 
recommended approach for effective breast cancer screening and early diagnosis of breast 
cancer.
The relationship between breast cancer survival and early stage at diagnosis is weB 
documented in the literature (Chu et al., 1996; Harris, Lippman, Veronesi, Willett, 1992;
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Kirkwood, Lotze, & Yasko, 1996; McPherson, Swenson, Jolitz, & Murray, 1997: 
Pederson & Trigg, 1995; Phillips, 1991). Early detection and treatment o f breast cancer 
is extremely important, and breast cancer diagnosis initiated by breast cancer screening 
activities (BSE, CBE, or mammography), is more likely to be diagnosed in an earlier 
stage than breast cancer discovered incidentally or secondary to some other medical 
condition. Numerous studies have looked concurrently and individually at African 
American and Caucasian women’s participation in breast cancer screening, and have 
identified access, cultural, social, personal, and economic barriers to participation in breast 
screening activities and breast health care programs (Adderley-Kelly & Green, 1997; 
Bakker, Lightfoot, Steggles, & Jackson, 1998; Bowen, Hickman, Powers, 1997; Brown & 
Williams, 1994; Burnett, Steakley, & Tefft, 1995; Champion, 1992; Champion & Miller, 
1996; Champion & Menon, 1997; Champion & Scott, 1997; Crane, Kaplan, Bastani, & 
Scrimshaw, 1996; Crooks & Neutens, 1993; Duke, Gordom-Sosby, Reynolds, & Gram, 
1994; Erwin, Spatz, Turturro, 1992; Frazier, Jiles, & Mayberry, 1996; Glenn & Moore, 
1990; Han, Bauman, Cimprich, 1996; Hoffman-Goetz & Mills, 1997; Kurtz, Given,
Given, & Kurtz, 1993; Lerman, Rimer, Trock, Balshem, & Engstrom, 1990; Lierman, 
Young, Kasprzyk, & Benoliel, 1990; Lierman, Young, Powell-Cope, Georgiadou, & 
Benoliel, 1994; Mandelblatt, et al., 1993; Miller & Champion, 1996, 1997; Miller &
Hailey, 1994; Morgan & Levin, 1995; Nemcek, 1990; Olsen & Frank-Stromborg, 1994; 
Olson & Morse, 1996; Patterson, Helvie, Joynt, Roubidoux, & Strawderman, 1998; 
Persson, Svensson, & Ek, 1997; Phillips & Wilbur, 1995; Sensiba & Stewart, 1995; 
Tessaro, Eng, & Smith, 1994; Thomas, Fox, Leake, & Roetzheim, 1996; Thompson,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Montano, Mahloch, Mullen, & Taylor, 1997; Valdini & Cargill, 1997; Williams, Abbott,
& Taylor, 1997) . However, these studies have not examined the impact o f these barriers 
on stage at diagnosis or breast cancer mortality. The studies listed above focused on 
uncovering reasons why women did or did not participate in breast health programs, and 
on identifying intervention strategies to increase involvement in breast cancer screening 
activities. Few studies have looked primarily at the relationship between participation in 
breast cancer screening activities and stage at diagnosis of breast cancer; and even fewer 
studies have examined the impact of race or economic access on this relationship. Several 
studies have examined differences in participation in breast cancer screening by race, 
secondary to exploring the relationship between race, SES, economic access, and stage at 
diagnosis of breast cancer (Franzini, Williams, Franklin, Singletary, & Theriault, 1997;
Eley et al., 1994; Hunter et al., 1993; Newman & Alfonso, 1997; Wells & Horm, 1992). 
The results of these studies were presented earlier in the literature review section. 
Therefore, the following section includes studies which concurrently examine breast 
cancer screening activities in African American and Caucasian women in relation to breast 
cancer diagnosis and survival outcomes. Studies looking primarily at BSE or CBE and 
their relationships to stage at diagnosis in African American and Caucasian women could 
not be located. Examination of CBE practices was consistently included in studies 
examining use o f mammography. Therefore, the following section is comprised of studies 
which examine all three screening activities, and studies focusing primarily on utilization of 
CBE and mammography in samples composed o f African American and Caucasian 
women.
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Vernon et al. (1992), used data from the 1987 American Cancer Society Texas 
Breast Screening project to examine attitudes and behaviors related to breast cancer 
screening in a multiethnic sample of women. The study included a population o f  31,000 
White, 1800 Hispanic, and 1100 Black women age 35 and older. There were more Black 
(30 percent) and Hispanic (28 percent) women in the younger 35 to 39 age group than 
White women (17 percent); and Black (16 percent)and Hispanic (16.4 percent) women 
had proportionately more women in the lowest (< 13,000 annual household income) 
income category, when compared to White women (8.6 percent). A higher proportion of 
Hispanic women had less than a high school education (19.2 percent), when compared to 
Black (9 percent) and White (7 percent) women. Vernon et al. used the chi-square test to 
compare the frequency of breast cancer screening behaviors across these groups o f women 
and found that White women (33 percent) were more likely than Black (27 percent) and 
Hispanic (24 percent) women to have had a mammogram prior to participating in the 
screening project. Income level was associated with prior mammography only in the 
White women, and educational level was not associated with prior mammography in any 
of the ethnic groups. In all three groups, women who had prior CBE were more likely 
than women who had not had prior CBE to report prior mammography. White and 
Hispanic women who practiced BSE were more likely than women who did not practice 
BSE to have had prior mammography. This pattern was also observed in the Black 
women in this study but was not statistically significant (P = 0.078). In all groups, women 
with a history o f breast cancer in their family were more likely to have had a mammogram 
prior to the screening project than those without a history. The two most important
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reasons for not having had a prior mammogram given by the women in this study were 
cost and lack o f physician referral. Lack o f physician referral ranked first for Black and 
White women; and cost ranked first for Hispanic women. Cost, as a reason for not having 
had a prior mammogram, was inversely associated with educational level in all three ethnic 
groups.
In a descriptive study, Douglass, Bartolucci, Waterbor, and Sirles (1995), 
administered the Breast Cancer Control and Health Beliefs Questionnaire to a group of 
117 African American and 157 White women educators employed by a public school 
system, to identify differences in health beliefs and practices regarding mammography, 
CBE, and BSE. Women included in the study were recruited from a list of randomly 
selected schools, within a selected school system, within a selected state, based on current 
employment as a professional educator, age 35 years or older, and no personal history of 
breast cancer. The mean age of the sample was 47.62 for the African American women 
and 44.71 for the White women. The SES score was calculated using Green’s two-factor 
procedure, and the difference in scores for the two groups of women was not statistically 
significant. The chi-square test was used to test for significant differences between the 
two groups on frequency of use of mammography, BSE, and CBE. The difference for the 
frequency of use of mammogram and CBE was not statistically significant (P = 0.735; P = 
0.083 respectively). The difference for BSE frequency approached significance (P = 
0.058), with a larger proportion o f the African American (41 percent compared to 31 
percent) women reporting performance o f  BSE during the previous 12 months. Analysis 
of variance was used in the calculation o f differences in health belief scores between the
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two groups. When compared with African American women, White women had a 
significantly higher (P = 0.002) mean score for perceived barriers to mammography and 
CBE (P =.05). The researchers looked at race as a predictor o f the use o f breast cancer 
screening modalities using logistic regression, and found no significant differences (P = 
0.50 - 0.99) in the ability of the health belief model to predict use of mammography, CBE, 
or BSE, according to  race.
Michels, Carter, Taplin, and Kugler (1995) examined barriers to mammography 
use in women eligible for military health care at Madigan Army Medical Center in 
Washington state. Data were collected using a questionnaire developed by the 
researchers. A random sample of zip codes in the Madigan Medical Center service area 
was obtained through the Defense Eligibility Enrollment Reporting System (DEERS) and 
500 questionnaires were mailed to women 40 years or older, who had been randomly 
selected based on two o f the digits in their social security numbers. A total o f 440 women 
responded to the survey, and 309 of those responding were eligible for inclusion in the 
study. Chi-square, analysis of variance, and Pearson’s correlation were used to conduct 
statistical analysis. The age of the respondents ranged from 41 to 89; 72.4 percent of the 
women were white, 10.7 percent African American, 15.9 percent Asian American, 3.7 
percent Hispanic, and 1 percent were of other ethnic origin. The proportion of women 
with less than a high school education was 22.6 percent, while the proportion o f women 
with greater than a high school education was 13 percent. The proportion o f  women with 
annual income levels less than $10,000 was 19.6 percent, and the proportion with income 
levels greater than $50,000 annually was 2.1 percent. A total o f 21.5 percent o f the
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women in the study had never had a mammogram; 39.2 percent had a mammogram within 
the past year, 56.4 percent within the past two years, and more than five years had passed 
since 10.8 percent o f the women in this study had had mammograms. Women with higher 
income levels, with a higher risk factor for breast cancer, and with a higher perceived risk 
of breast cancer were more likely to have participated regularly in mammography.
Women with a higher rate of mammography participation were more likely to state that 
their provider or the media recommended mammography. The researchers did not detect 
any difference between women with higher participation and all other women in the study 
based on age, race, education, insurance coverage for mammography, or military versus 
civilian source o f care. Overall, 12.8 percent o f the women included in this study 
participated in regular mammography, compared to 31 percent of the women in the 
general population.
Benedict, Williams, and Hoomani (1996) conducted a retrospective study of 
women diagnosed with breast cancer to determine the means of discovery according to 
adherence to American Cancer Society (ACS) guidelines for BSE, CBE, and 
mammography; and according to age, race, family history and educational level. A 
questionnaire with demographic questions, questions about the women’s breast cancer 
detection practices, and method of discovery of breast tumor was developed and mailed to 
women from the mailing list of a breast cancer support group in Charleston, South 
Carolina. O f the 190 questionnaires mailed, 188 were returned and 51 were selected for 
inclusion in the study based on the time o f diagnosis fitting within a 1990 to 1992 time 
frame. Nine o f the women included in the study were Black and 41 were White. The
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mean age at the time o f diagnosis for the Black women was 49.75 years as compared to 
50.08 years for the White women. The mode o f highest educational level for the Black 
women was “some college” (44%) as compared to “junior high school” (26.8%) for the 
White women; and 22.2 percent of the Black women had a family history of breast cancer 
as compared to 19.5 percent o f the White women. Method of discovery according to 
stage at diagnosis was extracted from the questionnaires of 20 women. Of the stage 1 
cancers diagnosed in the women in this study (n=13), 61.5 (n=8) percent were discovered 
by mammogram, as compared to 23.1 (n=3) percent by BSE, 7.7 (n=l) percent by 
accident, and 7.7 (n=l) percent by another person. One-hundred percent of the stage 3 
(n=2)cancers were discovered by BSE, and stage 4 (n=2) discoveries were equally divided 
(50%) between BSE and CBE. Within the stage 2 (n=12)grouping, 58.3 (n=7) percent of 
the discoveries occurred by BSE, 16.7 (n=2) percent by accident, and 16.7 (n=2) percent 
by mammogram. O f the Black women included in the study, 11.1 percent of the cancers 
were discovered by BSE, 33.3 percent by accident, and 55.6 percent by mammogram. Of 
the White women in the study, 34.1 percent of the cancers were discovered by BSE, 7.35 
percent by accident, 31.7 by mammogram, 7.3 percent by CBE, and 7.3 percent by 
another person. Twenty-two of the Black women in the study had mammograms every 1 
to 2 years before diagnosis, as compared to 56 percent o f the White women, and 55.6 
percent of the Black women performed BSE in the 12 months prior to diagnosis as 
compared to 51.2 percent o f the White women. Because o f the small sample size o f Black 
women, and the unequal group size (Black and White women), inferential statistics were 
not conducted.
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O’Malley, Earp, and Harris (1997) used data from the New Hanover Breast 
Cancer Screening program, a National Cancer Institute Consortium project conducted 
between 1987 and 1991 in two eastern North Carolina counties, to examine racial 
differences in mammography use in Black and White women . The researchers obtained 
data from a 1988 random digit dialing telephone survey of 1214 women age 30 to 74 
years. A total o f 948 Black and White women age 50 to 74 years were included in this 
study. Chi-square tests, t tests, Wilcoxon rank sums, Kruskal-Wallis chi-square 
approximations, and logistic regression analyses were used to compare attitudes and 
characteristics by race and by mammography use. Approximately 90 percent of the 
women included in this study were aware of mammography; 46 percent reported a prior 
mammogram; and 32 percent reported having a mammogram in the past year. Black 
women reported ever having had a mammogram (27 percent) approximately half as often 
as White women (52 percent); and White women reported having had a physicians’ 
recommendation for mammography twice (52 percent) as often as the Black women (25 
percent) in the study. When factors related to race and mammography use were 
controlled for, the initial racial differences in mammography use were eliminated.
Physician recommendation alone accounted for 60 to 75 percent of the mammography use 
differences by race.
In a cross sectional descriptive study, Dibble, Vanoni, and Miaskowski (1997) 
examined women’s attitudes toward breast cancer screening procedures from ten sites in a 
major metropolitan area in California. The study was conducted with a convenience 
sample of 233 White, 127 African American, 118 Pacific Islanders, 61 Hispanic, and 58
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Asian American women age 18 years or older, recruited from public health centers, mobile 
mammography vans, and hospital based radiology departments. Data were collected using 
a demographic questionnaire and the Attitude Toward Breast Cancer Screening 
Procedures Scale. Differences in women’s attitudes by ethnicity were calculated using 
descriptive statistics, analysis of covariance, and the Tukey post hoc analysis procedure. 
Mean scores o f the demographic characteristics of the sample were also calculated and 
included in the data analysis. The mean age of the participants was 53 years; 48 percent 
were married or partnered; 81 percent had children; 62 percent were currently employed; 
and 44 percent had an annual family income of less than $20,000. The average years of 
education was 13.9. Seventy-nine percent o f the women had had a previous mammogram; 
and 4 percent had been previously diagnosed with breast cancer, while 23 percent had 
experienced a lump in their breast. After controlling for age, education, number of 
pregnancies, marital status, income, employment status, previous mammogram, lump and 
family history, significant differences by ethnicity (F = 6.65, P < .0001), in the scores on 
the Attitude Toward Breast Cancer Screening Procedures Scale were detected. The 
African American women in this study had the most positive attitude towards breast 
cancer screening procedures.
Roberson (1997), compared breast cancer screening outcomes among 282 African 
American and 1079 White women participating in a multistrategy cancer control 
intervention in western New York. Data were collected from women who participated in 
the intervention between mid 1994 and mid 1996 using a screening intake form. Data 
collected included demographic information, as well as information regarding health
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practices, risk factors, screening status, and clinical findings. The mean age for African 
American women included in the study was 50 years as compared to 56 years for White 
women. Twelve or more years of high school had been completed by 79 percent o f  the 
African American women, as compared to 82 percent o f the White women. Across both 
groups, annual family incomes o f less than $15,000 were reported in 99 percent o f  the 
women studied. A significant difference in the health insurance status o f African American 
and White women was noted (P < .001). Twenty-four percent of the African American 
women reported Medicare and Medicaid as their primary source of health care insurance, 
while 75 percent reported having no health insurance coverage. Twenty-five percent of 
the White women reported having Medicare and Medicaid as their source o f health care 
insurance, and 53 percent reported having no insurance at all. Sixty-one percent o f  the 
White women in the study reported that they had a previous mammogram as compared to 
53 percent of the African American women (P < .002). Twenty four percent o f the White 
women reported that they practiced BSE monthly as compared to 33 percent o f the 
African American women included in this study (P < .009). Twelve percent of the African 
American women presented with breast abnormalities that were probably benign and 
required short term follow-up, as compared to 11 percent o f the White women; and 6 
percent o f the African American women were found to have breast abnormalities by 
mammogram, as compared to 5 percent o f the White women in this study. This study was 
limited in that it studied a sample of relatively low-income women. However, the study 
found that women in this low income group, who participated in cancer control 
interventions, were similar in educational and income levels. This study supported
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findings of other studies presented above, in that the African American women, in this 
study, were more likely to participate in BSE than were the White women. However, the 
White women in this study were slightly more likely to have had a previous mammogram 
than the African American women.
In the studies presented above, race was not a significant predictor of participation 
in breast cancer screening programs. In two of the studies, African American women were 
found to be more likely to participate in breast cancer screening than White women; and 
African American women were found more likely to practice self exam than White 
women. In another study, even though the percentage o f mammogram discovered breast 
cancer was higher for the African American women than for the White women, African 
American women were found to have had a lower percentage of mammography screening 
participation prior to breast cancer diagnosis, when compared to White women. Barriers 
to accessing breast cancer screening were attributed to the individual as well as the health 
care delivery system. In the study conducted on mammography use by women eligible for 
care within the MHS, mammography rates were found to be lower than those in the 
United States overall. Income level and cost of mammography were primary factors 
associated with prior mammography use by the women in the studies presented above. 
Physician referral was also demonstrated to be a major factor associated with 
mammography use; and physician referral is associated with economic access to care.
Even though most o f the studies presented above did not present results relating to the 
association between the particular means of discovery o f breast cancer and stage at
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diagnosis o f  breast cancer, there is support for inclusion o f this variable (the means of 
discovery o f breast cancer) in this study, as a measure o f potential access.
Realized Access and Stage at Diagnosis o f Breast Cancer 
Evaluation of the utilization o f health services by the consumer is a key factor in 
examining health care access; and the willingness of the consumer to seek care is crucial, if 
potential access is to become realized access (Aday & Andersen, 1974; Aday, Andersen,
& Fleming, 1980; Aday, Fleming, &, Andersen, 1984). The disposition of the consumer to 
utilize services is influenced by economic access concerns and social and cultural 
definitions o f  health and illness; as well as, attitudes towards and knowledge of health care 
(Adams, 1995; Bayne-Smith, 1996; Donnelly, 1995; Frank-Stromborg & Olsen, 1993; 
Jennings, 1996; Kagawa-Singer, 1995. 1997; Olsen & Frank-Stromborg, 1993; Palos, 
1994). As a result, economic access and realized access are not always synonymous, and 
timeliness in the utilization of services, by the consumer, can become an important factor 
in determining health care outcomes.
Women vary in their response to the discovery o f breast cancer symptoms . Some 
women seek provider attention and treatment immediately upon discovery, and other 
women delay diagnosis and treatment for greater than two years (Facione, 1993; Facione, 
Dodd, Holzemer, & Meleis, 1997; Katz, Hislop, Thomas, & Larson, 1993; Lauver, 1992a, 
1992b; Lauver & Angerame, 1993; Lauver & Ho, 1993; Lierman, 1988; Vernon, Tilley, 
Neale, & Steinfeidt, 1985). The relationship between delayed diagnosis and treatment of 
breast cancer, and increased mortality, has been well established (Bedell, Wood, Lezotte, 
Sedlacek, & Orleans, 1995; Hunter et al., 1993; Long, 1993; Mandelblatt, Andrews, Kao,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
67
Wallace & Kemer, 1995; Simon & Severson, 1996); and has been presented in earlier 
sections o f  this literature review. Therefore, the following section focuses on studies 
examining factors associated with diagnosis and treatment delay o f breast cancer, in 
samples including both African American and Caucasian women.
Diagnosis Delays
Coates et al. (1992) explored differences in the length o f time between symptom 
recognition and initial medical consultation between 410 Black and 325 White women, 
newly diagnosed with breast cancer in 1985 or 1986, from the Atlanta, New Orleans, and 
San Francisco/Oakland areas. The researchers conducted in person interviews to obtain 
information specific to race and recognition of breast cancer symptoms; and collected 
retrospective data on symptoms, dates o f recognition, and initial medical consultation. 
Tests used to conduct the statistical analyses included the Mantel-Cox test, Cox 
proportional hazards regression analysis, and logistic regression analysis. Women who 
had their breast cancer diagnosed prior to symptom recognition were more likely to have 
been White and older; to have smaller, earlier stage, lower grade tumors; and to have lived 
in the San Francisco/Oakland area. White women were more likely than Black women to 
have obtained medical consultation on each day after the first three days following 
symptom recognition; and 32 percent o f the Black women, compared to 40.3 percent of 
the White women had obtained medical consultation by the seventh day following 
symptom recognition. The difference in the median symptom duration was of borderline 
significance (P = .06) at 16 days for Black women compared to 14 days for White women. 
Even though Black women were two times more likely than White women (6.6 percent
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compared to 3.1 percent) to have stage IV breast cancer when diagnosed, and one and on- 
half times more likely to have stage EH breast cancer when diagnosed than White women 
(21.2 percent compared to 13.5 percent), the small racial difference in time between 
recognition o f symptoms and initial medical consultation could not explain the racial 
differences in stage or tumor size at diagnosis.
Lauver, Coyle, and Panchmatia (1995) assessed women’s reasons for and barriers 
to seeking care for breast cancer symptoms in a multiethnic sample o f 138 women 
recruited from a breast clinic in an urban teaching hospital providing care to the medically 
indigent. The women included in the study varied in age from 19 to 76 years. Sixty-three 
of the participants were Caucasian, 71 were African American, and 4 were Asian and 
Latina. Thirty-two percent of the women had not finished high school as compared to 
30.4 percent with a high school education. O f the women included in the study 22.5 
percent had completed some college and 15.2 percent had finished college. The median 
annual family income of the women was $12,000, with a range of $0 to $300,000. In 
regard to health care insurance, 58.7 percent o f the women were covered by public 
assistance; 26.8 percent by private insurance; 3.5 percent by private and public monies;
3.6 percent by Medicare; and 7.4 percent did not report a source o f health insurance 
coverage. The researchers determined delay in seeking care by calculating the number of 
days between the woman finding a breast change and the woman’s contact with the health 
care delivery system, concerning the change, by telephone or in person. Twenty-three 
percent o f  the women were discovered to have delayed three months or longer. Thirty- 
eight percent o f the women sought care within one week of symptom discovery; 49
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percent within two weeks; 65 percent within six weeks; and 77 percent within three 
months. Fifty percent of the women reported no barriers to seeking care for breast 
changes, and sought care sooner (mean = 53 days, median =11 days) than those women 
citing particular barriers to care (mean = 143 days, median = 32.5 days). The barrier most 
commonly cited as interfering with care seeking was conflicting commitments (15.8 
percent o f  responses); followed by limited finances/insurance (11.8 percent); fear or 
avoidance (9.9 percent); transportation problems (6.6 percent); lack of knowledge of how 
to access the system (3.3 percent); and other reasons (2.6 percent).
Caplan, Helzlsouer, Shapiro, Wesley, and Edwards (1996), examined reasons for 
system delay in breast cancer diagnosis, from the initial medical consultation to 
establishment of a diagnosis, in women from the National Cancer Institute’s Black/White 
Cancer Survival Study. There were 1,222 women eligible for inclusion in the Black/White 
Study. Data collection methods for the study included medical record review, centralized 
pathology review, and personal interview. The personal interview collected data on 
previous health practices, symptom recognition, care seeking behaviors, dietary patterns, 
personal health practices, attitudes toward the health care system, SES, and reasons for 
delay. Women were included in this study based on a system delay of four or more weeks 
between the initial medical consultation for a breast cancer symptom, and diagnosis of 
breast cancer. These inclusion criteria yielded a sample of 367 women. The Chi-square 
test was used to compare the Black and White women regarding basic demographics, 
symptom status, stage at diagnosis, and delay. Fifty-five percent o f the study sample was 
Black, and most o f the study sample used a private physician as their primary source of
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care. The White women were significantly more likely than the Black women to be 
asymptomatic at the time of initial presentation; and Black women were significantly more 
likely than White women to have advanced disease. The median system delay for Black 
women was 11 weeks as compared to 13 weeks for White women. Most women in both 
groups (45 percent) attributed delay to the health care system, due to physician inaction or 
difficulty scheduling appointments. When compared to White women, more Black women 
attributed system delays to scheduling delays, rather than to physician inaction. Women 
attributing delay in diagnosis to themselves (25 percent) tended to have more advanced 
disease. The reason most often given for delay by both groups o f women was that the 
problem was not important or urgent (37.6 percent); followed by the event o f a birthday, 
holiday, or out o f town commitment (17.8 percent); competing health problems (14 
percent); being too busy (12.7 percent); and fear (12.7 percent). Seventeen percent of 
the women in the study attributed delay to both themselves and the health care delivery 
system.
Even though the studies presented above primarily examined the length of time 
between discovery and initial contact with the health care delivery system, there is support 
for the inclusion of the length of time between discovery of a breast abnormality and the 
diagnosis o f breast cancer as a measure of utilization of health care services, in this study. 
Mean score diagnosis delays were comparable for African American and White women 
with no significant differences being reported above. Reasons for delay were attributed to 
characteristics o f both the individual and health care delivery system. Even though the 
perception o f barriers was found to delay care seeking in one of the studies presented
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above, the barrier most frequently cited in two of the studies in this section related to 
characteristics o f the individual, rather than characteristic o f the health care delivery 
system. Advanced disease was found to be higher in African American women than in 
White women in one of the studies; however, there was no significant difference in mean 
diagnosis delay scores between these two groups.
Treatment Delays
Bedell, Wood, Lezotte, Sedlacek and Orleans (1995) examined delay in diagnosis 
and treatment o f breast cancer in 225 women diagnosed with breast cancer between 
January 1, 1992 and December 31, 1993. The Colorado Central Cancer registry was used 
to identify women and data were collected from the medical records at three sites: a 
public hospital, a university hospital cancer center, and a private practice. Data were 
abstracted from the records of 52 women from the public hospital, 83 women from the 
university hospital, and 90 women from private practice, and included information on age 
at diagnosis, race, insurance status, stage at diagnosis of breast cancer, the initial breast 
cancer symptom, the date of the first medical consultation, the date of the biopsy for 
definitive diagnosis, and the date o f the initiation of treatment. The analysis o f the data 
focused on the length of time in days between the first medical consultation and biopsy 
for definitive breast cancer diagnosis, and the length of time in days between definitive 
diagnosis and the initiation of treatment. Sources for delay were divided into three 
categories. System delay referred to delay resulting from routine practices o f the specific 
health care delivery system, and included such sub-categories as scheduling delay or time 
spent waiting for appointments; cancellation or postponement o f appointments; delay in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72
reporting examination or test results to the provider; and delay attributed to lost or 
unavailable records. Provider delay referred to delay relating to physician or other health 
care provider behaviors, such as a work-up exceeding 14 days; a justifiable delay 
occurring when evaluation had not revealed cancer but the case was being closely 
followed; and misdiagnosis of cancer symptoms. Patient delay referred to delay relating to 
patient behaviors. Patient delay included sub-categories such as a prolonged period of 
decision making; refusal of further medical evaluation or treatment; concerns related to 
finances; scheduling rearranged for the patient’s convenience; and the patient’s seeking a 
second opinion. The Wilcoxon rank sum test and chi-square were used to conduct the 
statistical analysis. The majority of the women from the public hospital were Hispanic. 
African American women were seen more often at the public hospital than at the two 
other sites combined; and nearly half o f the women at the public hospital and the 
university hospital were uninsured. Five percent of the women from private practice were 
uninsured; and all three sites had similar proportions of women with Medicaid or Medicare 
as their source of health care insurance. The ages of the women in this study ranged from 
27 to 90 years with a mean age of 53.3. The diagnostic interval median was significantly 
different among the three sites (P = 0.003). The diagnostic interval median at the public 
hospital was 25 days, as compared to 14 days in private practice, and 24 days at the 
university hospital. The treatment interval median was also significantly different among 
the groups (P = 0.029), with a median o f 15 days in the public hospital, 10 days in private 
practice, and 13 days at the university hospital. During the diagnostic interval, differences 
in delay among the three groups was significant only for the system category (P = 0.038).
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There were longer intervals o f delay for the public hospital than for private practice (P = 
0.036) or the university hospital (P = 0.018). However, during the treatment interval, 
significant differences in delay among the three sights were found by system (P = 0.04) 
and by patient (P = 0.019). There were no significant differences across the three sites in 
the treatment interval, by provider. Patient caused delay, during the treatment interval, 
occurred more often in private practice than at any other site. A major finding o f this 
study was the significant difference observed in diagnosis delay between the public 
hospital and private setting. Over 50 percent of the diagnostic delay occurring in the 
public hospital was attributed to system factors. Even though this finding is enlightening, 
the researchers did not include stratification of the sample by race in their report of 
findings, nor did they evaluate the relationship between the diagnosis delay found in the 
public hospital, and the stage o f diagnosis of those women receiving care in that particular 
setting. Nevertheless, the study results support variance in breast cancer diagnosis and 
treatment intervals, by type of health care delivery setting. Even though it is not clear if 
the difference in patient delay occurring in the public hospital is influenced by system 
factors, source of health insurance coverage, or individual characteristics of the patient, 
this study supports the inclusion of both diagnostic and treatment delays as measures of 
realized access.
Conclusion
The review of literature presented above supports the research design for this 
study, and the inclusion o f each o f  the variables in this study’s conceptual framework. In 
addition, the review supports the relationship between economic access to breast health
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care and stage at diagnosis of breast cancer. Variation in breast cancer outcomes was 
found to be associated with the type o f health care insurance coverage; but even when 
health care insurance was comparable within a study population, stage at diagnosis varied 
by age, SES, the means of discovery o f breast cancer, and diagnosis and treatment delays.
Multiple factors are associated with stage at diagnosis o f breast cancer. These 
factors are components of both potential and realized access. Age, race, and SES were 
found to be related to stage at diagnosis and participation in breast cancer screening; and 
participation in breast cancer screening was found to be related to utilization of health care 
services. Even though no studies could be located which specifically addressed the 
relationship between participation in breast cancer screening and stage o f breast cancer at 
diagnosis, the literature presented above supports that women who participate in breast 
cancer screening activities are more likely to be diagnosed with early stage breast cancer 
than those who do not. Diagnosis and treatment delays were found to be associated with 
characteristics of the health care delivery system, as well as characteristics of the 
individual. Therefore, the studies presented above support the relationship between 
potential and realized access.
Many o f the studies presented above used existing data to conduct retrospective 
analyses. Several of the studies conducted retrospective analysis using the same data base. 
Data from the National Cancer Institute’s Black/White Study was analyzed by several 
different groups of investigators. However, each group addressed a set o f different 
research questions; and the variety of inclusion criteria used created a unique sample for 
each study. In addition, the sample sizes and statistical tests were appropriate for the
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research design and the questions being addressed. Therefore the results from the studies 
using the Black/White Study database are felt to be valuable in supporting the existence o f 
a relationship between the variables included in this study’s conceptual model.
Other studies collected data from a single health care institution, or from a specific 
socioeconomic strata or educational level. Even though these data are limited in their 
generalizability, the appropriateness o f the sample size and statistical tests, to the research 
design, make the results of these studies valuable to the construction o f the research 
design o f  this study.
Although several of the studies included in this review examined the majority of 
the variables included in the conceptual model for this study, in aggregate, no one study 
examined all o f the variables proposed for examination in this study, within an equal 
economic access health care setting. Economic access barriers such as health care 
insurance and availability of health care resources were demonstrated to be related to 
delayed diagnosis of breast cancer. However, demographic characteristics, as well as 
personal barriers to participation in breast cancer diagnosis and treatment were also found 
to be related to stage at diagnosis. Even though the review o f literature offers support for 
relationships between all o f the variables in this study’s conceptual model, the impact of 
equal economic access on variables of potential and realized access, and stage at diagnosis 
o f breast cancer, is unclear.
In summary, the review o f literature presented above indicates that research is 
needed to assess the relationship between access (economic, potential, and realized) and 
stage at diagnosis of breast cancer in women being treated for breast cancer inside the 
MHS. Descriptive comparative studies conducted in settings in which health care
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insurance coverage is equal, and distribution of health care resources is adequate, are 
needed to generate a better understanding o f the multiple factors influencing disparity in 
stage at diagnosis between African American and Caucasian women. This knowledge can 
lead to hypotheses development and testing for the purpose o f identifying appropriate 
interventions to increase access to breast cancer screening for all American women.
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CHAPTER m  
METHODOLOGY
The research design, the setting, the population, and the sample are described in 
this chapter. The methods and procedures for data collection, as well as the data analysis 
techniques are also described.
Design
The purpose of this study was to describe the relationship between access and 
stage at diagnosis in African American and Caucasian women being diagnosed with breast 
cancer within the DoD MHS. There was no experimental manipulation o f variables or 
random assignment of subjects, and the data were collected through secondary analysis. 
The research design for this study was non-experimental, descriptive-comparative (Bums 
& Grove, 1993).
Setting
The setting for this study was the Naval Medical Center, San Diego California 
(NMCSD), a health care facility within the DoD MHS. Data were collected in the 
NMCSD Tumor Board Registry, and the source of the data were tumor registry records 
compiled and maintained at NMCSD. The following section provides an overview of: (a) 
the structure o f the NMCSD, (b) the beneficiary population served by NMCSD, and (c) 
the structure and functioning of the NMCSD Tumor Board Registry.
Overview of NMCSD. The medical center is a 535 bed acute care military
77
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treatment facility with an occupancy rate of 66.3 percent and an average daily census of 
254 (Region Nine TRICARE, 1998). Constructed in 1987, NMCSD has the ability to 
expand to 696 beds in contingency situations. In 1995, NMCSD had a total of 1,014, 942 
outpatient visits and filled 1,280,002 outpatient prescriptions. The medical center is 
staffed by civilian and military personnel. In 1995, staffing included 707 clinician full time 
equivalents (FTEs), 521 registered nurse FTEs, 226 allied health professional FTEs, 2103 
para-professional FTEs, and 1095 administrative FTEs. The medical center is accredited 
by the Joint Commission for Accreditation o f Hospital Organizations (JCAHO).
Beneficiary Demographics. There are a total of 257,658 beneficiaries eligible to 
receive health care at NMCSD: 118, 065 females and 139,593 males (Defense Eligibility 
Enrollment Report System [DEERS], 1997). Thirty-one percent o f the eligible 
beneficiaries are family members o f active duty, 24 percent are active duty, 22 percent are 
family members of retired, 17 percent are retired, 4 percent are survivors of retired, 1 
percent are guard reserve, and 1 percent are family members of guard reserve. Thirty-nine 
percent o f the females are ages 18 to 44, 35 percent are ages 45 and older, and 26 percent 
are ages zero to 17. Forty-eight percent o f the males are ages 18 to 44, 29 percent are 
ages 45 and older, and 23 percent are ages zero to 17. According to the DEERS (1997) 
database, 26 percent of those beneficiaries eligible for care at NMCSD are of unknown 
race. O f those beneficiaries with known race, 43 percent are White, 12 percent are 
Asian/Pacific Islander, 11 percent are Black, 6 percent are Hispanic, 1 percent are Native 
American, and 1 percent are of other racial origin.
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NMCSD Tumor Registry. The information included in this section was obtained 
through observations at the NMCSD Tumor Registry, by review o f tumor registry 
certification documents, and by interviewing the NMCSD Tumor Registrar and registrar 
assistants.
The Tumor Registry for NMCSD is located on the medical center compound and 
is staffed by a certified Tumor Registrar (NTRA) and five specially trained tumor registrar 
assistants. The registry staff are responsible for performing a variety of technical duties 
necessary for the development and analysis of diagnostic and therapeutic cancer data. 
These duties include, but are not limited to, case finding, case accessioning, medical 
record abstracting, patient indexing, quality control, and patient follow-up. A brief 
overview of the processes supporting these duties is presented below.
Newly identified cancer cases are placed in the computerized numeric accession 
register, and in the alphabetic master patient index. An abstract is completed for each 
case, and the required follow-up data items are collected. The maximum delay for 
abstracting cancer cases at NMCSD is six to eight months, calculated from the date of 
initial diagnosis to the time the data are available for analysis. All NMCSD tumor registry 
abstracts are computerized. Abstract summaries and supporting medical record and 
follow-up data items are stored in registry files by year and accession number. Data 
collected by the tumor registry are used for special in-house and national studies, and are 
reported to the medical and administrative staff of NMCSD. A quality control plan is in 
place with documentation of procedures to monitor case finding, data collection, accuracy, 
and timeliness; and follow-up information is systematically obtained for patients in the data
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base to ensure that required follow-up rates are met. NMCSD registry data are submitted 
to the National Cancer Data Base (NCDB) for the purpose o f continuous quality 
improvement o f individual cancer programs, and evaluation of cancer therapies and 
outcomes. In addition, NMCSD cancer cases are recorded in the DoD Automated Tumor 
Registry (ACTTJR) and state of California Tumor Registry Reporting Program (CNET). 
The Tumor Registry at NMCSD is accredited by the American College o f Surgeons 
Commission on Cancer.
Population and Sample 
The target population for this study was all Caucasian and African American 
women being diagnosed with breast cancer within the DoD MHS; and the accessible 
population was all Caucasian and African American women being diagnosed with breast 
cancer at Naval Medical Center San Diego between January 1, 1988 and December 31, 
1997. The sampling design for this study was consecutive non-probability sampling 
(Hulley & Cummings, 1988). The sample was composed of two comparison groups, 573 
Caucasian women and 62 African American women. Even though every subject who met 
the selection criteria was included in this study, the minimum number of subjects (64) 
required in each group to conduct the t test at a power of .80, medium effect size of .50, 
and significance level of .05 (Cohen, 1988) were not obtained. In addition, the 
assumptions for conducting the t test were not met. Therefore, the Mann Whitney U test 
was used to detect a significant difference between the two groups, in the length of time in 
days between discovery of breast abnormality and diagnosis of breast cancer, and in the
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length o f time in days between diagnosis of breast cancer and initiation o f treatment 
(Sheskin, 1997).
Instrumentation
The subject’s tumor registry record was the primary source o f data in this study. 
The Breast Cancer Medical Record Data Collection sheet (Appendix A) was the 
measurement instrument used to collect the data. In order to minimize variance and 
increase the precision of measurement, all data were collected by the researcher (Hulley & 
Cummings, 1988), and inter-rater reliability was used to test for equivalence in collection 
of the data (Brink & Wood, 1994; Polit & Hungler, 1995). Data collection procedures 
and details relating to the conduction o f inter-rater reliability are presented in the data 
collection and recording section o f this chapter.
Data Collection and Recording 
A list o f African American and Caucasian women diagnosed with breast cancer 
between January 1, 1988 and December 31, 1997 was drawn from the NMCSD Tumor 
Board Registry computer data base. The list contained a total o f  714 records and was 
used to select records for preliminary screening. All records on the list were initially 
examined by the researcher to determine eligibility for inclusion in the study. Records 
were selected for inclusion in the study based on the subject’s race being identified as non- 
Hispanic African American, Black, Caucasian, or White; the subject’s patient status being 
designated as active duty, retired, or family member; diagnosis o f  breast cancer occurring 
at NMCSD or at another MHS with referral to NMCSD for treatment, and the date of 
diagnosis o f  breast cancer being documented in the tumor registry record as occurring
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between January 1, 1988 and December 31, 1997. In addition, tumor registry records 
were excluded from the study if the subject’s record contained an Hispanic surname 
(maiden name), and if the diagnosis of breast cancer occurred in a civilian health care 
institution with referral to NMCSD after initiation of treatment. Subjects with more than 
one diagnosis o f breast cancer appearing on the list had only the first diagnosis included in 
the analysis.
Finally, a total of 635 records were selected for inclusion in the study, 573 records 
of Caucasian women and 62 records o f African American women. Identification numbers 
were assigned to the data collection sheets to correspond to the subject’s tumor registry 
number, and a log of identification numbers and corresponding tumor registry record 
numbers was compiled and kept in a confidential file by the researcher. Names and tumor 
registry numbers were not included on any o f the data collection tools.
Approximately three months were spent collecting the data, coding the data 
collection sheets, and preparing the data for statistical analysis. Data collection sheets 
were grouped by year and categorized within each year grouping by identification number. 
Each data collection sheet was reviewed for accuracy and double checked with the 
corresponding tumor registry record by the researcher. Double-checked data collection 
sheets were numerically coded by the researcher, and the numerical codes were entered 
into a computerized spreadsheet in preparation for statistical analysis.
Inter-rater reliability was performed by the five tumor registrar assistants on nine 
percent o f  the 635 records included in the study. Each assistant was assigned two years 
between 1988 and 1997, and asked to select six records for review, for each year, from
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the pre-screened list o f African American and Caucasian women. Three of the 60 data 
collection sheets submitted by the tumor registrar assistants were excluded because the 
sheets reported data obtained from the tumor registry records of women with a second 
diagnosis o f breast cancer. There were a total o f 17 categories o f data on each data 
collection sheet, resulting in a total of 969 categories for the 57 data collection sheets used 
for inter-rater reliability. Of the 969 categories, there were 957 matches in each category 
between the data recorded by the researcher and the data recorded by the tumor registrar 
assistants. Inter-rater reliability results indicated that the total percentage of agreement 
between the data recorded by the researcher and the data recorded by the tumor registrar 
assistants was 98.76.
Data Analysis
The data analysis plan for this study involved descriptive and inferential statistics. 
Prior to statistical analyses, the data collection sheets with missing data were identified 
and coded (Norusis, 1997; Stevens, 1996). Missing data in the categories of marital 
status, service branch, and stage at diagnosis were coded as unknown and excluded from 
inferential statistical analysis. Missing data in the categories o f tumor size, number of 
positive lymph nodes, and length of time between diagnosis and treatment were coded 
with negative numbers and excluded from inferential statistical analysis. Because of the 
amount o f missing data within the category o f rank of sponsor, missing data were coded 
as a separate category labeled unknown, and included in the data analysis as a separate 
category (Cohen & Cohen, 1983). The categorical variables o f race, rank of sponsor, and 
means of discovery were dummy coded for the purposes of performing multiple and
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logistic regression (Cohen & Cohen, 1983; Daniel, 1995; Stevens, 1996; Tabachnick & 
Fidell, 1996). Data analyses were performed using the Statistical Package for the Social 
Sciences (SPSS) for Windows. A .05 level o f probability was considered to indicate 
statistical significance for all inferential statistical procedures.
Descriptive statistics Descriptive statistics (mean, standard deviation, minimum, 
maximum, frequency distributions) were utilized to summarize and describe the 
demographic characteristics of the sample, and the variables of the study (Hinkle, 
Wiersma, & Jurs, 1994; Norusis, 1997).
Inferential statistics. The independent samples chi-square test was used to assess 
the relationship between each stage and age, race, socioeconomic status, and the means of 
discovery of breast cancer; to detect any differences in the distribution of stage at 
diagnosis by race; and to examine the relationship between potential (age, race, 
socioeconomic status, means of discovery) and realized (length o f time between discovery 
and diagnosis, length o f time between diagnosis and treatment) access (Fisher & Van 
Belle, 1993; Hinkle, Wiersma & Jurs, 1994; Huck & Cormier, 1996; Sheskin, 1997). The 
Mann Whitney U test was used to test for significant differences between the two groups 
in the length of time between discovery o f breast abnormality and diagnosis, and the length 
of time between diagnosis and initiation o f treatment (Daniel, 1995; Huck & Cormier, 
1996; Sheskin, 1997). Analysis of variance (ANOVA) was used to test for differences 
between the mean scores for age and the five stages o f breast cancer diagnosis, within the 
two groups (Tabachnick & Fidell, 1996; Hinkle, Wiersma & Jurs, 1994) . Multiple 
regression was used to examine the relationships between age and the length of time
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between discovery o f breast abnormality and diagnosis, and the length o f  time between 
diagnosis and initiation o f treatment, between the two groups; and to examine the extent 
to which the predictor variables of age, race, socioeconomic status, and the means of 
discovery of breast cancer predict utilization o f  breast health services (Cohen & Cohen, 
1983; Fisher & Van Belle, 1993; Grimm & Yamold, 1995, Tabachnick & Fidell, 1996). 
Logistic regression was used to examine the extent to which the predictor variables of age, 
race, socioeconomic status, and the means o f discovery o f breast cancer predict early and 
late stage at diagnosis o f breast cancer; and to examine the extent to which utilization of 
health services predicts early and late stage at diagnosis o f breast cancer (Daniel, 1995; 
Fisher & Van Belle, 1993; Grimm & Yamold, 1995; Tabachnick & Fidell, 1996).
Limitations
This study was limited by its methodological design in that it did not include 
randomized selection o f subjects, control over the environment, or manipulation o f the 
variables. Other threats to external validity, such as exclusive focus on women diagnosed 
at Naval Medical Center San Diego, and restriction o f the race examined to African 
American and Caucasian, limit the generalizability o f the study results. Threats to internal 
validity related to the measurement approach include use of the medical record, compiled 
and completed by various other individuals, as the source of data. In spite o f these 
limitations, it is believed that some insight into the relationship between access and stage 
at diagnosis o f breast cancer in African American and Caucasian women receiving care 
inside the MHS has been gained by conducting this study.
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Human Subjects
In order to ensure protection of each subject’s freedom from intrinsic risk or 
injury, and to ascertain rights to privacy and dignity, a variety of human subject protective 
mechanisms were utilized in this study. To begin with, this proposal was submitted to 
both the University o f San Diego and Naval Medical Center San Diego Institutional 
Review Boards for approval. Appendices B and C are the approval letters received from 
these review boards.
The Naval Medical Center San Diego Institutional Review board grants human use 
exemption for research involving the collection or study of existing data, documents, or 
records, if  these sources are publicly available or if the information is recorded by the 
investigator in such a manner that the subjects cannot be identified directly or through 
identifiers linked to the subjects. In addition, the Privacy Act Statement, located in DoD 
healthcare records, specifically allows information to be used for research purposes. 
Therefore, written consent was not obtained from the subjects; however, confidentiality of 
the subject’s data was maintained throughout the study. Identification numbers instead of 
names or tumor board registry numbers were attached to the individual data collection 
tools, and only the researcher had access to the data. Anonymity was maintained in that 
individual names and individual characteristics are not presented, and data analysis 
expresses group information, not individual information.
There were no perceived potential physical, psychological, or social risks to the 
subjects in this study. The findings will be used to enhance current knowledge relating to
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the relationship between access, race, and stage at diagnosis of breast cancer in women 
being diagnosed and treated within the DoD MHS.
Summary
The purpose of this study was to describe the relationship between access and 
stage at diagnosis in African American and Caucasian women being diagnosed with breast 
cancer within the DoD MHS. The data analysis plan described above is felt to have been 
appropriate for the study’s purpose and methodology. It is hoped that this project has 
provided insight into the role of access and its influence on participation in breast health 
care programs and early diagnosis of breast cancer.
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CHAPTER IV 
RESULTS
The results of the data analysis are presented in four sections in this chapter. 
Section one presents a description of the sample. Section two presents comparative 
descriptive analysis of the study variables and selected demographic characteristics; and 
section three presents the statistical analysis related to each research question. Section 
four presents the results from supplemental data analysis.
Description o f the Sample
Table 5 provides a demographic profile of the subjects included in the study. Sixty 
two of the women were African American (9.8%) and 573 (90.2%) were Caucasian. The 
majority of the women were family members of active duty or retired service members 
(93.4%). Active duty women constituted 4.7 percent of the sample, and retired women 
constituted 1.9 percent. Of the 635 women included in the analysis 78.9 percent were 
married, and 70 percent were affiliated with the United States Navy. The largest rank of 
sponsor grouping was E-7 (17.8%), followed by the unknown grouping in which the 
sponsor’s rank could not be identified from the tumor registry record (16.1%). The mean 
age of the sample was 58.03 (SD = 13.57).
The majority of the women included in the study were diagnosed at stage 1 (n = 
274 or 43.1%). Stage 4 formed the smallest stage at diagnosis grouping (n = 29 or 
4.6%), and 2.8 percent (n = 18) of the tumor registry records analyzed did not have a
88
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Table 5
Summary o f Demographic and Study Variable Characteristics
Characteristic No. of cases % of total
Women with breast cancer 
Caucasian 
African American 
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Coast Guard 2 0.3
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Characteristic No. o f cases % of total

















Means o f discovery
Routine mammogram
Incidental BSE
Intentional BSE 62 9.8
Routine CBE 37 5.8
(table continues)


















Characteristic No. of cases % of total
Secondary CBE 25 3.9
Secondary Mammogram 17 2.7
Unknown 11 1.7
Length of time (in days) between discovery 
and diagnosis










Length o f time (in categories) between 
discovery and diagnosis
15-30  days 138 21.7
31 - 60 days 116 18.3
< 7 days 104 16.4
7 - 1 4  days 98 15.4
Unknown 47 7.4
61 - 90 days 38 6.0
(table continues)
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Characteristic No. of cases % of total
91 -120  days 36 5.7
121 -240 days 36 5.7
> 240 days 22 3.5
Length o f time (in days) between diagnosis 





Means o f initial treatment
Surgery after diagnosis 343 54
Surgery, concurrent with diagnosis 256 40.3
Chemotherapy 20 3.1
Radiation therapy 9 1.4
No treatment 5 0.8
Hormone therapy 2 0.3
Survival status at the time o f data collection
Alive 536 84.4
Deceased, breast cancer 51 8.0
Deceased, unknown 37 5.8
Deceased, other cause 11 1.7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
95
stage at diagnosis recorded. The mean tumor size was 2.2 centimeters (SD = 1.86), and 
the mean number o f positive lymph nodes examined was 2.07 (SD = 4.69).
Forty-five percent o f  the breast cancer cases were discovered by mammogram (n = 
288), followed by incidental BSE (n = 195 or 30.7%). The means o f discovery could not 
be determined from the tumor registry record in 1.7 percent o f the cases. The length of 
time between discovery o f a breast abnormality ana diagnosis of breast cancer could not 
be calculated by examining the exact date of discovery in 292 o f the cases. In these cases, 
the in-exact length of time in days was calculated by counting the number of days between 
the 15th o f the month in which the breast abnormality was discovered and the exact date 
of diagnosis. The mean in-exact length of time between discovery and diagnosis (N =
292) was 76.49 days (SD = 157.11). The mean exact length o f time in days between 
discovery and diagnosis (N = 297) was 45.53 (SD = 4.69). The length of time between 
discovery and diagnosis could not be identified from the tumor registry record in 46 of the 
cases. Twenty-two percent o f the cases included in the analysis had a length of time 
between discovery and diagnosis which fell into the 15 to 30 day range, 18.3 percent fell 
into the 31 to 60 day range, 14.4 percent had less than 7 days between discovery and 
diagnosis, and 20.9 percent o f  the cases fell into the greater than 60 day range. The mean 
length of time in days between diagnosis and treatment was 14.43 (SD = 18.41).
Surgery after diagnosis was the most frequently used means of initial treatment (n 
= 343 or 54%), and 40.3% (n = 256) of the women included in the study were treated 
initially with surgery concurrent with diagnosis. Chemotherapy was the means of initial 
treatment in 3.1 percent (n =  20) of the cases, and 1.4 percent (n = 9) of the women were
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treated initially with radiation therapy. At the time of data collection, the tumor registry 
records indicated that 84.8 percent (n = 536) o f the women included in the study were 
alive, 8 percent (n = 51) were deceased due to breast cancer, and 7.5 percent were 
deceased due to other ( n= 11) or unknown causes (n = 37).
Descriptive Analysis of the Study Variables
Comparative descriptive statistics o f the study variables and selected demographic 
characteristics o f the African American and Caucasian women, included in the study are 
presented in Table 6. T tests, Mann Whitney U tests, and independent samples chi-square 
tests were used to examine differences in means and frequency distributions.
There was a significant difference in the mean ages for African American (M = 
47.94) and Caucasian women (M = 59.13) (p = .000). Twenty-nine percent of the African 
American women diagnosed with breast cancer were less than 40 years old, compared to 
8.7 percent o f the Caucasian women; and 55.5 percent of the Caucasian women diagnosed 
with breast cancer were 60 or older as compared to 19.3 percent o f the African American 
women.
There was no significant difference between the two groups on marital status (p = 
.495), but the groups differed significantly on patient service status (p = .000). Sixteen 
percent o f the African American women were active duty, compared to 3.5 percent of the 
Caucasian women, and 94.8 percent o f the Caucasian women were family members, 
compared to 80.6 percent of the African American women. The two groups also differed 
significantly on the rank of the sponsor (p = .000). Twenty-eight percent of the African 
American women fell into the E l to E5 category as compared to 5.8 percent of the
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Table 6




Age (years), % (no. of cases)
<40 29 (18) 8.7 (50)
4 0 -4 9 24.2 (15) 17.3 (99)
50 -59 27.4 (17) 18.5 (106)
6 0 -6 9 14.5 (9) 33.7 (193)
> = 70 4.8 (3) 21.8 (125) .000*
Marital status, % (no. of cases)
Married 75.8 (47) 79.5 (454)
Unmarried 24.2(15) 20.5 (117) .495
Patient service status, % (no. of cases)
Active duty 16.1 (10) 3.5 (20)
Retired 3.2 (2) 1.7 (10)
Family member 80.6 (50) 94.8 (543) .000*
Rank of sponsor, % (no. of cases)
El -E 5 27.7 (13) 5.8 (28)
E 6 -E 9 63.8 (30) 52.3 (254)
CWO - 0 4 4.3 (2) 19.8 (96)
0 5 - 0 1 0 4.3 (2) 22.2 (108) 000*
(table continues)





Stage at diagnosis, %  (no. of cases)
In Situ 14.8 (9) 12.1 (67)
Stage 1 26.2 (16) 46.4 (258)
Stage 2 42.6 (26) 28.2 (157)
Stage 3 13.1 (8) 8.5 (47)
Stage 4 3.3 (2) 4.9 (27) .029
Tumor size, % (no. o f cases)
0 -1  cm 18.5 (10) 27.9 (143)
1 .1-2 .0  cm 27.8 (15) 38.4 (197)
2 .1 -3 .0  cm 27.8 (15) 17.2 (88)
3 .1 -5 .0  cm 18.5(10) 9 .2(47)
> 5.0 cm 7.4 (4) 7.4 (38) .035
No. of lymph nodes, % (no. of cases)
0 58.3 (28) 66.5 (306)
1-3 22.9 (11) 14.3 (66)
4-10 10.4 (5) 13.5 (62)
>10 8.3 (4) 5.7 (26) .336
Means of discovery, % (no. of cases)
Intentional BSE 17.5(10) 9 .2(52)
Incidental BSE 45.6 (26) 29.8 (169)
(table continues)





CBE 15.8 (9) 9.3 (53)
Mammogram 21.1 (12) 51.7 (293) .000*
Means of initial treatment 
% (no. of cases)
Surgery concurrent with 
diagnosis 37.1 (23) 41.0(233)
Surgery after diagnosis 61.3 (38) 53.7(305)
Other treatment 1.6 (1) 5.3 (30) .311
Survival status at the time o f data 
collection, % (no. of cases)
Alive 77.4 (48) 85.2 (488)
Deceased, Breast Cancer 16.1 (10) 7.2 (41)
Deceased (Unknown, Other) 6.5 (4) 7.7 (44) .047**
Note. All p values are 2 sided. P values were derived from chi-square tests. 
Other treatment includes chemotherapy, radiation therapy, and hormone therapy. 
* significant at p < .001 ** significant at p <.05
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Caucasian women; 63.8 percent of the African American women fell into the E6 to E 9 
category, compared to 52.3 percent of the Caucasian women; 19.8 percent of the 
Caucasian women fell into the CWO - 0 4  category compared to 4.3 percent of the 
African women; and 22.2 percent of the Caucasian women fell into the 05  to 0 10 
category, compared to 4.3 percent of the African American women.
The two groups differed significantly on stage at diagnosis of breast cancer (p = 
.029), tumor size (p = .035), and means of discovery (p = .000). But there were no 
significant differences between the two groups on number of positive lymph nodes 
examined (p = .336) or means of initial treatment (p = .311). At the time of data 
collection, tumor registry records reflected that 16.1 percent o f the African American 
women (n = 10) were deceased due to breast cancer as compared to 7.2 percent o f the 
Caucasian women (n = 41).
The mean exact length of time in days between discovery and diagnosis o f breast 
cancer was 45.15 for African American women (n = 20) and 45.55 for Caucasian women 
(n = 277). The mean in-exact length of time between discovery and diagnosis was 65.08 
for African American women (n = 36) and 78.09 for Caucasian women (n =256); and the 
combined exact and in-exact length of time between discovery and diagnosis was 57.96 
for African American women and 61.29 for Caucasian women. The mean length of time 
in days between diagnosis and initiation of treatment was 13.26 for African American 
women (n = 62) and 14.56 for Caucasian women (n = 567). Because of sample size and 
missing data on the length o f time between discovery and diagnosis, and the length of time 
between diagnosis and treatment variables, the minimum number o f subjects (64) required
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in each group to conduct the t test to detect differences between the two groups at a 
power o f .80, medium effect size of, 50 and .05 significance level using Cohen’s method, 
was not obtained. Therefore, the Mann Whitney test was used to detect differences 
between the African American and Caucasian women included in the study, on length of 
time between discovery and diagnosis, and length o f time between diagnosis and 
treatment. There were no significant differences between the two groups on length of 
time in days between discovery and diagnosis (U = 14296, p = .620, two tailed) or length 
of time in days between diagnosis and treatment (U = 17576.500, p = 1.000 two tailed).
Data Analysis Related to the Research Questions 
Research Question 1: What are the relationships between age, race, socioeconomic status, 
the means of discovery o f breast cancer, and stage at diagnosis of breast cancer in women 
identifying their race as Caucasian or African American, and being diagnosed with breast 
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997?
Independent samples chi-square tests, to assess the relationship between each stage 
and age, race, socioeconomic status, and the means o f discovery of breast cancer, and to 
detect any differences in distribution by race; and one-way analysis of variance to test for 
differences between the mean scores for the five stages o f breast cancer diagnosis between 
the two groups, were obtained using the Statistical Package for the Social Sciences 
(SPSS) for Windows.
Table 7 shows that a significant relationship was found between age at diagnosis 
and each stage, X2 (16, N  = 617) = 44.202, p = .000. Any standardized residual with an















Relationship Between Stage at Diagnosis and Age at Diagnosis
Age at diagnosis
< 40 vears 40- 49 vears 50- 59 vears 60--69 vears >70 vears
Stage at diagnosis n % n % n % n % n %
In situ 9 13.2 15 13.3 13 11.0 30 15.2 9 7.4
(Std. residual) .2 .3 -.4 1.2 -1.5
Stage 1 19 27.9 37 32.7 55 46.6 93 47.2 70 57.S
(Std. residual) -2.0 -1.9 .4 .6 2.2
Stage 2 32 47.1 40 21.9 33 28.0 47 23.9 31 25.6
(Std. residual) 2.6 1.1 -.3 -1.5 -.8
Stage 3 8 11.8 17 15.0 11 9.3 16 8.1 3 2.5
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absolute value greater than or equal to the tabled critical two-tailed .05 value z.os = 1.96 
is significant at the .05 level and contributes significantly to the obtained chi-square value 
(Sheskin, 1997). Based on the computation o f standardized residuals, the observed 
frequency o f women less than 40 years old, diagnosed at stage 2 (47.1%, std. residual =
2.6), women 40 - 49 years old diagnosed at stage 3 (15%, std. residual = 2.2), and 
women less than 40 years old diagnosed at stage 1 (27.9%, std. residual = -2.0) differed 
significantly from the expected frequency, and contributed significantly to the obtained 
chi-square value.
Table 8 shows that there were no significant differences between the mean scores 
for age and the five stages of breast cancer for African American women, F = 1.058, p = 
.386; however, there were significant differences detected in the group o f Caucasian 
women, F = 5.589, p = .000. Table 9 displays further analysis of the relationship between 
stage at diagnosis and age, and shows the distribution o f age by early (in situ, stage 1) and 
late (stage 2,3,4) stage at diagnosis, for African American and Caucasian women. In 
support of the data analysis reported in Table 8, Table 9 shows that the distribution o f age 
by early-late stage did not differ in the African American women included in the study, X2 
(2, N = 61) =4.331, p = .115. The significant difference in distribution o f age by stage in 
the Caucasian women, X2 (2, N = 556) = 14.902, p = .001, was contributed to by the 
observed frequency o f Caucasian women less than 40 and diagnosed in late stage breast 
cancer (14.7 %, std. residual = 2.1) differing significantly from the expected frequency.
As shown in Table 10, there was a significant relationship between race and stage 
at diagnosis, X2 (4, N = 617) = 10.83, p = .029. The observed frequency o f African 
American women diagnosed at stage 1 (26.2%, std. residual = -2.1) differed significantly
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Table 8

























Note. * significant atj> < .05
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Table 9
Relationship Between Stage at Diagnosis and Age at Diagnosis, bv Race
Age at diagnosis
< = 40 
(Std. residual)
4 1 -6 0  
(Std. residual)
> = 61 
(Std. residual) 
Total
< = 40 
(Std. residual)
4 1 -6 0  
(Std. residual)













































Note. aX2(2, N  = 61) = 4.331, p = .115 
bX2(2, N  = 556) = 14.902, p  = .001













Relationship Between Stage at Diagnosis and Race
Race
African American Caucasian
Stage at diagnosis n % n %
In situ 9 14.8 67 12.1
(Std. residual) .5 -.2
Stage 1 16 26.2 258 46.4
(Std. residual) -2.1 .7
Stage 2 26 42.6 157 28.2
(Std. residual) 1.9 -.6
Stage 3 8 13.1 47 8.5
(Std. residual) 1.1 -.4
Stage 4 2 3.3 27 4.9
(Std. residual) -.5 .2
Total 61 100 556 100
Note. X2(4, N = 617)= 10.83, e  = .029
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from the expected frequency, and contributed significantly to the obtained chi-square 
value. Table 11 shows a significant relationship between stage at diagnosis and 
socioeconomic status (rank of sponsor), X2 (12, N = 519) = 26.72, p = .008. The 
obtained chi-square value was contributed to significantly by the observed frequency of 
women with a sponsor’s rank of E l - E5 and diagnosed at stage 2 (53.8%, std. residual =
2.7) differing significantly from the expected frequency.
Table 12 shows that a significant relationship was found between stage at 
diagnosis of breast cancer and the means of discovery, X2 (12, N = 606) = 134.46, p = 
.000. The observed frequency of women with breast cancer discovered by mammogram 
and diagnosed at stage 2 (15.8%, std. residual = -4.4), by mammogram and diagnosed at 
in situ (20.9%, std. residual = 4.2), by incidental BSE and diagnosed at stage 2 (44.5%, 
std. residual = 3.8), by CBE and diagnosed at stage 4 (15.5%, std. residual = 3.7), by 
incidental BSE and diagnosed at in situ (3.7%, std. residual = - 3.4), by mammogram and 
diagnosed at stage 1 (57.2%, std. residual = 3.4), and by incidental BSE and diagnosed at 
stage 1 (21.3%, std. residual = -3.0), differed significantly from the expected frequency 
and contributed significantly to the obtained chi-square value.
The distribution of rank of sponsor (see Table 13) for African American women 
was significantly different from the distribution for Caucasian women, X2 (3, N  = 533) = 
40.09, p = .000). The observed frequency o f African American women with a  sponsor’s 
rank of E l - E5 (27.7%, std. residual = 4.9), CWO - 0 4  (4.3%, std. residual =  -2.3), and 
05 - O10 (4.3%, std. residual = -2.5) differed significantly from the expected frequency 
and contributed significantly to the obtained chi-square value. Table 14 shows that the 
distribution of the means of discovery for African American women was significantly















Relationship Between Stage at Diagnosis and Rank of Sponsor
Rank of Sponsor
El -E5 E6 -E9 cwo -0 4 05 -010
Stage at diagnosis n % n % n % n %
In situ 2 5.1 32 11.5 12 12.6 16 15.1
(Std. residual) -1.2 -.2 .2 .9
Stage 1 10 25.6 122 43.7 43 45.3 58 54.7
(Std. residual) -1.8 -.3 .1 1.5
Stage 2 21 53.8 82 29.4 31 32.6 23 21.7
(Std. residual) 2.7 -.3 .4 -1.6
Stage 3 6 15.4 27 9,7 5 5.3 7 6.6









































Note. X2 (12, N = 519) = 26.72, p = .008
















Relationship Between Stage at Diagnosis and Means of Discovery
Means of discovery
Intentional BSE Incidental BSE CBE Mammogram
Stage at diagnosis n % n % n % n %
In situ 4 5 7 3.7 3 5.2 62 20,9
(Std. residual) -1.6 -3.4 -1.6 4.2
Stage 1 20 33.3 57 21.3 21 36.2 170 57.2
(Std. residual) -1.3 -3.0 -.9 3.4
Stage 2 27 45 85 44.5 21 36.2 47 15.8
(Std. residual) 2.2 3.8 .9 -4.4
Stage 3 8 13.3 29 15.2 4 6.9 13 4.4
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Distribution o f Rank o f Sponsor Bv Race
Race
African American Caucasian
Rank of sponsor n % n %
El -E 5 13 27.7 28 5.8
(Std. residual) 4.9 -1.5
E 6 -E 9 30 63.8 254 52.3
(Std. residual) 1.0 -.3
CWO - 0 4 2 4.3 96 19.8
(Std. residual) -2.3 .7
0 5 - 0 1 0 2 4.3 108 22.2
(Std. residual) -2.5 .8
Total 47 100 486 100
Note. X2(3, N = 533) = 40.09, E =.000
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Intentional BSE 10 17.5 52 9.2
(Std. residual) 1.8 -.6
Incidental BSE 26 45.6 169 29.8
(Std. residual) 1.9 -.6
CBE 9 15.8 53 9.3
(Std. residual) 1.4 -.4
Mammogram 12 21.1 293 51.7
(Std. residual) -3.0 1.0
Total 57 100 567 100
Note. X2(3, N = 624) = 19.90, j> = .000)
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different from the distribution for Caucasian women (X2 (3, N = 624) = 19.90, p = .000). 
The observed frequency of African American women with breast cancer discovered by 
mammogram (21.1%, std. residual = -3.0) differed significantly from the expected 
frequency and contributed significantly to the obtained chi-square value.
Research Question 2: What are the relationships between the length of time between 
discovery and diagnosis of breast cancer, and the length of time between diagnosis and 
initiation of treatment of breast cancer, and stage at diagnosis of breast cancer in women 
identifying their race as Caucasian or African American, and being diagnosed with breast 
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997?
Independent samples chi-square tests to assess the relationship between each stage 
and the length o f time between discovery and diagnosis, and the length o f  time between 
diagnosis and treatment were obtained using SPSS.
Table 15 shows that a significant relationship was found between the length of 
time between discovery and diagnosis and stage at diagnosis of breast cancer, X2 (16, N = 
572) = 35.834, p = .003. The observed frequency of breast cancer cases diagnosed at 
stage 3 and having greater than 91 days between discovery and diagnosis (18.9%, std. 
residual = 3.2), and at stage 4 and having 61 to 90 days between discovery and diagnosis, 
differed significantly from the expected frequency and contributed significantly to the 
obtained chi-square value.
As shown in Table 16, there was also a significant relationship between stage at 
diagnosis and the length o f time between diagnosis and treatment, X2(12, N  = 617) = 
53.330, p = .000. Length of time in days between diagnosis and treatment categories were 
compressed to ensure that no more than 25 percent of the cells had expected frequency















Relationship Between Stage at Diagnosis and Length of Time Between Discovery and Diagnosis
Length of time between discovery and diagnosis
0-■14 davs 15 -30 davs 31 - 60 davs 61 - 90 davs >91 days
Stage at diagnosis n % n % n % n % n %
In situ 25 12.5 17 12.6 18 16,2 3 8.3 7 7.8
(Std. residual) .1 .1 1.2 .5 -1.2
Stage 1 97 48.5 62 45.9 52 46.8 15 41.7 28 31.1
(Std. residual) .9 .3 .4 -.2 -1.9
Stage 2 52 26.0 47 34.8 30 27.0 11 30.6 29 32.2
















Length of time between discovery and diagnosis
0 - 14 davs 15- 30 davs 31 - 60 davs 61 - 90 davs > 91 davs
Stage at diagnosis n % n % n % n % n %
Stage 3 15 7.5 5 3.7 10 9.0 4 11.1 17 18.9
(Std. residual) -.7 -2.0 .0 .4 3.2
Stage 4 11 5.5 4 3.0 1 .9 3 8.3 9 10,0
(Std. residual) .4 -1.0 -1.9 .9 2.2
Total 200 100 135 100 111 100 36 100 90 100
















Relationship Between Stage at Diagnosis and Length of Time Between Diagnosis and Treatment
Length of time between diagnosis and treatment
0 -14 davs 15 -• 30 davs 31-60 days > 60 davs
Stage at diagnosis n % n % n % n %
In situ 50 14.4 12 5.9 11 23.4 3 15.8
(Std. residual) 1.1 -2.6 2.2 .4
Stage 1 147 42.4 101 40.4 19 40.4 7 36.8
(Std. residual) -.6 1.1 -.4 -.5
Stage 2 101 29.1 65 31.9 15 31.9 2 29.7
















Length of time between diagnosis and treatment
0-■14 davs 15- 30 davs 31 - 60 davs > 60 davs
Stage at diagnosis n % n % n % n %
Stage 3 34 9.8 20 9.8 0 0 1 5.3
(Std. residual) .6 .4 -2.0 -.5
Stage 4 15 4.3 6 2.9 2 4.3 6 3.1
(Std. residual) -.3 -1.2 -.1 5.4
Total 347 100 204 100 47 100 19 100
Note. X2 (12, N = 617) = 53.330, p. = .000
Five cells (25%) have an expected count of less than 5. The minimum expected frequency is .89.
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counts o f less than five (Daniel, 1995; Norusis, 1997). The observed frequency of breast 
cancer cases diagnosed at stage 4 and having greater than 60 days between diagnosis and 
treatment (3.1%, std. residual = 5.4), at in situ and having 15 to 30 days between 
diagnosis and treatment (5.9%, std. residual = -2.6), at in situ and having 31 to 60 days 
between diagnosis and treatment (23.4%, std. residual = 2.2), and at stage 3 and having 31 
to 60 days between diagnosis and treatment, differed significantly from the expected 
frequency, and contributed significantly to the observed chi-square value.
Research Question 3: To what extent do the variables age, race, socioeconomic status, 
and the means of discovery o f breast cancer predict the length o f time between discovery 
and diagnosis of breast cancer, and the length of time between diagnosis and initiation of 
treatment of breast cancer, in women identifying their race as Caucasian or African 
American, and being diagnosed with breast cancer at Naval Medical Center San Diego 
from January 1, 1988 to December 31, 1997.
Standard multiple regression analysis to examine the relationships between age and 
the length of time between discovery and diagnosis, and the length of time between 
diagnosis and treatment; and to examine the extent to which the predictor variables o f age, 
race, socioeconomic status, and means of discovery of breast cancer predict the length of 
time between discovery and diagnosis, and the length o f time between diagnosis and 
treatment was obtained using SPSS.
Table 17 shows that there were no significant relationships between age at 
diagnosis o f breast cancer and the length of time between discovery and diagnosis, and the 
length o f time between diagnosis and treatment, F(2, 579) = 2.129, p = . 120.
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Table 17
Relationship Between Age at Diagnosis and Variables of Realized Access N = 582











Variable B SE Beta p value
DISDIAG -5.139E-03 0.004 -0.055 0.189
DIAGTRT 4.799E-02 0.030 0.066 0.111
Constant 57.628 .744
Key: DISDIAG = Length of time between discovery and diagnosis
DIAGTRT = Length o f time between diagnosis and treatment
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Table 18 shows multiple R, R square, and the unstandardized regression 
coefficients (B) for the regression model, and the standardized regression coefficients ((3), 
the standard error (SE) for the unstandardized coefficients, and the p value, for each of the 
predictor variables. The multiple R (.251) between the predictor variables (age, race, 
rank o f sponsor, and means of discovery) and the outcome variable (length of time 
between discovery and diagnosis), was statistically significant, F(9, 573) = 4.279, p =
.000. Six percent of the variance in the length of time between discovery and diagnosis 
was explained by the predictor variables. When taken separately, only incidental BSE (3 = 
.255, p = .000) and CBE (3 = .091, p = .033) were found to be significant predictors of 
the length of time in days between discovery and diagnosis of breast cancer.
Multicollinearity and singularity occur when variables are too highly correlated and 
can cause problems with interpretation o f partial coefficients, sampling stability, and 
computational accuracy (Cohen & Cohen, 1983). In order to eliminate high correlation 
and redundancy among variables, bivariate correlations greater than or equal to .70 should 
not be included in the analysis (Tabachnick & Fidell, 1996).
Tolerance statistics can also be computed to assess multicollinearity among 
predictor (independent) variables. Tolerance is the proportion o f variability of a predictor 
variable that is not explained by its relationships with the other predictor variables. 
Multicollinearity is a problem if tolerances are less than 0.1 (Norusis, 1997).
To assess the extent to which the predictor variables were independent of each 
other, tolerance statistics were calculated and an intercorrelation matrix was obtained (see 
Table 19). Tolerances ranged from .46 to .90 and were well above the 0.1 level, and none
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Table 18
General Regression of Age at Diagnosis. Race. Socioeconomic Status, and Means of 
Discovery on Length of Time Between Discovery and Diagnosis N = 583
Multiple R  = 0.251 df F £
R Square = 0.063 Regression 9 4.279 0.000
Residual 573
Variable B SE Beta p value
Age at diagnosis -0.119 0.472 -0.011 0.801
Race3 -21.442 21.504 -0.043 0.319
Rank (El - E5)b -40.699 28.183 -0.069 0.149
Rank (E6 - E 9)b -18.177 17.455 -0.062 0.298
Rank (CWO - 0 4 )b -7.612 21.341 -0.019 0.721
Rank (05 - O10)b -22.691 20.501 -0.060 0.269
Intentional BSEC 20.250 21.369 0.041 0.344
Incidental B SEC 79.852 13.866 0.255 0.000*
CBEC 44.061 20.625 0.091 0.033**
Constant 54.748 34.021
Note. 3 Reference category - African American 
b Reference Category - Unknown 
c Reference category - Mammogram
* significant at p < .001 ** significant at p < .05















Intercorrelation Matrix of the Variables of Potential Access (Length of Time Between Discovery and Diagnosis) 
N = 583
Variable Age Race Rank 1 Rank 2 Rank 3 Rank 4 INTBSE INCBSE MAMM
Age 1.000
Race -0.231* 1.000
Rank 1 -0,223* 0.189* 1.000
Rank 2 -0.016 0.036 -0.239* 1.000
Rank 3 0.024 -0.104 -0.111** -0.385* 1.000
Rank 4 0.071** -0.119** -0.122* -0.424* -0.197* 1.000
INTBSE -0.171* 0.080* 0.043 -0.012 -0.006 -0.043 1.000
INCBSE -0.155 0.099* 0.078** 0.025 0.035 -0.076** -0.225* 1,000
CBE 0.059 0.065 0.025 -0.046 -0.017 -0.024 -0.110** -0.221* 1,000









= E6 - E9 
= 0 5 - 0 1 0  
= Incidental BSE
* p_< .001 one tailed ** g < .05 one tailed
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of the correlations in Table 19 were greater than .70. Therefore multicollinearity was not 
considered a problem for these analyses.
Table 20 shows the multiple R, R square, and the unstandardized regression 
coefficients (B) for the regression model, and the standardized regression coefficients (3), 
the standard error (SE) for the unstandardized regression coefficients, and the p value, for 
each of the predictor variables. The multiple R (. 161) between the predictor variables 
(age, race, rank of sponsor, and means of discovery) and the outcome variable (length of 
time between diagnosis and treatment), approached the accepted .05 level o f significance, 
F(9, 608) = 1.793, p =.067. Taken separately, age at diagnosis was found to be a 
significant predictor of the length o f time between diagnosis and treatment (3 = . 110, p = 
.011). Rank of E l - E5 (3 = .090, p = .058), intentional BSE (3 = .079, p = .067), and 
CBE (3 = .078, p = .065) approached the .05 significance level as predictors of the 
length of time between diagnosis and treatment. Table 21 is an intercorrelation matrix of 
the predictor variables. All correlations were less than .70 and tolerances ranged from .45 
to .90, therefore multicollinearity was not considered a problem for these analyses. 
Research Question 4: To what extent do the variables age, race, socioeconomic status, 
and the means of discovery o f breast cancer predict stage at diagnosis of breast cancer in 
women identifying their race as Caucasian or African American, and being diagnosed with 
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 
1997.
A direct logistic regression analysis was performed on stage at diagnosis (early vs. 
late) as an outcome, and age, race, SES, and means of discovery as predictor variables
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Table 20
General Regression o f Age at Diagnosis. Race. Socioeconomic Status, and Means of 
Discovery on Length of Time Between Diagnosis and Treatment N = 618
Multiple R = 0.161 df F p
R Square = 0.026 Regression 9 1.793 0.067
Residual 608
Variable B SE Beta p value
Age at Diagnosis 0.151 0.059 0.110 0.011*
Race3 -0.982 2.707 -0.015 0.717
Rank (El - E5)b 6.796 3.576 0.090 0.058
Rank (E6 - E9)b 2.100 2.210 0.057 0.342
Rank (CWO - 0 4 )b 4.161 2.709 0.081 0.125
Rank ( 0 5 - 0 1 0 ) b 0.178 2.613 0.004 0.946
Intentional BSEC 4.848 2.639 0.079 0.067
Incidental B SEC 2.477 1.745 0.062 0.156
CBEC 4.857 2.628 0.078 0.065
Constant 2.080 4.323
Note. a Reference category - African American 
b Reference Category - Unknown 
c Reference category - Mammogram
* significant at p < .05















Intercorrelation Matrix of the Variables of Potential Access (Length of Time Between Diagnosis and Treatment) N = 618
Variable Age Race Rank 1 Rank 2 Rank 3 Rank 4 INTBSE INCBSE MAMM
Age 1.000
Race -0.231* 1.000
Rank 1 -0.223* 0.189* 1.000
Rank 2 -0.016 0.036 -0.239* 1.000
Rank 3 0.024 -0.104** -0.111** -0.385* 1.000
Rank 4 0.071** -0.119** -0,122* -0.424* -0.197* 1.000
INTBSE -0.171* 0,080** 0.043 -0.012 -0.006 -0.043 1.000
INCBSE -0.155* 0.099** 0.078** 0.025 0.035 -0.076** -0.225* 1.000
CBE 0.059 0.065 0.025 -0.046 -0.017 0.024 -0.110** -0.221* 1.000
Note. Key: Rank 1 = El -E5 Rank 2 E 6-E9
Rank 3 = CWO - 04
INTBSE = Intentional BSE
Rank 4 = 0 5 -0 1 0
INCBSE = Incidental BSE
* g < .001 one tailed ** g < .05 one tailed
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using SPSS. After deletion of 18 cases with missing values, data from 617 women were 
available for analysis: 61 African American and 556 Caucasian.
A test o f  the fiill model with all o f the predictors against a constant only model was 
statistically reliable, X2(10, N = 617) = 126.358, p = .000, indicating that the predictors as 
a set, reliably distinguished between early (in situ, stage I) and late (stages 2,3,4) stage at 
diagnosis. In regard to prediction success, 70.57 percent o f the early stage and 73.41 
percent o f the late stage breast cancer was correctly predicted, for an overall success rate 
of 71.80 percent.
Table 22 shows regression coefficients, Wald statistics, odds ratios and 95 percent 
confidence intervals for odds ratios, for each of the variables. Means of discovery was the 
only grouping which reliably predicted late stage at diagnosis, z = 88.0578, p = .0000.
The odds for African American women (OR = 1.06, 95% Cl .57 - 2.00) being 
diagnosed with late stage breast cancer were slightly higher than the odds for Caucasian 
women (OR = 1.00). Women with a sponsor’s rank of E l to E5 (OR = 2.11, 95% Cl .87 
- 5.08) were three times more likely to be diagnosed at late stage breast cancer than 
women whose sponsor’s rank was 05  - O10 (OR = .68, 95% Cl .36 - 1,29), and twice as 
likely to be diagnosed in late stage breast cancer than any o f the other rank o f sponsor 
groupings. Women who had their breast cancer discovered by incidental BSE ( OR =
3.79, 95% Cl 1.02 - 14.13) were almost six times more likely to be diagnosed at late stage 
breast cancer than women who had their breast cancer discovered by mammogram (OR = 
.68, 95% Cl = .36 - 1.29).
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Table 22
Logistic Regression Analysis o f Late Stage at Diagnosis as a Function of Variables of
Potential Access N = 617





Interval for Odds Ratio
Lower Upper
Age -0.0092 1.6803 0.99 0.98 1.00
Race
African American 0.0626 0.0381 1.06 0.57 2.00
Caucasian3 1.00
Rank of sponsor
E l -E 5 0.7447 2.7457 2.11 0.87 5.08
E 6 -E 9 0.0906 0.1182 1.09 0.65 1.83
CWO - 0 4 -0.0608 0.0353 0.94 0.50 1.77
0 5 - 0 1 0 -0.3844 1.3869 0.68 0.36 1.29
Unknown Rank3 1.00
Means of discovery
Intentional BSE 1.0740 2.3313 2.93 0.74 11.62
Incidental BSE 1.3319* 3.9338 3.79 1.02 14.13
CBE -0.0608 0.0353 2.93 0.74 11.65
Mammogram -0.3844 1.3869 0.68 0.36 1.29
Unknown means3 1.00
Note. a Reference Category * £ < .05
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Research Question 5: To what extent do the variables length of time between discovery 
and diagnosis o f  breast cancer, and length o f  time between diagnosis and initiation of 
treatment o f breast cancer, predict stage at diagnosis of breast cancer in women 
identifying their race as Caucasian or African American, and being diagnosed with breast 
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
A direct logistic regression analysis was performed on stage at diagnosis (early vs. 
late) as an outcome and the length of time between discovery and diagnosis, and the 
length of time between diagnosis and treatment as predictors using SPSS. After deletion 
of 67 cases with missing values, data from 568 women were available for analysis.
A test o f  the frill model with all o f  the predictors against a constant only model was 
statistically reliable, X2 (2, N = 568) = 28.928, p = .000, indicating that the predictors as a 
set, reliably distinguished between early (in situ, stage 1) and late (stages 2,3,4) stage at 
diagnosis. In regard to prediction success, 90.74 percent of the early stage and 20.49 
percent of the late stage breast cancer was correctly predicted for an overall success rate 
of 60.56 percent.
Table 23 shows regression coefficients, Wald statistics, odds ratios and 95 percent 
confidence intervals for odds ratios for each o f the variables. Only length o f time between 
discovery and diagnosis reliably predicted late stage diagnosis, z = 17.3248, p = .0000.
Presentation of Results from Supplemental Data Analysis
In order to examine: (a) the relationship between means of discovery and variables 
of potential access (race, age, SES); (b) the distribution of variables of potential access by 
age, (c) differences in age, tumor size, length o f time between discovery and diagnosis, 
and length o f time between diagnosis and treatment, by means of discovery (self
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Table 23
Realized Access N = 568








DISDIAG 0.0058* 17.3248 1.006 1.003 1.009
DIAGTRT -0.0029 0.3705 0.997 0.988 1.007
Note. Key: DISDIAG
DIAGTRT
Length o f time between discovery and diagnosis 
= Length o f time between diagnosis and treatment
£  < .001
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discovered, provider discovered); (d) the extent to which age, race, marital status, patient 
service status, and SES (rank of sponsor), predict self discovered (intentional and 
incidental BSE) and provider discovered (CBE, mammogram) breast cancer; and (e) the 
distribution of race, age, SES, means of discovery, and stage at diagnosis by year of 
diagnosis, additional data analyses were performed.
Relationship between means o f discovery and variables of potential access. 
Comparative analyses of means of discovery and race, age, and SES are presented in 
Table 24. Independent samples chi-square tests were used to examine differences in 
frequency distributions, and standardized residuals were calculated to determine which 
cells contributed to any obtained significant p values.
As shown earlier in table in Table 14, and repeated in Table 24 for illustrative 
purposes, there was a significant difference in the distribution of means of discovery by 
race (p = .000). Fifty-two percent of the Caucasian women included in the study had 
breast abnormalities discovered by mammogram, as compared to 21 percent o f the African 
American women; and 46 percent of the breast abnormalities in the African American 
women were discovered by incidental BSE, as compared to 30 percent of the Caucasian 
women.
There was a significant difference in the means o f discovery by age (p = .000). 
Fifty-six percent o f the women less than 40 years old had their cancers discovered by 
incidental BSE, as compared to 20 percent who had cancers discovered by intentional 
BSE, 17 percent by mammogram, and 6 percent by CBE. Women 40 -49 years old had 
almost equal percentages of their cancers discovered by incidental BSE (37.2%) and















Relationship Between Variables of Potential Access (Race. Age. SES) and Means of Discovery 
Characteristic/ Variable Intentional BSE Incidental BSE CBE Mammogram
Race, % (no. of cases)
African American 17.5(10) 45.6 (26) 15.8 (9) 21.1 (12)***
Caucasian 9.2 (52) 29.8(169) 9.3 (53) 51.7 (293)
% (no. of cases)
<40 20.3 (13)*** 56.3 (36)*** 6.3 (4) 17.2(11)***
40-49 17.7(20)*** 37.2 (42) 8.8 (10) 36.3 (41)
50-59 6.6 (8) 28.9(35) 10.7(13) 53.7 (65)
60-69 7.0 (14) 22.0 (44)*** 9.0 (18) 62.0(124)***



















Characteristic/ Variable Intentional BSE Incidental BSE CBE Mammogram
Rank of sponsor, % (no. of cases)
El -E5 15.0(6) 45.0 (18) 12.5 (4) 27.5 (10)
E 6-E9 9.6 (27) 32.6 (92) 8.2 (23) 49.6 (140)
CWO - 04 9.4 (9) 34.4 (33) 9.4 (9) 46.9 (45)
0 5 -0 1 0 7.3 (8) 23.6 (26) 8.2 (9) 60.9 (67)
Unknown 12.5 (12) 27.1 (26) 16.7 (16) 43.8 (42)
Note. All p values are 2 sided and were derived from chi-square tests.





mammogram (36.3); and women 50 years and older had greater than 50 percent o f their 
cancers discovered by mammogram.
The four means o f  discovery groupings differed significantly on the distribution by 
rank of sponsor (p = .043). Forty-five percent o f the discoveries in the E l - E5 sponsor 
rank group occurred by incidental BSE, as compared to 34 percent in the CWO - 0 4  
group, 33 percent in the E6 - E9 group, and 24 percent in the 05 - 010 group. Sixty-one 
percent of the discoveries in the 05  - 010 sponsor’s rank group occurred by 
mammogram, as compared to 50 percent in the E6 - E9 group, 47 percent in the CWO - 
0 4  group, and 28 percent in the E l - E5 group.
Distribution o f variables o f potential access bv age. Comparative frequencies of 
the distribution of race, SES and means of discovery, by age categories, are presented in 
Table 25. Thirty-one percent o f the African American women included in the study were 
less than 40 years old as compared to 10 percent o f the Caucasian women. Within the 
rank of sponsor grouping, 39.1 percent of the women in the E l -E5 category were less 
than 40 years old, as compared to 9.8 percent of the E6 through E9, 10.2 percent o f the 
CWO - 04 , and less than one percent of the 05  through 010. Eighty-two percent of the 
incidental BSE cancer discoveries occurred in women 40 years or older. Within the 
intentional BSE means o f discovery, 79.9 percent of the women were 40 years and older, 
and 96.4 percent of the mammogram discovered cancers occurred in women 40 years and 
older.
Differences in mean scores o f selected study variables bv means of discovery.
Means of discovery was recoded into self discovered means (intentional and incidental 
BSE) and provider discovered means (CBE and mammogram) and the t-test for
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Table 25
Distribution o f Variables of Potential Access (Race. SES. Means of Discovery). Bv Age 
(<40 and > = 40)
Variable < 40 Years Old > = 40 Years Old
Race %(no. of cases)
African American 30.6(19) 69.4 (43)
Caucasian 9.9 (57) 90.1 (516)
Rank of Sponsor %(no. of cases)
El -E5 39.1 (16) 60.9 (25)
E 6-E 9 9.8 (28) 90.2 (256)
CWO - 04 10.2 (10) 89.8 (88)
0 5 -0 1 0 .9 (1) 99.1 (109)
Means of Discovery %(no. of cases)
Intentional BSE 20.1(13) 79.9 (49)
Incidental BSE 18.5(36) 81.5(159)
CBE 6.5 (4) 93.5 (58)
Mammogram 3.6(11) 96.4 (294)
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independent samples was used to test for significant differences between the mean scores 
of the two groups on age, tumor size, length of time between discovery and diagnosis, and 
length of time between diagnosis and treatment. A minimum sample size o f a least 200 
was achieved for all groups, therefore a power o f greater than .995 was obtained using a 
medium effect size o f  .50 and a significance level o f .05 (Cohen, 1988). Unequal 
variances, as determined by calculating the F test, were treated by using the separate 
variance formula (Hinkle, Wiersma, & Jurs, 1994).
Table 26 displays a summary o f differences in mean scores of selected study 
variables, by self and provider discovered means. There were significant differences in 
means between the self discovered and provider discovered breast abnormalities on age at 
diagnosis (t = -6.096; p = .000), size of tumor in centimeters (t = 6.820; p = .000), and 
length of time in days between discovery and diagnosis (t = 4.321; p = .000). There were 
no significant differences in the means between self discovered and provider discovered 
abnormalities on length o f time in days between diagnosis and treatment (t = 1.047; p = 
.295).
Extent to which age, race, patient service status, marital status, and SES predict 
self or provider discovered means. Means of discovery was recoded into self discovered 
means (intentional and incidental BSE) and provider discovered means (CBE and 
mammogram), and age at diagnosis was categorized into five nominal groups. Marital 
status and patient service status were included as additional demographic descriptors o f 
the women in this study. A direct logistic regression analysis was performed on means of 
discovery (self vs. provider) as an outcome, and age, race, marital status, patient service















T-Test Summary Table of Selected Study Variables by Means of Discovery
Self Discovered Provider Discovered
(BSE) (CBE and Mammogram)
Variable N M SD N M SD t df p value
AGE 257 54.15 14.90 367 60.91 11.58 -6.096 461 .000*
SIZE 237 2.839 2.007 320 1.755 1.626 6.820 444 .000*
DISDIAG 236 94.62 179.94 347 37.94 109.94 4.321 354 .000*
DIAGTRT 255 15.47 18.75 363 13.88 18.32 1.047 539 .295
Note. * g < .001 two tailed
Key: AGE = Age at Diagnosis
SIZE = Size of Tumor in Centimeters
DISDIAG = Length of time in days between discovery and diagnosis
DIAGTRT = Length of time in days between diagnosis and treatment
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status, and SES as predictor variables, using SPSS. After deletion of 13 cases with 
missing values, data from 622 women were available for analysis.
A test of the full model with all of the predictors against a constant only model was 
statistically reliable, X2(12, N = 622) = 64.992, p = .000, indicating that the predictors as 
a set, reliably distinguished between self (intentional and incidental BSE) and provider 
(CBE, mammogram) discovered means. In regard to prediction success, 41.80 percent o f 
the self discovered abnormalities, and 83.06 percent of the provider discovered 
abnormalities were correctly predicted, for an overall success rate of 66.08 percent.
Table 27 shows regression coefficients, Wald statistics, odds ratios and 95 percent 
confidence intervals for odds ratios, for each of the variables. Age (z = 36.4114, p =
.0000) and race (z = 3.8065, p = .0511) reliably predicted provider discovered breast 
abnormalities.
Women 60 to 69 years old (OR = 1.36, 95% Cl .84 - 2.21) were seven times more 
likely to have provider discovered breast abnormalities, than were women less than 40 
years old (OR = .20, 95% Cl .091 - .42); and three times more likely than women 40 to 
49 years old (OR = .46, 95% Cl .27 - .80). The odds for women 60 to 69 years old 
having provider discovered breast abnormalities were also higher than for women 50 to 
59 years old (OR = 1.02, 95% Cl .59 - 1.77), and for women 70 years and older (OR =
1.00).
Caucasian women (OR = 1.00) were more likely to have provider discovered 
breast abnormalities than were African American women (OR = .54, 95% Cl .29 - 1.00). 
The odds for married women (OR =1.14, 95% Cl = .73 - 1.77) having provider
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Table 27
Logistic Regression Analysis o f Provider Discovered Breast Abnormality as a Function of
Variables of Selected Demographic Variables N = 622









<40 -1.6283* 17.3136 .20 .091 .42
40-49 -.7723** 7.4602 .46 .27 .80
50-59 .0230 .0068 1.02 .59 1.77
60-69 .3077 1.5375 1.36 .84 2.21
_> 70a 1.00
Race
African American -.6183** 3.8065 .54 .29 1.00
Caucasian* 1.00
Marital Status
Married .1280 .3226 1.14 .73 1.77
Unmarried* 1.00
Patient Service Status
Active Duty .0886 .0319 1.09 .41 2.89
Retired -.1279 .0388 .88 .25 3.14
Family Member* 1.00
(table continues)
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El -E5 -.2232 .2716 .80 .35 1.85
E 6 -E 9 -.1175 .2104 .89 .54 1.47
CWO - 04 -.1937 .3860 .82 .45 1.52
0 5 - 0 1 0 .2183 .4881 1.24 .67 2.30
Unknown Rank3 1.00
Note. a Reference 
* p <.001 **p < .05
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discovered breast abnormalities were higher than the odds for unmarried women (OR =
1.00); and active duty women (OR = 1.09, 95% Cl .41 - 2.89) were more likely to have 
provider discovered breast abnormalities than were women who were family member 
beneficiaries (OR = 1.00), or women who were retired from active duty (OR = .88, 95%
Cl .25 - 3.14). The odds for women with a sponsor’s rank o f 0 5  to O10 (OR= 1.24,
95% Cl .67 - 2.30) having provider discovered breast abnormalities were higher than the 
odds for women with a sponsor’s rank o f  E l to E5 (OR = .80, 95% Cl .35 - 1.85), CWO 
to 0 4  (OR = .82, 95% Cl .45 - 1.52), and E6 to E9 (OR = .89, 95% Cl .54 - 1.47).
Distribution of race, age. SES. means of discovery, and stage at diagnosis by year 
of diagnosis. Independent samples chi-square tests were used to examine differences in 
distributions o f race, age at diagnosis, rank of sponsor, stage at diagnosis (early versus 
late), and means o f discovery, by year. There were no significant differences in 
distributions o f race X2 (9, N = 635) = 5.388, £ = .799, age X2 (36, N  = 635) = 36.616, £ 
= .440, rank o f  sponsor X2 (27, N = 533) = 32.096, £ = .229, or stage at diagnosis X2 (9, 
N = 617) = 15.392, £  = .081, by year. There was a significant difference in the 
distribution o f means of discovery by year X2 (27, N = 624) = 56.817, £  = .001. Table 28 
displays the trends in means of discovery from 1988 through 1997. In 1988 and 1989, the 
percentage of incidental BSE and mammogram discoveries were both 34.2 and 38.2 
percent respectively. From 1992 through 1996, the percentage o f mammogram 
discoveries consistently increased from 43.2 to 64.2 percent. Incidental BSE discoveries 
were at 39.2 percent in 1992, 20.6 percent in 1993, 35.8 percent in 1994, 25.4 percent in















Distribution of Means of Discovery bv Year
Means of Discovery
Intentional BSE Incidental BSE
Year of Diaanosis n % n %
1988 6 15.8 13 34.2
1989 7 12.7 21 38.2
1990 7 11.5 17 27.9
1991 5 7.7 15 23.1
1992 6 8.1 29 39.2
1993 16 23.5 14 20.6
1994 4 7.5 19 35.8
1995 3 4.5 17 25.4
1996 1 1.5 15 22.4
CBE Mammogram
n % n %
6 15,8 13 34.2
6 10.9 21 38.2
6 9.8 31 50.8
10 15.4 35 53.8
7 9.5 32 43.2
4 5.9 34 50.0
1 1.9 29 54.7
9 13.4 38 56.7
















Intentional BSE Incidental BSE CBE Mammogram
Year of Diagnosis n % n % n % n %
1997 7 9.2 35 46.1 5 6.6 29 38.:
Total 62 195 62 305
Note. X2 (27, N = 624) = 56.817, p = . 001
Percentage displayed within the % category is the percent within the year of diagnosis.
144
145
1995, and 22.4 percent in 1996. Mammogram discoveries were at 38.2 percent in 1997, 
as compared to 46.1 percent for incidental BSE discoveries.
Summary
This chapter presented the results o f the data analysis for this study in four 
sections. The first section presented a description of the sample, and was followed by 
presentation o f  comparative descriptive analysis o f the study variables and selected 
demographic characteristics, in section two. The third section presented statistical analysis 
related to each o f the research questions, and the results of supplemental statistical 
analysis were presented in section four.
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CHAPTER V
SUMMARY, DISCUSSION, IMPLICATIONS, AND CONCLUSION 
This chapter includes: a summary of the research design and method, discussion o f 
the research findings, implications for nursing practice, education, and research, and the 
conclusion o f the research study.
Summary of the Research Design and Method 
The purpose of this descriptive comparative study was to examine the relationship 
between access and stage at diagnosis o f  breast cancer in African American and Caucasian 
women diagnosed with breast cancer at NMCSD between January 1, 1988 and December 
31, 1997. The conceptual framework for this study: (a) was based on the Aday/Andersen 
Framework for the Study of Access, (b) asserted that in addition to economic access, 
there are additional delineators o f access to breast health care; and (c) theorized that there 
are influential relationships between potential access, realized access, and stage at 
diagnosis o f breast cancer, within an equal economic access health care system. Indicators 
of potential access were defined as race, age, socioeconomic status, and means of 
discovery o f breast cancer. Indications o f realized access were defined as the length of 
time between discovery of breast abnormality and diagnosis, and the length of time 
between diagnosis and treatment.
146
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The following research questions were addressed:
1. What are the relationships between age, race, socioeconomic status, the means 
of discovery o f breast cancer, and stage at diagnosis of breast cancer in women identifying 
their race as Caucasian or African American, and being diagnosed with breast cancer at 
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
2. What are the relationships between the length of time between discovery and 
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of 
treatment o f breast cancer, and stage at diagnosis o f breast cancer in women identifying 
their race as Caucasian or African American, and being diagnosed with breast cancer at 
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
3. To what extent do the variables age, race, socioeconomic status, and the 
means of discovery o f breast cancer predict the length of time between discovery and 
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of 
treatment o f breast cancer, in women identifying their race as Caucasian or African 
American, and being diagnosed with breast cancer at Naval Medical Center San Diego 
from January 1, 1988 to December 31, 1997.
4. To what extent do the variables age, race, socioeconomic status, and the means 
of discovery of breast cancer predict stage at diagnosis of breast cancer in women 
identifying their race as Caucasian or African American, and being diagnosed with breast 
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
5. To what extent do the variables length o f time between discovery and diagnosis 
of breast cancer, and length of time between diagnosis and initiation of treatment of breast
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cancer, predict stage at diagnosis of breast cancer in women identifying their race as 
Caucasian or African American, and being diagnosed with breast cancer at Naval Medical 
Center San Diego from January 1, 1988 to December 31, 1997.
Data were collected from the tumor registry records o f 573 Caucasian and 62 
African American women, and were analyzed using SPSS for Windows. Descriptive 
statistics were used to summarize and describe the demographic characteristics of the 
sample and the study variables; and inferential statistics were used to  examine the 
relationships between the study variables. The results of the study confirm the existence 
of non-economic delineators of access to breast health care, support the influential 
relationships between potential access, realized access, and stage at diagnosis of breast 
cancer, and provide some new insights into the disparity in stage at diagnosis of breast 
cancer between African American and Caucasian women. Discussion of the results of the 
study are presented in the next section o f this chapter.
Discussion
Descriptive Characteristics of the Sample and Study Variables
The racial distribution of African American (9.8%) and Caucasian (90.2%) women 
in this study is representative of the racial distribution of African Americans (12%) and 
Caucasians (84%) in the United States population. In addition, the racial distribution of 
women included in the DoD MHS wide studies of breast cancer conducted by Zaloznik 
(1995; African American women 10.41 %; Caucasian women 89.58%), and Wojcik,
Spinks, and Optenberg (1998; African American women 10.6%; Caucasian women
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89.4%) is consistent with the distribution o f African American and Caucasian women in 
this study.
The significant difference in the mean age at the time o f diagnosis of breast cancer, 
between the African American and Caucasian women in this study, concurs with studies 
conducted both within and outside o f the DoD MHS. In this study, the mean age for 
African American women was 47.94 years as compared to 59.13 for Caucasian women, 
and 29 percent of the African American women were diagnosed at an age less than 40 
years as compared to 8.7 percent of the Caucasian women. In the DoD-wide study 
conducted by Zaloznik (1995), 24 percent of the African American women were 
diagnosed at an age less than 40 years old as compared to 9 percent o f the Caucasian 
women; and in the DoD-wide study conducted by Wojcik, et al. (1998), the mean age for 
African American women was 50 years as compared to 57.1 years for Caucasian women, 
and 22.8 percent of the African American women were diagnosed at an age less than 40 
years as compared to 9.2 percent of the Caucasian women. In a study conducted outside 
of the DoD by Newman and Alfonso (1997), the mean age for African American women 
was 56 years as compared to 63 years for Caucasian women, and approximately one third 
of the African American women were diagnosed at an age less than 50 years, as compared 
to one fifth o f the Caucasian women.
In relation to patient service status, the results of this study correspond to the 
results of the study conducted by Wojcik, et al. (1998). In the Wojcik et al. study, 90 
percent of the women were family members of active duty members or retirees, and 4.9 
percent of the women were active duty. Within the group of active duty women, 10.3
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percent were African American, as compared to 4.3 percent Caucasian. In this study, 93.4 
percent o f the women were family members, 4.7 percent active duty, and 16.1 percent of 
the women within the active duty group were African American as compared to 3.5 
Caucasian.
African American women in this study were diagnosed at significantly later stages 
than were Caucasian women. Forty-one percent of the African American women in this 
study were diagnosed with tumors confined to the breast (early stage breast cancer), as 
compared to 58.5 percent of the Caucasian women. This finding is consistent with the 
percentages reported by other studies (Coates et al., 1990; Eley et al., 1994; Hunter et al., 
1993; Mandelblatt et al., 1995; Roach et al., 1997; Simon & Severson, 1996; Wojcik et 
al., 1998). Specifically, Landis, Murray, Bolden and Wingo (1999) reported that from 
1989 to 1994, 50 percent of the African American women diagnosed with breast cancer 
presented with tumors confined to the breast, as compared to 62 percent of the Caucasian 
women. Wells and Horm (1992) reported that 45.7 percent of the African American 
women they studied were diagnosed in early stage breast cancer, as compared to 52.1 
percent of the Caucasian women; and Newman and Alfonso (1997) found that 21.3 
percent of the African American women in their study presented at early stage breast 
cancer as compared to 49 percent of the Caucasian women.
In this study, African American women tended to have larger tumors at the time of 
diagnosis. This significant difference in tumor size is in keeping with the findings of other 
studies. Roach et al. (1997), Wojcik et al. (1998), and Zaloznik (1995), all reported that 
African American women had significantly larger tumors at the time o f diagnosis, when
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
151
compared to Caucasian women. However, neither this study, nor any o f the studies 
presented in chapter two reported significant differences in the number o f positive lymph 
nodes between the two groups of women.
The primary means of discovery for the women in this study was mammogram 
(45.4%). The significant difference in mammogram discovered breast cancers, for the 
African American (21.1% mammogram) and Caucasian (51.7% mammogram) women in 
this study, will be discussed in detail under research question one.
The mean exact length of time in days between discovery and diagnosis o f breast 
cancer was 45.15 for African American women and 45.55 for Caucasian women. When 
the exact length o f time was combined with the calculated in-exact length o f time between 
discovery and diagnosis, the mean for African American women became 57.96, as 
compared to a mean o f 61.29 for Caucasian women. In keeping with the findings of 
studies reported in chapter two and conducted outside of the DoD MHS, there were no 
significant differences between African American and Caucasian women on length of time 
between discovery and diagnosis of breast cancer. However, neither the study by 
Zaloznik (1995), nor the study by Wojcik et al. (1998), conducted within the DoD MHS, 
investigated the length of time between discovery o f breast abnormality and diagnosis of 
breast cancer.
The mean length o f time in days between diagnosis and treatment for African 
American women in this study was 13.26 as compared to 14.56 for Caucasian women, and 
there were no significant differences between the two groups. The mean length o f time 
between diagnosis and treatment for the African American and Caucasian women in this
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study, was however, shorter than the mean time reported by Wojcik et al.(1998), in which 
African American women were found to have a significantly shorter length o f time 
between diagnosis and treatment (21.15 days), than were Caucasian women (29.51 days).
Surgery was the means of initial treatment in 94.3 percent o f the women in this 
study, and there were no significant differences between African American (98.4%) and 
Caucasian (94.7%) women. This finding is consistent with the DoD wide study finding of 
Wojcik et al. (1998) in which surgery was the means of initial treatment for 93.8 percent 
of the African American women and for 90.3 percent o f the Caucasian women.
In keeping with the finding that African American women are more likely to die 
from breast cancer than Caucasian women (Chaulk, Kazandijan, & Pipesh, 1995; Coates 
et al., 1990; Eley et al., 1994; Wagner & Schatzkin, 1994; Wojcik et al., 1998), 16.1 
percent of the African American women in this study were deceased due to breast cancer 
at the time of data collection, as compared to 7.2 percent of the Caucasian women.
Research Question 1: What are the relationships between age, race, 
socioeconomic status, the means of discovery o f breast cancer, and stage at diagnosis of 
breast cancer in women identifying their race as Caucasian or African American, and being 
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to 
December 31, 1997.
The significant finding in this study, regarding the relationship between late age 
and early stage at diagnosis, is in keeping with the finding of Newman and Alfonso (1997). 
In both studies, women 50 years o f age and older were diagnosed at in situ (stage 0) and 
stage 1 at a higher percentage than women less than 50 years old. On the other hand, the
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finding relating to the distribution of stage by age and race in this study, was different 
from the finding in Newman and Alfonso’s study. Both studies reported detecting a 
significant difference in stage at diagnosis between African American and Caucasian 
women, and in the distribution of stage by age within the group of Caucasian women. 
However, while Newman and Alfonso reported a significant difference in the distribution 
of stage at diagnosis between African American women less than 50 years old, and African 
American women 50 years o f age and older, this study found that there was no significant 
difference in the distribution of stage by age in the group African American women.
The finding o f a significant difference in the stage at diagnosis of breast cancer 
between the African American and Caucasian women in this study, echo the results o f 
other studies examining the relationship between race and stage at diagnosis of breast 
cancer. In studies conducted by Hunter et al. (1993) Mandelblatt et al. (1995), and 
Newman and Alfonso (1997), African American women were found to be diagnosed at 
significantly later stages than Caucasian women. Hunter et al. attributed this disparity to 
access to health care, lifestyle, and antecedent medical experiences in the African 
American women, and suggested that higher stage at diagnosis was related to poorer 
access to health care and lower socioeconomic status (SES). Mandelblatt et al. also 
attributed the disparity in stage at diagnosis to health care access and SES. Mandelblatt et 
al. found that the odds for being diagnosed with late stage breast cancer were higher for 
women living in areas with low SES rankings, and that mammography capacity was a 
significant independent predictor of stage at diagnosis. On the other hand, Newman and 
Alfonso reported that the disparity in stage at diagnosis o f breast cancer in the African
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American and Caucasian women in their study, did not appear to be related to economic 
access to health care. The majority of the African American women in the Newman and 
Alfonso study had access to and used private medical care; and the distribution o f stage at 
diagnosis in African American women receiving care through the public clinic was similar 
to the distribution o f those receiving care through the private practice setting.
Zaloznik (1995) reported finding no significant difference in stage at diagnosis 
between African American and Caucasian women receiving care in the DoD MHS. In a 
study conducted using the tumor registry records o f 6414 Caucasian and 746 African 
American women entered in the DoD Automated Tumor Registry from 1976 to 1992, 
Zaloznik reported that African American women were significantly younger than 
Caucasian women, had significantly larger tumors than Caucasian women, but were not 
diagnosed at significantly later stages than Caucasian women. This finding is interesting in 
light of the results o f the study by Wojcik et al. reported in 1998. Wojcik et al. examined 
the breast cancer survival status of 698 African American and 5879 Caucasian women 
with records entered in the DoD central tumor registry from 1975 to 1994 and found that 
African American women were significantly younger than Caucasian women at the time of 
diagnosis, had significantly larger tumors than Caucasian women, and were diagnosed at 
significantly later stages than Caucasian women. Neither o f the studies conducted inside 
the DoD MHS examined the effects of SES, or means o f discovery on stage at diagnosis, 
but Wojcik et al. asserted that factors other than economic access may contribute to 
diagnosis of African American women at younger ages and later stages of breast cancer. 
The findings of this study, relating to the relationship between age, race, and stage at
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diagnosis support the assertion made by Wojcik et al., and indicate that in this sample, 
delineators o f access, other than economic, appear to be related to the disparity in age, 
race, and stage at diagnosis.
Approximately 93 percent of the women included in this study were family 
members o f active duty members or retirees. Therefore, the rank o f the sponsor is not 
considered to be an effective measure o f military rank or educational level for 93 percent 
of the women in this study. However, the rank o f the sponsor is viewed as an appropriate 
measure o f the SES of the household of the woman being diagnosed with breast cancer, 
and is supported as an effective means of comparing and contrasting the SES of the 
women included in this study.
The relationship between SES and stage at diagnosis was significant. Junior 
enlisted (lower pay level than senior enlisted, junior officer, senior officer) were diagnosed 
at stages 2 and 3 at a higher percentage than senior enlisted, junior officers, and senior 
officers. This finding of late stage at diagnosis o f breast cancer at lower SES rankings is 
consistent with other studies reported in chapter two (Franzini et al., 1997; Wagner & 
Schatzkin, 1994; Wells & Horm, 1992). However, prior studies on the relationship 
between SES and stage at diagnosis o f breast cancer, within an equal economic access 
system, were not available for comparison. In addition, this disparity in stage at diagnosis 
could be related to age at diagnosis, since junior enlisted and their spouses are frequently 
younger than senior enlisted, junior officers and senior officers. Furthermore, the 
significantly higher percentage o f African American women with a sponsor’s rank o f
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junior enlisted, as compared to Caucasian women, could also be related to the disparity in 
stage at diagnosis by SES.
The percentage o f women diagnosed in early stage breast cancer, by mammogram, 
is significantly higher than the percentage o f women diagnosed in early stage breast cancer 
by any other means. Forty-five percent o f the stage 2 cancers were diagnosed by 
incidental BSE, as compared to 16 percent diagnosed by mammogram, and 21 percent of 
the stage 0 breast cancers were diagnosed by mammogram, as compared to five percent 
diagnosed by intentional BSE, and four percent diagnosed by incidental BSE. These 
findings support the existing literature on breast cancer screening which reports that early 
stage diagnosis is more likely to be associated with mammogram than with any other 
means.
The finding relating to the distribution o f means o f discovery by race was 
significant. Fifty-two percent of the Caucasian women in this study had their breast 
cancers discovered by mammogram as compared to 21 percent of the African American 
women; and 30 percent of the Caucasian women discovered their breast cancers by 
incidental BSE as compared to 46 percent o f the African American women. Nine percent 
of the Caucasian women discovered their breast cancers by intentional BSE as compared 
to 18 percent of the African American women; and 9 percent of the cancers in the group 
of Caucasian women were discovered by CBE, as compared to 16 percent in the group of 
African American women. Only one study examining the relationship between stage at 
diagnosis and means of discovery in African American and Caucasian women could be 
located for comparison with the findings o f this study. However, the available studies on
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
157
the breast cancer screening behaviors and practices of African American and Caucasian 
women provide an additional avenue for discussion of this study’s findings, in relation to 
the means o f discovery. Vernon et al. (1992), O’Malley, Earp, and Harris (1997), and 
Roberson (1997) found, when examining breast cancer screening behaviors in African 
American and Caucasian women, that Caucasian women were more likely to participate in 
mammography than African American women. In these studies, the difference in 
screening practice was attributed to cost and lack of physician referral. On the other hand, 
Douglass, Bartolucci, Waterbor, and Sirles (1995), and Michels, Carter, Taplin, and 
Kugler (1995) reported finding no significant difference in mammography participation 
between African American and Caucasian women.
In the one study located examining the relationship between means of discovery 
and stage at diagnosis, Benedict, Williams, and Hoomani (1996) found that 55.6 percent 
of the African American women had cancers discovered by mammogram as compared to 
31.7 percent of the Caucasian women; even though the Caucasian women had higher rates 
for annual CBE and mammogram, than the African American women. In addition, 
Benedict et al. reported that 33.3 percent of the cancers in African American women were 
discovered by accident, as compared to 7.35 in the Caucasian women; and that 11.1 
percent o f the cancers in African American women were discovered by BSE as compared 
to 34.1 in the Caucasian women. Benedict et al. did not include stage 0 in their analysis, 
and stage at diagnosis, in relation to means of discovery, was not stratified by race. In 
addition, inferential statistics were not conducted because of sample size. Therefore, even 
though the study conducted by these investigators offers some insight into the relationship
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between stage at diagnosis and means o f discovery for women receiving care outside o f an 
equal economic access system, the comparability of the results with this study’s findings is 
difficult because of research design and methodology.
The results of these studies both support and contrast the findings of this study.
The majority o f  the studies available on means of discovery relate to self reported breast 
cancer screening behaviors and activities of women who have not had breast cancer; and 
the one study located on means o f discovery in women diagnosed with breast cancer did 
not provide optimal comparability. Nevertheless, the significant difference in stage at 
diagnosis in the African American and Caucasian women in this study appears to be 
related to the means of discovery.
Research Question 2 . What are the relationships between the length of time 
between discovery and diagnosis o f breast cancer, and the length of time between 
diagnosis and initiation of treatment of breast cancer, and stage at diagnosis of breast 
cancer in women identifying their race as Caucasian or African American, and being 
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to 
December 31, 1997.
The finding of a significant relationship between length o f time in days between 
discovery and diagnosis, and stage at diagnosis supports that increased length of time 
between discovery and diagnosis is associated with late stage at diagnosis. Women with 
greater than 90 days between discovery and diagnosis seemed to have poorer outcomes in 
relation to stage at diagnosis. Sixty-one percent of the women with greater than 90 days 
between discovery and diagnosis were diagnosed in late stage breast cancer. Women with
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61 to 90 days between discovery and diagnosis were equally distributed (50%) between 
early and late stage at diagnosis; and women with 0 to 60 days between discovery and 
diagnosis were diagnosed at late stage breast cancer at a range o f 37 to 42 percent. Even 
though there are no prior studies which specifically examine the relationship between stage 
at diagnosis and length of time between discovery and diagnosis, available for comparison 
with the findings o f this study, the existing literature on breast cancer maintains that late 
stage diagnosis o f breast cancer is associated with prolonged time between discovery and 
diagnosis; occurs more frequently in African American women; and is a result of lack o f 
economic access to care. However, the existence o f economic access to health care within 
the group o f  women in this study renders economic access barriers irrelevant as the 
primary cause o f diagnosis delay, and support the existence o f other access barriers to 
care. Furthermore, the African American women in this study were diagnosed at 
significantly later stages than the Caucasian women, yet there was no significant difference 
between the two groups on length o f time between discovery and diagnosis.
The relationship between length of time between diagnosis and treatment and stage 
at diagnosis was significant. This finding is interesting in light o f the fact that diagnosis, 
and assignment o f stage, occur primarily before the period o f time between diagnosis and 
treatment commences. This finding will be discussed further under research question 
number three.
Research Question 3. To what extent do the variables age, race, socioeconomic 
status, and the means of discovery o f  breast cancer predict the length o f time between 
discovery and diagnosis of breast cancer, and the length of time between diagnosis and
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initiation of treatment of breast cancer, in women identifying their race as Caucasian or 
African American, and being diagnosed with breast cancer at Naval Medical Center San 
Diego from January 1, 1988 to December 31, 1997.
The group of variables comprising potential access accounted for six percent o f the 
variance in length of time between discovery and diagnosis. Incidental BSE emerged as 
the variable explaining the greatest amount o f variance, followed by CBE; and none o f the 
other variables of potential access contributed significantly to the variance in this model. 
The amount o f explained variance is low, and there are no prior studies available for 
comparison. Still, one interpretation of the low explained variance might be the existence 
of several other undefined variables o f potential access, which influence both means of 
discovery of breast cancer, and the length of time between discovery and diagnosis. In 
addition, unidentified personal and health care delivery system factors related to length of 
time between discovery of breast abnormality and initial contact with the health care 
delivery system might also impact length o f time between discovery and diagnosis.
The findings of this study did not support the variables o f potential access (age, 
race, SES, means of discovery), as a group, as significant predictors o f the length o f time 
between diagnosis and treatment o f breast cancer. The regression model did approach the 
level o f significance, and age at diagnosis, when taken separately was found to be a 
significant predictor of the length o f time between diagnosis and treatment. However, in 
the regression model examining the relationship between age and realized access, age at 
diagnosis was not found to be significantly related to the length of time between diagnosis 
and treatment.
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The results discussed thus far in this chapter support that stage at diagnosis is 
significantly related to the variables of potential access. While Aday and Anderson (1974) 
maintain that potential access can be conceptualized as characteristics of the individual 
and/or the health care delivery system, in this study, potential access has been supported as 
a characterization of the individual. Even though statistical analyses have also 
demonstrated the existence o f significant relationships between the variables o f realized 
access and stage at diagnosis, length of time between discovery and diagnosis appears to 
be a characteristic of the individual related to the means o f discovery, while length o f time 
between diagnosis and treatment appears to be a characteristic o f the health care 
institution related to economic access to health care. If  this conjecture is true, variables of 
potential access, which define characteristics of the individual, would not be expected to 
significantly predict length of time between diagnosis and treatment within an equal 
economic access system; and variables defining means of discovery would be expected to 
significantly predict the length o f  time between discovery and diagnosis. Given the 
findings of this study, it can be posited that the results relating to the extent to which 
variables of potential access predict the length of time between diagnosis and treatment, 
are consistent with the other results of this study.
Research Question 4 . To what extent do the variables age, race, socioeconomic 
status, and the means of discovery of breast cancer predict stage at diagnosis of breast 
cancer in women identifying their race as Caucasian or African American, and being 
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to 
December 31, 1997.
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Means o f discovery was the only potential access variable which reliably predicted 
late stage diagnosis o f  breast cancer. Within the means o f discovery grouping, incidental 
BSE was the strongest predictor, and women with breast cancers discovered by incidental 
BSE were almost six times more likely to be diagnosed at late stage than were women 
with breast cancers discovered by mammogram. This finding supports study results 
discussed earlier relevant to the significant relationship between stage at diagnosis and 
means of discovery, in that mammogram appears to be related to early stage diagnosis, 
while incidental BSE seems to be related to late stage diagnosis. Both intentional BSE 
and CBE were four times more likely to result in late stage diagnosis, when compared to 
mammogram. Therefore, overall, the results o f this study confirm that early stage 
diagnosis is more likely to be associated with mammogram than with any other means o f 
discovery.
African American women, in this study, were slightly more likely to be diagnosed 
with late stage breast cancer, when compared to the Caucasian women. This odds ratio 
supports this study’s finding of a significant difference between the two groups on stage 
at diagnosis o f breast cancer. In addition, the increased likelihood of African American 
women being diagnosed at a later stage seems to be related to a higher percentage of 
African American women having breast cancers discovered by incidental BSE, the means 
of discovery most associated with late stage diagnosis; and a higher percentage of 
Caucasian women having cancers discovered by mammogram, the means of discovery 
most associated with early stage diagnosis.
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Women with a sponsor’s rank of E l to E5 were three times more likely to be 
diagnosed with late stage breast cancer than were women with a sponsor’s rank o f  0 5  to 
010, and were twice as likely to be diagnosed in late stage than any of the other rank o f 
sponsor groupings. These findings support the discussion presented earlier in this chapter, 
and reiterate the assertion that the stage at diagnosis disparity in SES may be related to 
stage at diagnosis disparities within the age and race variables.
According to the results discussed above, late stage diagnosis is more likely to be 
associated with African American women from low SES (sponsor’s rank of E l to E5), 
with their breast cancers discovered by some means other than mammogram. Once again, 
this study’s findings confirm the association between potential access and stage at 
diagnosis, and echo the findings of much of the breast cancer disparity literature, which 
reports that late stage breast cancer is more likely to be diagnosed in African American 
women from low SES and with low mammogram usage. But if economic access is the 
primary cause of late stage diagnosis in African American women, the profile for women 
diagnosed with late stage breast cancer within an equal economic access system should be 
different, and it appears to be the same. Even though the finding of significant 
relationships between age, race, SES and stage at diagnosis has been repeatedly reported 
in the literature (Coates, et al., 1990; Eley, et al., 1994; Hunter, et al., 1993; Mandelblatt, 
et al., 1995; Newman & Alfonso, 1997; Wojcik, et al., 1998), studies specifically 
investigating and reporting the relationship between means o f discovery and stage o f 
diagnosis are not available in the literature. In this study, significant findings involving the 
relationship between means of discovery and stage at diagnosis appear to have an
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underlying association with significant findings relating to race, age, SES and length of 
time between discovery and diagnosis. Therefore, additional studies are needed to explore 
the relationships between age, race, SES, means of discovery, and stage at diagnosis, both 
inside and outside of the DoD. Discussion relating to additional statistical analyses 
conducted with these variables, in this study, is presented later in this chapter.
Research Question 5. To what extent do the variables length of time between 
discovery and diagnosis of breast cancer, and length o f time between diagnosis and 
initiation o f treatment of breast cancer, predict stage at diagnosis of breast cancer in 
women identifying their race as Caucasian or African American, and being diagnosed with 
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 
1997.
Within the group of realized access variables, only the length of time between 
discovery and diagnosis reliably predicted late stage at diagnosis. This finding supports 
the discussion presented earlier under research question number 3.
Supplemental Data Analysis
The findings of this study: (a) identify significant relationships between age, race, 
SES, means of discovery and stage at diagnosis; (b) identify significant differences in age, 
SES, and means of discovery by race; (c) identify significant relationships between length 
of time between discovery and diagnosis, and length o f time between diagnosis and 
treatment, and stage at diagnosis; (d) identify means o f  discovery (incidental BSE and 
CBE) as a significant predictor of length of time between discovery and diagnosis; (e) 
identify means of discovery as a reliable predictor o f late stage diagnosis; and (f) identify
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the length of time between discovery and diagnosis as a reliable predictor of late stage 
breast cancer. Furthermore, the disparity in stage at diagnosis, between the African 
American and Caucasian women in this study, and the significant relationship between 
length o f  time between discovery and diagnosis and stage at diagnosis, seem to both be 
related to means of discovery. In light of these findings, and the suggestion of underlying 
relationships to means of discovery, supplemental data analyses were conducted. 
Discussion relevant to these supplemental findings are presented below.
Comparative analyses reflect a significant difference in the distribution of means o f 
discovery by race, age, and SES. Previous discussions have identified the significant 
difference in distribution o f means o f discovery by race, and supplemental analyses reflect 
similar differences in the distribution of means of discovery by age and sponsor’s rank.
The American Cancer Society (ACS) and the DoD MHS breast cancer screening 
guidelines recommend annual mammography for women age 40 and older (American 
Medical Women’s Association [AMWA], 1997). Therefore, the percentage of women 
less than 40 years old, having their cancers discovered by mammogram, is expected to be 
significantly less than those 40 years and older. But the ACS and DoD MHS also 
recommend monthly BSE, and CBE at least every 3 years for women 20 to 39 years old. 
Thus, age can be supported as a possible influencer o f low mammography percentages in 
the women less than 40, but the high percentage of incidental discoveries in women less 
than 40, as compared to intentional BSE and CBE, can not be readily related to age.
Previous discussions have already identified the significant difference in mean age 
at diagnosis between African American and Caucasian women. Therefore, the disparity in
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stage at diagnosis between the two groups might be related to this significant difference in 
age, which might be related to the significant difference in mammogram discovered breast 
cancers in the two groups, which might be related to the DoD MHS age guidelines for 
annual screening mammography. However, the number o f African American women 40 
years and older is almost four times the number having breast cancers discovered by 
mammogram, so age may be one influencer o f the number of mammogram discovered 
breast cancers diagnosed in the African American women in this study, but additional 
influencers exist and must be identified. This assertion is supported by the finding that 
while 516 o f  the Caucasian women in the study were 40 years and older, only 293 of the 
breast cancers discovered in this group o f women occurred by mammogram. In addition, 
within the 40 to 49 year old age group 37.2 percent of the cancers were discovered by 
incidental BSE as compared to 36.3 by mammogram, and 8.8 percent by CBE. 
Mammography is the optimal secondary prevention strategy for breast cancer, but some 
cancers palpated on CBE and/or BSE, may not be detected on mammography (AMWA, 
1997). As a result, a certain percentage o f cancers may only be found by CBE or BSE. 
However, the large percentage of cancers discovered by incidental BSE raise questions 
about routine breast cancer screening practices in all age groups.
The disparity in stage at diagnosis of breast cancer by sponsor’s rank, may also be 
related to age. Women with a sponsor’s rank of E l through E5 were diagnosed at 
significantly later stages than any of the other groupings, and 39.1 percent o f the women 
in the E l to E5 group were less than 40 years old, as compared to 10.2 percent for the 
CWO through 0 4  group, 9.8 percent for the E6 to E9 group, and less than one percent
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for the 0 5  to OlO group. But, there were 25 women with a sponsor’s rank of E l to E5 
40 years o f age and older, and only 10 had cancers discovered by mammogram. Of the 
women falling into the E l to E5 category, 16 were less than 40 years old, however, 18 of 
the women in the E l to E5 category had cancers discovered by incidental BSE, 6 by 
intentional BSE, and 4 by CBE. The disparity in stage at diagnosis within the sponsor’s 
rank group may be related to race, but 63.8 percent of the African American women in the 
study had a sponsor’s rank of E6 to E9, as compared to 27.7 percent for E l to E5; and 
women in the E l to E5 group were twice as likely to be diagnosed at late stage breast 
cancer, when compared to women in the E6 to E9 group.
In this study, breast cancers discovered by intentional BSE had the same odds for 
being diagnosed at late stage as those discovered by CBE. But the odds for cancers 
discovered by incidental BSE being diagnosed at late stage were almost six times the odds 
for mammogram discovered cancers. In addition, self discovered (BSE) breast cancers 
were diagnosed at a significantly earlier age, when compared to provider discovered (CBE 
and mammogram) cancers. While there was no significant difference in mean length of 
time between diagnosis and treatment between self discovered and provider discovered 
breast cancers, women who had self discovered cancers had significantly larger tumors, 
and a significantly higher mean length o f time between discovery and diagnosis. 
Furthermore, supplemental logistic analysis supported that Caucasian women, 50 years of 
age and older, with a sponsor’s rank of 05  through OlO, were most likely to have 
provider discovered breast cancers.
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Improvements in the diagnosis and treatment of breast cancer have emerged over 
the past 20 years (Chu et al., 1996), and the findings of significant relationships between 
the variables o f potential access and stage at diagnosis may be influenced by significant 
differences in the distribution of these variables across the years. However supplemental 
analysis revealed that there were no significant differences in the distribution o f race, age, 
SES, or stage, by year; and even though chi-square analysis demonstrated a significant 
difference in the distribution of means o f discovery by year, the trends in mammography 
and incidental BSE discoveries appear to be inconsistent.
The additional analyses conducted in this study have confirmed means of discovery 
as a major influencer o f the significant differences in stage at diagnosis by race, age, and 
SES, and have demonstrated that the women with self discovered breast cancers had 
poorer stage at diagnosis outcomes. Nevertheless, additional study is needed to explore 
the relationship between means of discovery and stage at diagnosis in other races, and in 
other health care institutions inside and outside of the DoD.
The existence of significant differences in means of discovery by race, age, and 
SES, within an equal economic access health care system, provide support for the theory 
that a woman’s participation in breast health care is influenced by the perception of the 
availability, necessity, and appropriateness o f care. Knowledge o f the “need” for breast 
health care and the existence of the “economic means” to obtain that care may have little 
or no influence on a woman’s expediency in seeking care, if the care is not perceived as 
necessary, appropriate, or available. A perception o f  the availability o f breast health care 
is influenced by economic factors as well as location of care, fit with time schedules, fit
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with family and personal responsibilities, and fit with cultural beliefs, values, and 
expectations. A perception of the necessity o f breast health care is influenced by 
incorporation of health promotion and disease prevention into definitions of health, 
symptomatology and cultural definitions o f severity, and personal and family priorities. A 
perception o f appropriateness of care is influenced by the fit o f breast health care with 
cultural values, beliefs, and practices, interactions and relationships with providers of care, 
and previous experience associated with breast cancer and breast health care. These 
perceptions are generated through experiences resulting from the interaction o f cultural, 
structural, and social factors, and assessment o f these perceptions can provide insight into 
differences in means of discovery by age, race and SES. Therefore, additional studies are 
also needed to evaluate the knowledge o f the “need” for breast health care, and the 
perception o f access appropriateness, necessity, and availability.
In addition, studies are needed: to evaluate adherence to breast cancer screening 
guidelines by women receiving care within the DoD MHS; to identify other elements of 
potential access which may influence participation in breast cancer screening programs and 
care seeking behaviors; to explore differences in the length o f time between discovery of 
breast abnormality and contact with the health care delivery system, and length of time 
between discovery o f abnormality and diagnosis o f breast cancer; and to explore factors 
associated with the length of time between first medical consultation and diagnosis of 
breast cancer.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
170
Implications for Nursing
The implications of the findings o f this study for nursing practice, education, and 
research, along with recommendations for further research, are presented in this section. 
Nursing Practice
The results of this study confirm the existence of non-economic access barriers to 
participation in breast cancer screening programs for some women. Within the DoD 
MHS, “easy” access did not exist for all women receiving breast health care, and while the 
African American women in this study seemed to have poorer stage at diagnosis 
outcomes, the implications of this study impact women of all ethnicities and age groups, 
and provide opportunities for improvement o f nursing practice in all clinical settings.
Early detection is the best defense against late stage breast cancer diagnosis. 
Therefore, every effort should be employed to ensure that women inside and outside of the 
DoD MHS are aware of, and participate in health promotion and disease prevention 
activities related to breast health care. Existence of economic access to care, did not 
translate into utilization of care in this study. Variables o f potential access, such as age, 
race, SES, and means of discovery, were significantly related to stage at diagnosis, and 
explained a small amount of the variance in length of time between discovery and 
diagnosis. Therefore, breast health promotion and disease prevention programs should 
focus on being economically available, perceptually necessary, and culturally appropriate.
In this study, there was no significant difference in the length of time between 
diagnosis and treatment, by race, or by means o f discovery. These findings support the 
existence o f equal economic access to “superior medical and diagnostic technology” for all
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eligible DoD MHS beneficiaries. But diagnosis and treatment cannot be initiated if the 
health care system is not utilized. Therefore, breast health care programs must also 
emphasize utilization of health care resources, and the steps to be taken when breast 
abnormalities are discovered.
The results o f this study confirmed findings o f other studies investigating the 
disparity in stage at diagnosis between African American and Caucasian women.
According to this study, late stage breast cancer was more likely to be diagnosed in 
African American women, from low SES, and with low mammogram usage. Even though 
the implications presented above apply to all age groups and ethnicities, the observation 
that the profile for women with delayed diagnosis within this equal economic access health 
care system reflects the profile for women outside of this system has specific implications 
for provision of breast health care and education to African American women. The 
percentage of incidental discoveries of breast cancer for African American women was 
significantly high, when compared to Caucasian women; and since African American 
women were diagnosed at younger ages and with larger tumors, emphasis on practicing 
monthly BSE and routine CBE and mammogram, in this population of women, is 
essential. If  late stage diagnosis and mortality are to be decreased, BSE instruction must 
include “the how to” and “the what to do”, and nurses must incorporate assessment of the 
woman’s definition of health, and attitudes about seeking care into this breast health care 
instruction. In addition, African American women must be consistently encouraged to 
seek out breast health care, and to participate in CBE, BSE, and mammogram, even in 
the absence of symptoms.
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This study has provided new insights into the relationship between access to care 
and stage at diagnosis, and has tremendous implications for nursing practice. Even though 
additional study and exploration is needed to further identify, describe, and verify non­
economic access barriers to breast health care, incorporation of the implications discussed 
above, into current nursing practice, will enhance the success o f breast health care 
programs targeting women o f all ethnicities and ages.
Nursing Education
Nursing education programs must continue to make health promotion and disease 
prevention an integral part of their curriculums. Approaches to teaching health promotion 
and disease prevention should promote breast health care; and breast health care 
curriculums should emphasize the impact of non-economic access barriers on participation 
in breast cancer screening.
In addition, nursing education programs should expand their perceptions of 
culturally appropriate care, and begin to view each nurse-client encounter as an 
opportunity for increasing cultural awareness, and gaining insight into client’s definitions 
of health, and care seeking behaviors. In this study, characteristics of the individual (such 
as age, race, and SES) had significant relationships to both means of discovery and stage 
at diagnosis. Therefore, non-economic access barriers to participation in breast health 
care might be more readily identified by assessing the client’s cultural perception of health 
care necessity, appropriateness, and availability.
Finally, educators o f  nurses should emphasize the importance of breast cancer 
screening in students of nursing, at all levels. Educational programs should help students
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evaluate their own adherence to ACS recommendations for breast cancer screening, and 
identify personal barriers to accessing breast health care. Enhancing awareness of the 
relationship between access and stage at diagnosis, and increasing personal participation in 
breast health care, through nursing education, will contribute significantly to decreasing 
the percentage o f incidental breast cancer discoveries, and subsequent late stage 
diagnoses.
Nursing Research
The findings of this study suggest a revised conceptual model (Figure 2). Within 
this equal economic access system, the identified variables o f potential access influenced 
length of time between discovery and diagnosis, but did not influence length of time 
between diagnosis and treatment. Both the variables of potential access and length of time 
between discovery and diagnosis influenced stage at diagnosis, but length of time between 
diagnosis and treatment, although a measure of realized access, seemed to be influenced 
primarily by stage at diagnosis o f breast cancer.
The revised conceptual model for the study of access to breast health care for 
women within the MHS should be tested with other races serviced by NMCSD, and with 
African American and Caucasian populations at other DoD MHS institutions. Although 
studies conducted using an automated data base, across a number of institutions 
simultaneously, provide generalizability, studies focusing on means o f discovery and 
length of time between discovery and diagnosis will be best conducted by the review o f 
actual tumor registry records. Since the findings from this study relating to means of 
discovery and length of time between discovery and diagnosis were most significant, it is
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recommended that these findings be confirmed by conducting studies within the MHS, 
using tumor registry records in conjunction with data bases.
Within the equal economic access health care system focused on in this study, 
barriers to access seemed to occur at the individual level (versus health care system level). 
The means o f discovery influenced the timeliness o f diagnosis, and questions surrounding 
the individual’s ability and willingness to participate in health care arise from the poorer 
stage at diagnosis outcomes associated with self discovered breast cancer. In addition, the 
group of potential access variables identified in this study were only able to explain a small 
amount o f the variance in length of time between discovery and diagnosis. Therefore, 
additional studies using the access framework and examining additional variables of 
potential and realized access are recommended. Within the potential access variable, 
additional predisposing factors such as family history of breast cancer and health 
promotion practices (alcohol use, tobacco use; body mass index) could be added, as well 
as other enabling factors such as geographic proximity to the health care institution, and 
transportation availability. Within the realized access variable, length o f time between 
discovery and contact with the health care system should be evaluated in conjunction with 
length of time between discovery and diagnosis.
Stage at diagnosis influences both treatment and survival outcomes, and although 
this study did not examine treatment or survival outcomes in relation to stage at diagnosis, 
early stage diagnosis was associated primarily with mammogram, while late stage 
diagnosis was associated primarily with incidental BSE. Questions arise surrounding both 
of these means o f discovery, but because mammogram discovered breast cancers were
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associated primarily with early stage diagnosis, it is recommended that additional studies 
be conducted within the DoD MHS describing the demographic characteristics and 
diagnostic outcomes of women receiving mammograms.
Even though this study was conducted with a sample o f women at one institution, 
the demographic characteristics o f this sample correspond to the demographic 
characteristics o f studies conducted with populations o f African American and Caucasian 
women both inside and outside of the DoD MHS. Therefore, it is recommended that the 
findings o f  this study be used to guide exploratory studies o f  a qualitative nature, inside 
and outside o f the DoD, to identify other variables of potential access.
In addition, it is recommended that additional exploratory studies be conducted to 
further examine the significant relationship between age, race, SES, means of discovery, 
and stage at diagnosis. These studies should be conducted both inside and outside of the 
DoD MHS, and should explore these relationships in regard to potential access need 
factors such as health beliefs, health practices, and perceptions about the necessity, 
appropriateness, and availability of care.
Although this study added foundational knowledge on the relationship between 
access and stage at diagnosis of breast cancer, the additional studies discussed above are 
needed to substantiate the findings o f this study, and develop hypotheses to be tested in 
future breast health care research. A summary of the recommendations for further study is 
presented below.
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Summary o f recommendations for further study.
1. Conduct an expanded study, using the revised conceptual model, and comparing 
the findings of this study on African American and Caucasian women with data collected 
from the tumor registry records of Asian women, diagnosed with breast cancer at 
NMCSD.
2. Using the revised model, replicate this study at another large DoD MHS 
institution.
3. Conduct a study of the relationship between access and stage at diagnosis between 
African American and Caucasian women within the DoD MHS, using a revised framework 
which includes additional variables o f potential and realized access.
4. Conduct a descriptive study o f the demographic characteristics and diagnostic 
outcomes o f  women receiving mammograms within the DoD MHS.
5. Conduct qualitative exploratory studies inside and outside o f the DoD MHS to 
identify other variables of potential access.
6. Conduct qualitative exploratory studies inside and outside o f the DoD MHS to 
explore the relationships between potential access and stage at diagnosis, as they relate to 
health beliefs, health practices, and perceptions of access.
Conclusion
The findings of this study support the theorized relationships between the study 
variables. As in other studies examining the relationship between economic access and 
stage at diagnosis o f breast cancer, the existence of economic access to care in this 
sample, did not always result in early diagnosis, and other factors such as age, race, SES,
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and means o f discovery influenced diagnosis outcomes. Within this study, length of time 
between discovery and diagnosis was a function of means of discovery; and even though 
length of time between diagnosis and treatment was not predicted by potential access, this 
variable seemed to be a measure o f equal access to treatment within this DoD MHS.
In this equal economic access system, there was a significant difference in stage at 
diagnosis between the African American and Caucasian women. Delayed diagnosis was 
the cause o f this significant difference. African American women were diagnosed at later 
stages and with larger tumors, as compared to Caucasian women. However, this 
diagnosis delay did not appear to be related to economic access, in that there was no 
significant difference between the African American and Caucasian women in the length o f 
time between diagnosis and treatment. The disparity in diagnosis delay between the 
African American and Caucasian women, and within the age and rank of sponsor 
categories, seemed to be related to the means of discovery. Self discovered breast cancers 
were associated primarily with late stage diagnosis, while provider discovered cancers 
were associated with early stage; and while intentional BSE and CBE had similar 
diagnostic outcomes, late diagnosis was most strongly associated with incidental BSE, 
while mammogram was most strongly associated with early diagnosis.
The results of this study clearly indicate that interventions aimed at increasing 
participation in breast health care programs among African American women, women of 
color, and all other categories of women, must focus on all aspects of access to health 
care. Economic access makes the difference from diagnosis to treatment, but treatment 
cannot be initiated until diagnosis occurs, and diagnosis cannot occur until access is
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realized. Therefore, breast health care interventions should be directed towards increasing 
awareness, increasing discovery, and decreasing the length o f time between discovery and 
diagnosis, especially in women ages 20-40.
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Breast Cancer Medical Record Data Collection Sheet 
Identification Number:________________________________
Race:____________________________________ Date o f Birth:____________________
Patient Status: Active Duty Retired Family Member
Marital Status: Married Single Divorced Separated Widowed
Branch o f Service Affiliation: ______________________
Rate/Rank: _______________________________________ _
Date o f Diagnosis:_____________________________________  Age at Diagnosis:_________________
Stage at Diagnosis: 0 1 II HI IV
Tumor Size in centimeters:_______________________________________________
Number o f Positive Lymph N o d e s : _____________________________________________
Means o f Discovery:
Intentional Breast Self Exam Incidental Breast Self Exam
Routine Clinical Breast Exam Secondary C linical Breast Exam
Routine Mammogram Secondary Mammogram
Length o f time in days between discovery o f breast abnormality and diagnosis:___________________
Date Discovered:______________________
Length o f time in days between diagnosis o f breast cancer and initiation of treatment:_____________
Date Treatment Initiated:__________________________
Means of Treatment: Surgery at the Time o f D iagnosis Surgery after D iagnosis
Radiation Therapy Chemotherapy
Hormone Therapy No Treatment
Survival Status at the Time o f Data Collection:
Alive Deceased Due to Breast Cancer
Deceased Due to Other Cause Deceased Due to Unknown Cause
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From: Chairman, Scientific Review Committee (SRC)
Chairman, Committee for the Protection of Human Subjects
Via: Deputy Commander
Subj : EXPEDITED REVIEW OF CIP STUDY #S-98-107, “FACTORS RELATED
Ref: (a) NSHSBETHINST 6000.41A
(b) NAVMEDCEN SDIEGOINST 6500.4D
1. The subject study was reviewed by members of the respective 
committees. In accordance with references (a) and (b), local 
expedited approval of the above protocol is requested effective 
the date of your endorsement below.
2. Local expedited approval was authorized for the above 
research project by two members of the SRC on 11 June 1998. The 
signature below is provided to reflect the approval by the 
committee members. This protocol was processed in accordance 
with part 2, section A(i) of reference (a). This protocol is a 
retrospective chart review.
3. The Chairman, CPHS determined that the study is exempt from 
CPHS review. The signature below is provided to reflect that 
exemption.
4. This expedited approval will allow the investigator to begin 
the study as soon as the minor changes requested by the reviewers 
have been submitted. An administrative entry will be included in 
the next set of committee minutes.
To: Commander
TO STAGE AT DIAGNOSIS OF AFRICAN AMERICAN AND CAUCASIAN 
WOMEN DIAGNOSED WITH BREAST CANCER IN THE MILITARY HEALTH 
SYSTEM"
D . L . REEVES 
CDR, MSC, USN
Chairman, Scientific Review 
Committee
K. DEAN GUBLER 
CDR, MC, USN
Chairman, Committee for the 
Protection of Human Subjects
5 . Approved/ Bi 3 app Lnoved
1LSON
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From: Head, Clinical Investigation Department (CID)
To: CAPT Sandra Bibb, NC, USN
Subj : OFFICIAL APPROVAL OF CLINICAL INVESTIGATION PROGRAM (CIP)
STUDY #S-98-107 "FACTOR RELATED TO STAGE' AT DIAGNOSIS IN 
AFRICAN AMERICAN AND CAUCASIAN WOMEN DIAGNOSED WITH BREAST 
CANCER IN THE MILITARY HEALTH SYSTEM"
Ref: (a) NAVMEDCEN SANDIEGOINST 6500.4D
(b) NAVMEDCEN SANDIEGOINST 6500.5C
Enel: (1) Approved version, of CIP Study
(2) Travel information
(3) Revisions to the protocol
1. Your research protocol (enclosure (1)) has been approved for 
initiation as of this date. Your protocol has met the 
requirements of references (a) and (b) and has been approved by 
the Scientific Review Committee (SRC). An annual review will be 
required in May 1999.
2. Requests for travel funds for presentations related to your 
protocol must be processed through Medical Editing and include 
your CIP #. Travel funds are allocated by Naval School of Health 
Sciences (NSHS), Bethesda, MD and are available on a first come 
first served basis. The information needed to apply for TAD 
funded by NSHS is in enclosure (2).
3. Articles/abstracts for publications must be submitted to the 
DCR Medical Editing staff. They will assist in the preparation, 
ensure proper acknowledgment of BUMED as sponsor, obtain command 
approval and submit them to journals and publications.
4. Changes to the protocol (i.e., increasing/decreasing subjects 
or budget, addition/deletion of investigators, and changes in 
protocol procedures) must be submitted to DCR for approval 
(enclosure (3)) prior to initiation.
5. Sincere best wishes for a successful research project. For 
assistance, please contact the Research Program Administration 
office at 532-8125/36.
d : l . r e e v e s
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University of San Diego
P hil ip  Y. H a h n  Schoo l o f  N ursing
July 18,1998
Sandra Bibb DNSc (c)
Doctoral Student
Philip Y. H ahn School of Nursing 
Dear Sandra:
I have received and reviewed your application to the USD Committee for the 
Protection of Human Subjects for your doctoral dissertation proposal. On July 
17, 1998, I consulted with Dr. Gary Schneider, Chairperson of the Committee 
regarding the status of your application.
Both Dr. Schneider and I concur that your proposal as described is exempt 
from review by the Committee for the Protection of H um an Subjects under 
the guidelines stipulated in  the USD Faculty Handbook. Therefore, you may 
now proceed w ith the conduct of your dissertation.
I wish you success in your research endeavors. Please contact me if your 
require any additional information.
Jane Georges, PhD, RN
Assistant Professor
School of N ursing Representative
Committee for the Protection of Human Subjects
5998 Alcala Park, San Diego, California 92110-2492 619/260-4548 Fax: 619/260-6814
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